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SCOPE OF THE THESIS 
The aim of this thesis is to investigate mammalian DNA interstrand cross-link (ICL) 
repair. ICLs are formed by a number of agents used in tumor therapy, like mitomycin C 
and cisplatin. They constitute one of the most toxic damages to DNA, as they inhibit 
DNA strand separation. However, little is known about the mechanisms of!CL repair. A 
number of DNA repair pathways exist, each involved in the repair of specific types of 
DNA damage that continuously threaten cellular function. An intriguing aspect of ICL 
repair is the involvement of several of these repair pathways, mainly nucleotide excision 
repair, homologous recombination, and postreplication/translesion repair. An overview of 
the involvement of these different repair pathways in ICL repair is given in Chapter 4. 
This chapter also depicts putative models describing the co-operation of these pathways in 
repairing ICLs. 
Next to genes involved in several repair pathways, other genes have been isolated that 
are exclusively involved in ICL repair, such as yeast SNMJ. snml mutant yeast cells are 
sensitive to a number of ICL agents, but they are hardly or not sensitive to other DNA-
damaging agents. As described in Chapter 5, we have investigated the human and mouse 
homologs of Snml. We isolated mouse SNMJ and made embryonic stem cells and mice 
deficient for SNMJ. Both cells and mice are viable and sensitive to mitomycin C. These 
results indicate that mammalian Snm 1 is involved in the cellular response to at least some 
types of!CLs. We also showed that Snml is probably not involved in the homologous 
recombination pathway of ICL repair, as two parameters for homologous recombination, 
the formation of mitomycin C-induced Rad51 foci and sister chromatid exchanges, are not 
affected in SNMJ-deficient mouse cells. 
Therefore, as a second approach to gain insight into ICL repair, we analyzed the 
homologous recombination repair pathway, as discussed in Chapter 1. Homologous 
recombination is one of the main DNA double-strand break (DSB) repair pathways and is 
the pathway used to repair DSBs occurring during ICL repair. Homologous 
recombination uses intact homologous sequences, usually from the sister chromatid or 
homologous chromosome to repair a DSB. It consists of several subpathways, gene 
conversion with or without crossover, single-strand annealing, and in yeast, break-induced 
replication. Key genes involved in homologous recombination are amongst others RADSJ 
and RAD54. RAD54-deficient mouse embryonic stem cells and mice are sensitive to 
mitomycin C. As described in Chapter 2, we investigated the involvement of the different 
subpathways of homologous recombination and the role of RAD54 in mouse embryonic 
stem cells. As it is currently not possible to create cells with a chromosomal site-specific 
ICL to enable the analysis of individual repair events, we decided to create site-specific 
DSBs. We used different recombination-test substrates designed to measure specific 
subpathways of homologous recombination in wild-type and RAD54-deficient cells. 
Single-strand annealing is a major pathway to repair these DSBs. Gene conversion with 
crossover preferentially involves the sister chromatid instead of a homologous sequence 
on the same chromatid. Mutation of RAD54 results in an increase in single-strand 
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annealing and a decrease in gene conversion with or without crossover using the sister 
chromatid. RAD54-deficient cells also have a reduced frequency of mitomycin C-induced 
sister chromatid exchanges, which is the cytological equivalent of gene conversion with 
crossover. These results suggest that Rad54 promotes error-free gene conversion with or 
without crossover using the sister chromatid both during DSB and ICL repair at the 
expense of error-prone single-strand annealing. Finally, we analyzed the cellular 
localization and interactions of mouse Rad54B, a paralog of mouse Rad54, as described in 
Chapter 3. 
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CHAPTERl 
DNA double-strand break repair by homologous recombination 

DNA DOUBLE-STRAND BREAK REPAIR BY HOMOLOGOUS 
RECOMBINATION 
MIES L.G. DRONKERT1, ROLAND KANAAR1•2 
1 Department of Cell Biology and Genetics, Erasmus University Rotterdam, PO Box 1738, 3000 DR 
Rotterdam, The Netherlands 
2 Department of Radiation Oncology, University Hospital Rotterdam/Daniel, The Netherlands 
DNA double-strand breaks (DSBs) can be caused by several endogenous and exogenous 
DNA-damaging agents. Proper repair is needed to protect cells from DSB-promoted 
mutations and chromosomal aberrations, which may contribute to cell death, uncontrolled 
cell proliferation or cellular dysfunction. This overview focuses on homologous 
recombination as a means to repair DSBs. Homologous recombination uses homologous 
sequences elsewhere in the cell to repair a DSB accurately. Key proteins in homologous 
recombination are discussed with respect to their biochemistry, cellular biology, and role 
in different subpathways of homologous recombination. Models for these different 
subpathways, gene conversion, break-induced replication, and single-strand annealing, are 
described. The importance of different subpathways to repair a specific DSB can be 
assessed in specially designed assays. Apparently, the different homologous 
recombination pathways complement and compete with each other. In addition, the 
relationship of homologous recombination with the other major DSB repair pathway, 
nonhomologous end-joining, is also characterized by competition and co-operation. A 
challenging question for future research will be to elucidate how cells regulate these 
pathways to minimize the occurrence of chromosomal aberrations. 
1 INTRODUCTION 
Cell survival depends on the integrity of genetic information contained in DNA. This 
integrity is continuously at risk due to endogenous and exogenous DNA-damaging agents. 
In response, cells have developed a number of DNA repair pathways. These repair 
pathways are specialized in dealing with certain types of damage, but there is a significant 
overlap and co-operation, creating a network of repair pathways. One of the major threats 
to DNA integrity is formed by DNA double-strand breaks (DSBs). Unrepaired DSBs can 
lead to chromosome breaks and loss of chromosomes. Improper repair of DSBs may lead 
to chromosomal aberrations such as translocations, deletions, inversions, amplifications, 
loss of heterozygosity, and ring chromosomes, or to mutations [404]. These events will 
contribute to cell dysfunction, cell death, or tumor formation. 
DSBs can occur accidentally during normal cellular metabolism, due to, for example, 
replication blocks, oxidative damage, and mechanical stress. A DSB can also be formed 
during the repair of other DNA damages, like DNA interstrand cross-links, or excision 
repair of two lesions that lie close together on different strands. Some cell types 
purposely create DSBs to accomplish recombination events. This happens during 
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meiosis, V(D)J recombination, immunoglobulin class switching, somatic hypermutation, 
and, in yeast, during mating-type switching. Exogenous sources of DSBs are ionizing 
radiation and a number of chemicals. To restore genetic integrity after the formation of a 
DSB, the cell has to ligate the proper two ends and, if necessary, supply lost information. 
To accomplish this, most cells contain two main DSB repair pathways: nonhomologous 
end-joining (NHEJ) and homologous recombination. 
This chapter will focus on the repair pathways of homologous recombination. 
Therefore, we will only shortly describe the NHEJ pathways and discuss the relationships 
between NHEJ and homologous recombination. Then, we will discuss the proteins 
involved in homologous recombination and consider in detail the different subpathways of 
homologous recombination and their requirements. Finally, we will describe the assays 
that can be used to assess the importance of different pathways in cellular DSB repair and 
factors that influence the use of these pathways. 
2 NONHOMOLOGOUS END-JOINING VERSUS HOMOLOGOUS 
RECOMBINATION 
NHEJ joins the two DSB ends by direct ligation or with the use of a few homologous 
bases near the ends, referred to as microhomology. NHEJ has no need for extensive 
homologous sequences and therefore is suitable for DSB repair in haploid cells during G I 
phase, when no homologous DNA is present. Homologous recombination makes use of 
homologous sequences, usually from the sister chromatid or the homologous 
chromosome. Thereby, lost information can be replaced and this repair is principally 
error-free. Main pathways of NHEJ and homologous recombination are summarized in 
Figure I. 
Key proteins known to be involved in NHEJ in eukaryotes are Ku70, Ku80, Mre II, 
Rad50, Xrs2/Nbsl, DNA ligase IV, Lifl/Xrcc4, and in vertebrate cells also DNA-PK" 
[232, 294, 302]. The Ku70-Ku80 heterodimer binds to DNA ends, thereby targeting 
DNA-PK" to the ends [563]. The DNA-PK complex, consisting of Ku70, Ku80, and 
DNA-PK", might hold the DSB ends together, prevent end degradation, and 
phosphorylate other proteins involved in repair [19, 90, 291, 292, 581]. Mrell, Rad50, 
and Xrs2/Nbs I form a complex that may function in signaling the presence of the break 
and in processing the DSB [73, 138, 196, 539]. The Xrcc4-ligase IV complex is 
responsible for ligating the ends [90, 115, 188, 211, 522, 568]. The abovementioned 
proteins function in the subpathway of NHEJ that assures precise, direct joining of 
complementary DNA ends (Fig. !AI). This pathway is efficient in both yeast and 
mammalian cells [54, 134, 355, 432]. When the ends cannot be ligated directly, for 
example when they are not complementary, the efficiency of repair in yeast declines, but 
mammalian repair remains efficient, often producing small deletions or insertions using 
the same set of proteins [134, 270, 355, 432, 535]. Independent of these proteins, joining 
of the ends using microhomology can be observed (Fig. IA2) [54, !59, 186, 535]. In this 
pathway, deletion of a few base pairs up to several kb occurs until two to six base pair 
homology is revealed. These base pairs anneal and the nicks are ligated. 
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mology-mediated end-joining. (A2.1) The DSB ends are nucleolytically processed creating either short 3' (as shown) or 5' 
single-stranded DNA (ssDNA) overhangs. Nucleolytic degradation continues until the ssDNA overhangs have two to six 
nucleotides of complementary sequence. Furthermore, microhomology could be exposed by the action of DNA helicases. 
(A2.2) The complementary ssDNA overhangs anneal. (A2.3) Nonhomologous ssDNA ends are removed, remaining gaps are 
filled in by DNA synthesis, and the nicks are ligated. This process can lead to deletions or insertions. 
(B) DSB repair by homologous recombination. The first step in homologous recombination is 5' to 3' nucleolytic degradation of 
the DSB ends, which leads to the formation of long 3' ssDNA tails. (B1) Repair by single-strand annealing. SSA can occur 
when resection has revealed long, complementary stretches of DNA, due to the presence of directly oriented repeats. (81.2) 
The complementary DNA strands anneal. (81.3) Nonhomologous ssDNA tails are removed and the nicks are ligated. (B2) 
Repair by gene conversion. (B2.2) The ssDNA tails search for homologous DNA and either one or both ends invade the 
homologous duplex. The invaded strands start DNA synthesis. (B2.3) When DNA synthesis has reached the other end of the 
DSB, the joint molecule resolves by unwinding (shown here) or Holliday junction resolution. This can lead to gene conversion 
with or without crossover. 
Key proteins in homologous recombination are Rad51, Rad52, Rad54, and their 
homologs/paralogs [253, 386]. Mrel1, Rad50, and Xrs2/Nbs1 are also involved in 
homologous recombination [253, 386]. The first step of homologous recombination 
consists of processing of the DSB ends yielding 3' single-stranded DNA (ssDNA) tails 
[ 494]. The proteins responsible for this processing are not yet known. Exonuclease I and 
the Mre11-Rad50-Xrs2/Nbsl complex may be involved, as mutations in these proteins 
slow DSB processing [227, 494, 534]. When the 3' ssDNA tails are homologous, they 
can anneal onto each other in a process called single-strand annealing (SSA) (Fig. 1B1) 
[307]. Alternatively, in the major models for homologous recombination, one or both 3' 
ssDNA tails invade homologous duplex DNA and initiate DNA synthesis, thereby 
copying information from intact homologous DNA (Fig. 1B2) [160, 507]. After DNA 
synthesis, the newly-synthesized DNA can unwind from the homologous duplex and 
anneal with the other DSB end. Alternatively, a four-stranded DNA structure containing 
Holliday junctions is formed. The Holliday junctions are resolved, resulting in gene 
conversion with or without crossover. Crossovers of sufficient size can be detected 
cytologically as sister chromatid exchanges (SCEs). 
Both NHEJ and homologous recombination can induce genomic rearrangements. 
DSB repair by NHEJ can lead to translocations when several DSBs are present and the 
wrong ends are joined [433]. Furthermore, small insertions or deletions have been found, 
especially when the DSB ends are not complementary [270, 301,355,432, 535]. Repair 
by homologous recombination can also induce translocations, or lead to loss of 
heterozygosity, deletions, inversions, and amplifications [199, 322, 364, 387]. However, 
chromosomal instability and sensitivity to DSB-inducing agents are much higher in cells 
deficient for one of the DSB repair pathways, and increase synergistically when both DSB 
repair pathways are impaired [155, 231, 368, 409, 510, 543]. 
NHEJ and homologous recombination compete with each other in the repair of DSBs. 
The importance of either DSB repair pathway differs per species, cell type, and cell cycle 
phase, as cells apparently try to minimize the risks involved in either pathway [155, 510]. 
Furthermore, they complement each other in the repair of different specialized types of 
DSBs that occur in the cell. V(D)J recombination, for example, is achieved by NHEJ, 
whereas homologous recombination is the main pathway to repair DSBs in DNA 
interstrand cross-link repair (Chapter 4) [146, 187]. Homologous recombination is 
important for the pairing of homologous chromosomes during meiosis, which is necessary 
for proper chromosome segregation during meiosis I [597]. In Saccharomyces cerevisiae, 
homologous recombination is the main DSB repair pathway and effects of NHEJ can 
only be detected when homologous recombination is impaired, for example when no 
homologous DNA is present to repair the break or by genetic ablation of homologous 
recombination [20, 349, 469]. Most DNA inS. cerevisiae is coding DNA and the progeny 
of such a single cell organism needs intact genes without mutations. The choice between 
NHEJ and homologous recombination in yeast mainly depends on the mating-type locus. 
Cells expressing only one mating-type allele, usually haploid cells, are most proficient in 
NHEJ. Cells expressing two mating-type alleles, usually diploid cells, are most proficient 
in homologous recombination [12, 293]. In diploid cells, accurate repair of a DSB by 
homologous recombination is feasible during the whole cell cycle, in contrast to the 
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situation in haploid cells. The mechanism by which mating-type determines the 
preference for a certain repair pathway is not known. Part of it may be a difference in the 
expression of proteins involved in NHEJ versus homologous recombination, or in proteins 
regnlating these pathways [ 103]. 
In mammalian cells, NHEJ is an important DSB repair pathway [302]. Mammalian 
cells might tolerate the inaccuracy of NHEJ better than yeast cells. Much more of the 
mammalian DNA is noncoding, and small mutations are much less likely to have 
devastating effects in somatic, differentiated cells than in germ line cells. Furthermore, 
the presence of many repeats in the mammalian genome increases the risk of homologous 
recombination using ectopic DNA, which can cause translocations, inversions, and 
deletions. Homologous recombination nevertheless plays a major role especially early 
during development, and in the repair of meiotic DSBs, when accurate repair is very 
important [153, 155, 300, 477]. Mutations in some of the genes involved in homologous 
recombination in mammalian cells even lead to cellular or embryonic lethality, due to the 
occurrence of chromosomal abnormalities [527]. 
NHEJ and homologous recombination are not just separate pathways, they can also 
interact. Surprisingly, DSB repair events have been found that combine features of 
homologous recombination and NHEJ [239, 418, 425, 435]. These events apparently start 
with invasion of one DSB end into homologous DNA. When the homologous DNA lies 
on a different chromosome, DNA synthesis may continue into nonhomologous sequences. 
The junction of the newly-synthesized DNA with the other DSB end has to be made by 
NHEJ. Which proteins from the homologous recombination and NHEJ pathways are 
involved in these rare coupled events is not yet clear. 
3 PROTEINS INVOLVED IN HOMOLOGOUS RECOMBINATION 
3.1 RadSl and paralogs 
The eukaryotic Rad51 proteins are homologous to Escherichia coli RecA protein, 
which is the central protein for bacterial homologous recombination. Rad51 is a weak 
ATPase that can bind both ssDNA and double-stranded DNA ( dsDNA), but it prefers 
ssDNA ends of a tailed dsDNA molecule (Table I) [34, 333, 338, 588]. On ssDNA, it 
forms a nucleoprotein filament with one protein molecule per three nucleotides [504]. 
This nucleoprotein filament can perform D-loop formation and DNA strand exchange 
reactions in vitro [26, 501]. In yeast, this reaction is inhibited when the ssDNA-binding 
protein RP A is present before Rad51 is added, due to its higher affinity for ssDNA [ 499, 
503]. However, RPA stimulates Rad51-mediated strand exchange when added after 
Rad51, probably by resolving secondary structures [26, 499, 504]. It may increase the co-
operativity ofRad51, when Rad51 is present in a suboptimal concentration [29, 338]. In 
vivo, Rad51 is thought to be responsible for coating the 3' ssDNA tail and to perform the 
search for homologous DNA and strand invasion during homologous recombination. 
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TABLE 1. Proteins involved in mitotic homologous recombinationa. 
Protein Interacting partners Biochemical activities Functions in 
recombinationb 
Yeast Vertebrate 
Rad51 Rad51 Rad52, Rad54, DNA-dependent ATPase Gene conversion 
RPA, Dmcl Performs DNA strand Y:BIR 
Y: Rad55 exchange V: SCE 
V: Brca2, Blm 
Rad55,57 - Rad51, each other Rad55-Rad57 complex Gene conversion 
stimulates Rad51-
mediated strand exchange 
Rad51B, Rad51, each other Gene conversion 
C,D SCE 
Xrcc2,3 Gene targeting 
Rad52 Rad52 Rad51, RPA Binds DNA ends Y: Gene conversion 
Stimulates annealing of SSA 
complementary ssDNA BIR 
Stimulates Rad51- V: Gene targeting 
mediated strand exchange 
Rad59 Binds DNA ends Plasmid gene conversion 
Stimulates annealing of SSA 
complementary ssDNA BIR 
Rad54 Rad54 Rad51 Induces ATP-dependent Gene conversion 
topological changes into Y: BIR 
dsDNA V: Gene targeting 
Y: stimulates Rad51- SCE 
mediated strand exchange 
Rdh54 Rad51, Dmcl Induces ATP-dependent Gene conversion 
topological changes into BIR 
dsDNA 
Stimulates Rad51-
mediated strand exchange 
Rad54B Rad51 
Mrell Mrell Rad50, Xrs21Nbsl 3' to 5' dsDNA Y: Gene conversion 
exonuclease SSA 
dsDNA endonuclease 
Involved in DSB 
processing 
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TABLE 1 (continued) 
Protein 
Yeast 
Rad50 
Xrs2 
Rad!O,l 
Msh2,3,6 
Mlhl, 
Pmsl 
Vertebrate 
Rad50 
Nbs! 
Erccl,Xpf 
Msh2,3,6 
Mlhl, 
Pmsl 
Interacting partners 
Mrell, Brcal 
Mrell 
V:Atm 
MMR proteins, 
each other 
each other 
Biochemical activities 
Binds dsDNA ATP-
dependent 
Complex removes 3' 
ssDNA tail by 
endonuclease activity 
Recognize base pair 
mismatches and loops 
Brcal Brca2, Rad50, Atm Binds DNA 
Sgsl 
Brca2 Brcal, Rad51 
Atm Nbsl, Brcal 
Blm, Wrn, Sgsl: topo-
RecQL4 isomerase II, III 
Elm: RP A, Rad51, 
topoisomerase Ilia 
Wm:DNA-PK, 
topoisomerase I, 
PCNA,RPA 
Protein kinase 
ATP -dependent 3' to 5' 
DNA helicase 
Functions in 
recombinationb 
Y: Gene conversion 
SSA 
BIR 
Cell cycle checkpoints 
Y: Gene conversion 
SSA 
Gene conversion 
SSA 
only when two nonhomo-
logous tails are present 
V: Gene targeting 
Gene conversion 
SSA 
when internal hetero-
logies or nonhomologous 
tails are present 
Gene conversion 
SSA 
Gene targeting 
Cell cycle checkpoints 
Gene conversion 
Gene targeting 
Cell cycle checkpoints 
Cell cycle checkpoints 
Prevent replication-
associated recombination 
Suppression of 
recombination 
a Some important properties of the proteins mentioned in this chapter and involved in homologous 
recombination are summarized. When data have only been obtained for either the yeast or 
vertebrate homolog this is indicated by the Y and V, respectively. This does not mean that the 
homolog in the other species could not fulfill the same function. 
b Abbreviations: BIR, break-induced replication; SCE, sister chromatid exchange; SSA, single-
strand annealing; V, vertebrate; Y, yeast. 
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Rad51 can be found in damage-induced nuclear foci after exposure to ionizing 
radiation or treatment with DNA interstrand cross-linking agents [194, 513]. In the cell, 
these foci are found at sites of DNA damage and are supposed to be sites of 
recombinational repair of the damage [416, 516]. Rad51 is also involved in the 
recombinational repair of stalled replication forks, as foci are found in cells which are in 
the late Sand G2 phases of the cell cycle [299, 515, 516]. This latter function is probably 
much more important in higher eukaryotes, due to the large size of their genome. This 
could explain the fact that while yeast cells deficient for Rad51 are viable, though very 
sensitive to DSB-inducing agents, vertebrate RAD51 is an essential gene [305, 536]. 
Mutant vertebrate cells accumulate chromosomal breaks before death, probably due to 
disrupted DSB repair of spontaneous damage [ 481]. 
In both yeast and mammalian cells, a meiosis-specific homolog of Rad51 is present, 
called Dmc 1. Both Rad51 and Dmc I are needed for proper homologous recombination 
during meiosis and they colocalize on the synapsed chromosomes [44, 354, 462]. Dmcl 
is one of the proteins that ensure a preference for recombination using the homologous 
chromosome instead of the sister chromatid during meiosis [453]. 
S. cerevisiae contains two other proteins with homology to Rad51, namely Rad55 and 
Rad57. These two proteins form a heterodimer, that can interact with Rad51 [203, 241]. 
They stimulate DNA strand exchange reactions by Rad51, and help to overcome the 
inhibiting effects of RPA [503]. The ionizing radiation sensitivity and recombination 
defect of rad55 and rad57 mutants can be suppressed by overexpressing RAD51 and/or 
RAD52 [203]. 
Vertebrate cells contain five Rad51 paralogs, Rad51B, Rad51C, Rad51D, Xrcc2, and 
Xrcc3 [524]. These paralogs interact with each other and with Rad51 and could be 
involved in stimulating Rad51-mediated DNA strand exchange [60, 142, 310, 451]. 
Chicken cells deficient for any one of these paralogs are viable, but show chromosomal 
instability, sensitivity to ionizing radiation and DNA interstrand cross-linking agents, 
deficient damage-induced Rad51 foci formation, and impaired gene targeting [509, 511]. 
These defects can be partially rescued by overexpressing RAD51. Mice deficient for 
RAD51B, RAD51D, and XRCC2 show embryonic lethality, similar to RAD5J-deficient 
mice [131, 407, 466]. XRCC2 andXRCC3 mutant cells are severely impaired in the repair 
of DSBs by homologous recombination and in the formation of damage-induced Rad51 
nuclear foci [45, 64, 240, 380, 405]. This severe phenotype of mutations in the Rad51 
paralogs, with chromosomal instability and chromosome missegregation, leading to cell 
death, is probably due to an important role for these proteins in homologous 
recombination [116, 191]. The relatively mild sensitivity ofRad51 paralog mutant cells 
to ionizing radiation and their severe sensitivity to DNA interstrand cross-linking agents 
suggests that the Rad5l paralogs are not equally important for the repair of all DSBs [509, 
511]. 
3.2 Rad52 and paralog 
Rad52 is the most important protein in homologous recombination in yeast. rad52 
mutant cells are almost completely deficient in all pathways of homologous 
18 Chapter I 
recombination [386]. Nevertheless, vertebrate RAD52-deficient cells are not sensitive to 
ionizing radiation and have only a mild defect in homologous recombination reactions 
[428, 579]. In mammalian cells, the function of Rad52 in stimulating Rad51-mediated 
strand exchange might have been taken over partially by the Rad51 paralogs [353]. 
Rad52 forms heptameric ring structures that interact with DNA, it binds preferably to 
ssDNA ends and protects the ends against degradation (Table 1) [360, 391,463,490,541, 
542]. The protein catalyzes strand annealing of complementary ssDNA molecules, which 
is stimulated by adding RPA [360, 421, 463, 498]. In vitro, Rad52 interacts with Rad51 
and stimulates Rad51-mediated DNA strand exchange, as it overcomes the inhibition of 
the strand exchange reaction by RPA [33, 141, 350, 375, 461, 463, 502]. Similar to 
Rad51, Rad52 forms damage-induced nuclear foci colocalizing with the RPA and Rad51 
foci [177, 309,312, 313]. 
Yeast contains a sequence homolog ofRad52, called Rad59. Rad59 was identified as 
a protein, needed for Rad51-independent recombination reactions [16, 23]. Similar to 
Rad52, it also binds ssDNA and stimulates annealing of complementary ssDNA 
molecules, but this reaction is not stimulated by RPA [401]. Rad52 is dominant over 
Rad59 as the phenotype of rad59 mutants can be suppressed by overexpression of RAD52, 
but not the other way around [ 16]. 
3.3 Rad54 and paralogs 
Rad54 is a member of the Swi2/Snf2 family of proteins that contain helicase motifs. 
Some of these proteins are involved in chromatin remodeling reactions [395]. Rad54 has 
a strong dsDNA-dependent ATPase activity, but no helicase activity has been identified 
[ 400, 505]. Rad54 interacts with Rad51 and, in S. cerevisiae, can stimulate Rad51-
mediated DNA strand exchange [102, 185,235,332,400,403,479, 546]. In vitro, Rad54 
can induce topological changes in DNA, introducing supercoiled regions in a nicked 
plasmid in an ATP-dependent way [430, 513, 546]. This reaction is stimulated by the 
presence of a Rad51 nucleoprotein filament [332]. Rad54 could translocate along the 
DNA, and it could facilitate partial unwinding of the DNA by causing local increases in 
supercoiled helix density, when rotation around the DNA during translocation is 
prevented, for example by its binding to the Rad51 nucleoprotein filament [430, 480]. 
This partial unwinding could facilitate the search for homologous duplex DNA and the 
strand invasion reaction of the Rad51 nucleoprotein filament by making the DNA more 
accessible. Consistent with this, Rad54 is found in the nucleus and forms damage-
induced foci, that colocalize with Rad51 foci [513]. Rad51 foci formation, however, is 
not dependent on the presence of Rad54 [509]. In contrast to RAD51, RAD54-deficient 
chicken and mouse cells are viable, though they are ionizing radiation sensitive and 
defective in homologous recombination (Chapter 2) [40, 144, 154]. 
Both in yeast and in mammalian cells, a homolog of Rad54 is found. The yeast 
homolog, called Rdh4 or Tid!, has similar biochemical properties as Rad54 [264, 402, 
465]. It can introduce unconstrained positive and negative supercoils in a plasmid in an 
ATP-dependent way. Rdh54 interacts with Rad51 and Dmcl and stimulates Rad51-
mediated D-loop formation [143, 402]. The functions of Rdh54 and Rad54 in yeast 
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partially overlap, with Rad54 being more important for recombination in mitosis, using 
the sister chromatid as a template, and Rdh54 being more important in meiosis, using the 
homologous chromosome as a template for homologous recombination [10, 46, 264, 452, 
464, 465]. The mammalian homolog of Rad54, called Rad54B, is most homologous to 
the mammalian Rad54, and is not a clear homolog of Rdh54 [212]. Rad54B is a nuclear 
protein that shows homomeric interaction and can interact with Rad51 (Chapter 3) [514]. 
The homology of Rad54B with Rad54 suggests that it could also induce topological 
changes into the DNA to facilitate Dmcl- and/or Rad51-mediated strand exchange. 
3.4 Mrell, RadSO, and Xrs2/Nbsl 
Mrell, Rad50, and Xrs2 form a stable complex in yeast cells [245, 378]. In 
mammalian cells, no obvious sequence homolog of Xrs2 has been detected, with instead 
Nbs 1 taking its place [73, 138]. The complex formed by Mre 11, Rad50, and Xrs2/Nbs 1 is 
involved in NHEJ, homologous recombination, and telomere maintenance [55, 65, 295]. 
During meiosis, the complex is needed for DSB formation and processing [225, 500]. In 
mitotic recombination, the processing of DSB ends is slowed down in mutant cells, but 
recombination products can be formed [227, 533]. Nbs! functions both in DSB repair and 
in DNA damage signaling to activate cell cycle checkpoints [73, 179, 183]. 
Mre II is a DNA binding protein that can stimulate annealing of complementary 
ssDNA molecules [125]. In vitro, both Mrell by itself and the whole complex display 
Mn2+-dependent 3' to 5' dsDNA exonuclease and endonuclease activities [393, 394, 532]. 
However, nuclease-negative Mre 11 mutants are not significantly impaired in NHEJ, 
mitotic recombination, or telomere maintenance [356]. Nbsl is needed for translocation 
of the Mrell-Rad50 complex to the nucleus and phosphorylation of Mrell upon DNA 
damage [73, 135, 139]. After treatment with ionizing radiation, the complex can be found 
in foci at the position of DNA damage [328, 371]. Usually, cells show either foci 
containing Rad51 or foci containing Mrell-Rad50-Nbsl. Mutations in the MREI I gene 
have been found in patients with ataxia telangiectasia-like disorder (ATLD) and mutations 
in NBS! in patients with Nijmegen breakage syndrome (NBS) [73, 492]. Cells from 
patients with these diseases are sensitive to DSB-inducing agents and show radio-resistant 
DNA synthesis [269]. MRE!l, RAD50, and NBS! null mutations in mice result in 
inviable cells or embryonic lethality, indicating their importance in cellular metabolism 
[318, 577, 596]. 
3.5 Radl!Xpf and Rad!O/Erccl 
The yeast Radl-Rad!O heterodimer and its mammalian homolog Xpf-Erccl are 
primarily known for their role as endonuclease in nucleotide excision repair [169, 473]. 
In nucleotide excision repair, Radl-Radl 0/Ercc 1-Xpf is responsible for the incision of the 
damaged DNA strand at the 5' side of the lesion. The complex incises dsDNA near the 
dsDNA-ssDNA transition when a 3' ssDNA tail is present [18, 126]. In homologous 
recombination the complex is needed to remove nonhomologous ssDNA tails during SSA 
and gene conversion reactions, when the tails are longer than 30 nucleotides [1, 18, 223, 
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385, 448]. Additionally, in mouse cells Erccl-Xpf is essential for gene targeting, even 
when no nonhomologous ssDNA tails are present. The complex could make incisions at 
the border of the homologous and nonhomologous DNA in the heteroduplex intermediate, 
thereby facilitating integration of the targeting DNA (L.J. Niedemhofer, personal 
communication). 
3.6 Mismatch repair proteins 
Mismatch repair (MMR) proteins, like Msh2, Msh3, Msh6, Mlhl, and Pmsl, function 
in the recognition and repair of base pair mismatches and loops that occur due to 
replication errors [9]. However, they also have several roles in homologous 
recombination that are not always directly correlated to mismatches. First of all, MMR 
proteins impair homologous recombination and reduce the frequency of crossovers, when 
recombination occurs between sequences that are not completely homologous, but show 
heterologies [121, 122, 149, 457]. In this way, they inhibit ectopic recombination 
between similar, repeated sequences at different positions in the genome and prevent 
translocations. Secondly, the MMR proteins are needed for the correction of heteroduplex 
DNA that is formed during strand invasion and branch migration reactions in homologous 
recombination [149, 562]. They also limit the length of gene conversion tracts when 
heterologies are present [93, 94]. Thirdly, Msh2 and Msh3 work together with Radl-
RadlO/Erccl-Xpf in the removal of nonhomologous ssDNA tails during SSA and gene 
conversion reactions [385, 446, 497]. 
3. 7 Other proteins involved in homologous recombination 
A number of other proteins are needed for the reactions during homologous 
recombination. It is not yet quite clear which nuclease( s) are responsible for the resection 
of the DSB ends, resulting in 3' ssDNA tails, although the Mre l I complex is known to be 
involved in processing the ends. Later in the reaction, many proteins required for DNA 
replication, like leading and lagging strand DNA polymerases, are needed for DNA 
synthesis [21 7]. A complex that could perform branch migration and Holliday junction 
resolution has been isolated, but its components are not yet known [109]. Apart from 
these proteins directly involved in enzymatic reactions during homologous recombination, 
other proteins will be involved in the regulation of homologous recombination reactions. 
A number of human diseases are associated with defects in (the regulation of) 
homologous recombination. A common feature of these diseases is chromosomal 
instability resulting in an increased risk of cancer. We will discuss some of the proteins 
involved and indicate how mutations could lead to defects in homologous recombination. 
Brcal and Brca2 are associated with familiar breast and ovarian cancer [456, 592]. Null 
mutations are cellular lethal, due to spontaneous chromosomal instability [456]. Both 
proteins have been shown to be required for homologous recombination after the 
induction of a DSB [362, 365, 478]. Brcal interacts with the Mreii-Rad50-Nbsl 
complex, and can be found both in damage-induced Mrel I and Rad5l foci [89, 455, 593]. 
Brca2 interacts with Rad51 and is needed for the induction of Rad51 foci, with which it 
Homologous recombination 21 
colocalizes [87, 89,327,571, 587]. The two Brca proteins can also be found in the same 
foci [88]. Similar to Nbs!, they are not only supposed to be involved in DSB repair but 
also in cell cycle checkpoints [87, 326, 592]. Upon treatment of cells with ionizing 
radiation, both Brcal and Nbs! are phosphorylated by Atm, which is involved in the 
disease ataxia telangiectasia (AT) and which is one of the proteins that play a crucial role 
in damage-induced cell cycle checkpoints [ 112, 178, 179, 257, 306, 346]. Cells from AT 
patients are radiosensitive and show radio-resistant DNA synthesis, similar to NBS and 
ATLD patient cells [347]. All these proteins could have a role in coupling DSB repair to 
the DNA damage response and cell cycle checkpoints. 
A quite different type of defect in homologous recombination is seen in cells from 
patients with Bloom's syndrome, Werner's syndrome, and Rothmund-Thomson syndrome 
[168, 256]. These diseases are caused by a mutation in one of the human homologs of E. 
coli RECQ helicase, BLM, WRN, and RECQL4, respectively [151, 260, 585]. Cells from 
Bloom's, Werner's, and Rothmund-Thomson syndrome patients show chromosomal 
instability and the patients have a highly increased risk of tumor formation [168, 170, 180, 
256, 308, 547]. BLM mutant cells are characterized by hyperrecombination and an 
increased number of SCEs and ELM-deficient mice show an increased tumor frequency 
[180, 317]. WRN mutant cells are characterized by an increase in translocations and 
deletions [170]. Cells mutant for BLM, WRN, or SCSI, the S. cerevisiae RECQ homolog, 
are specifically sensitive for perturbations of replication by S phase-specific damaging 
agents and have abnormal replication intermediates [84]. Interactions have been found 
between Blm and Rad51, RPA, and topoisomerase lila, and between Wrn and 
topoisomerase I, PCNA, DNA-PK, and RPA [66, 110, Ill, 290,296,460,487, 572, 573, 
584]. Both Blm and Wm form foci that partially colocalize with Rad51 and RPA foci 
when DSBs have been induced [43, 443]. The RecQ helicases are ATP-dependent 3' to 5' 
helicases that can unwind both duplex DNA, forked DNA structures and synthetic 
Holliday junctions [84, 256]. They are supposed to play a role in resolving abnormal 
replication structures, like those occurring when replication stalls or when replication 
forks meet each other. Thereby, they could prevent the occurrence of DSBs during 
replication. Mutations in these genes would then lead to increased homologous 
recombination due to DSB formation during replication, which would result in increased 
frequencies of SCEs, translocations, and deletions. Furthermore, the RecQ helicases 
could have a role during recombination, like E. coli RecQ, in promoting joint molecule 
formation or in resolving joint molecules by branch migration [200, 201]. 
4 PATHWAYS OF HOMOLOGOUS RECOMBINATION 
4.1 Gene conversion with or without crossover 
Gene conversion constitutes the major fom1 of DSB repair by homologous 
recombination in meiosis and is also very important during mitosis. It consists of the 
transfer of genetic information from intact homologous sequences to the region containing 
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the DSB. The extent of information transfer, the length of the gene conversion tract, can 
vary from a few base pairs up to hundreds of kilobases [98, 150, 372, 506, 562]. In 
meiosis, up to 50 % of gene conversions can be associated -with crossover [52). During 
mitotic chromosomal gene conversion reactions, a lower percentage of crossovers is 
observed, with hardly any crossovers during mating-type switching in yeast [261, 278, 
364, 437]. Up to now, two different models for gene conversion have been described, 
with experimental evidence present for both of them. One is the modified DSB gap repair 
model, the other is synthesis-dependent strand annealing (SDSA) [31, 160, 370, 507]. 
These models are not mutually exclusive and events may occur in which parts of both 
models can be recognized. 
In both models, the first step consists of nucleolytic processing of the 5' ends of the 
DSB, resulting in the formation of 3' ssDNA tails, that can be more than 1 kb in length 
(Fig. 2Al, Bl) [494, 564]. Nucleolytic processing is retarded in MREII group mutants, 
while RAD51, RAD52, and RAD54 mutants show excessive nucleolytic processing [226, 
292, 496]. The original DSB gap repair model assumed that the 3' ends were also 
partially degraded, resulting in a gap that would be filled in during DNA synthesis, and 
therefore resulted in the gene conversion event. Nowadays, it is known that the 3' ends 
are not degraded, but that gene conversion of markers around the DSB that differ with the 
template sequence is due to mismatch repair of the heteroduplex DNA that is formed 
during the next step in the repair, strand invasion [297, 562]. 
In the DSB gap repair model, the 3' ssDNA tails search the genome for homologous 
sequences and invade the homologous duplex DNA, forming a joint molecule (Fig. 2A2). 
When the homology does not extend to the end of the 3' tail, the nonhomologous end is 
cut off. In this process, Radl-RadlO/Erccl-Xpf, Msh2, Msh3, and Rad59 are involved 
[385, 495, 497]. DNA synthesis starts from the 3' ssDNA ends and continues until the 
other end of the DSB is reached. As a result, a four-stranded intermediate is formed with 
two so-called Holliday junctions connecting the strands (Fig. 2A3). The Holliday 
junctions can branch migrate, thereby creating new regions ofheteroduplex DNA that can 
elongate the gene conversion tract after mismatch repair of diverged markers directed to 
restore the sequence of the intact molecule (Fig. 2A4). Mismatch repair can also convert 
the heteroduplex DNA to the sequence of the broken molecule. Surprisingly, the intact 
molecule usually remains unchanged, while the broken molecule undergoes a varying 
extent of mismatch repair leading to gene conversion [387]. Finally, the Holliday 
junctions are resolved, resulting in two intact duplexes (Fig. 2A5). DNA synthesis in this 
model is semi-conservative, as both the broken molecule and the intact homolog contain 
one newly-synthesized DNA strand. Resolution of the Holliday junctions can occur in 
two directions, horizontal or vertical (indicated by the arrows a and b in Figure 2A4). 
When both junctions are resolved in the same direction, gene conversion without 
crossover results (Fig. 2A5a), when they are resolved in different directions, the gene 
conversion is associated with a crossover (Fig. 2A5b ). Theoretically therefore, 50% of the 
gene conversion reactions should also yield a crossover, unless some bias in the direction 
of resolution occurs. There are some indications that bias does exist, but the low 
percentage of crossovers can more easily be explained by the SDSA model for gene 
conversion [167, 182]. 
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In the SDSA model, similar to the DSB gap repair model, the 3' ssDNA tails formed 
during nucleolytic processing of the DSB search for homologous sequences. In this 
model, either one or both 3' ssDNA tails invade homologous DNA (Fig. 2B2). After 
DNA strand invasion, the 3' ssDNA end is elongated by DNA synthesis (Fig. 2B3). The 
invading DNA is unwound from the intact homologous duplex either during DNA 
synthesis, leading to a migrating D-loop (as depicted in Figure 2B3), or after DNA 
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synthesis. Once DNA synthesis has resulted in overlap between the DNA sequences of 
both ends, the invading DNA unwinds completely from the homologous template (Fig. 
284). When both DS8 ends have invaded homologous DNA, the unwound newly-
synthesized DNA of one end anneals with the newly-synthesized DNA of the other end. 
When only one DS8 end has invaded homologous DNA, its newly-synthesized DNA 
anneals with the 3' ssDNA tail of the other DS8 end (Fig. 284). ssDNA gaps that 
eventually remain are filled in by further DNA synthesis and the ends are ligated (Fig. 
285). The homologous DNA remains unchanged and all newly-synthesized DNA is 
present in the DNA molecule that was broken. This conservative DNA synthesis contrasts 
with the semi-conservative DNA synthesis of the DS8 gap repair model. 
The occurrence of contractions and expansions during DSB repair in tandem repeats 
can be understood with the SDSA model [387, 388, 423]. The model also accounts for 
the fact that the DS8 ends can use different homologous sequences as a template for DNA 
synthesis [387]. Finally, it explains the DS8 repair events that occur when homologous 
sequences are only present on one side of the DSB, when one DSB end invades 
homologous DNA, while the other end is joined by NHEJ [424, 425]. This simple SDSA 
FIG. 2. Pathways for DSB repair via gene conversion. The black and white DNA duplexes 
represent sister chromatids, homologous chromosomes, or ectopic homologous 
sequences. Newly-synthesized DNA is indicated in gray. 
(A) Gene conversion according to the DSB gap repair model. (A 1) The DSB ends are 
nucleoly1ically processed yielding long 3' ssDNA tails. (A2) Both DNA ends invade 
homologous duplex DNA, forming a joint molecule. DNA synthesis starts from the ends. 
(A3) When DNA synthesis reaches the other ends of the DSB, two Holliday junctions are 
formed. (A4) The Holliday junctions can branch migrate in either direction, creating 
heteroduplex DNA. (A5) The Holliday junctions are resolved by making two nicks, either 
horizontally (a), or vertically (b), leading to the formation of two intact duplex DNA 
molecules. Two horizontal or two vertical incisions result in gene conversion without 
crossover (a), one horizontal and one vertical incision result in gene conversion with 
crossover (b). 
(B) Gene conversion according to the synthesis-dependent strand annealing model. (B1) 
The DSB ends are nucleoly1ically processed yielding long 3' ssDNA tails. (B2) Either one 
(depicted here) or both DNA ends invade homologous duplex DNA, forming a joint 
molecule. (83) The invading end is elongated by DNA synthesis, probably leading and 
lagging strand DNA synthesis by a modified replication fork. Unwinding may occur after 
DNA synthesis, or during DNA synthesis, resulting in a migrating D-loop. (84) When DNA 
synthesis has reached the other end of the DSB, the invading DNA unwinds from the 
homologous duplex and anneals with the other end of the DSB. (85) Remaining gaps are 
filled in by DNA synthesis, and the nicks are ligated. Crossover recombinant products are 
not generated by this pathway. 
(C) Adaptation of the SDSA model for DSB repair to account for the occurrence of 
crossovers. (C1-C3) See (81-83). (C4) The other end of the DSB becomes engaged in 
the reaction by annealing to the displaced strand of the homologous duplex. As a result, 
two Holliday junctions are formed. Branch migration may take place. (C5) The Holliday 
junctions can be resolved horizontally or vertically, like in (A5) and result in gene 
conversion without crossover (a) or qene conversion with crossover (b). 
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model, however, does not account for the occurrence of crossovers. Crossovers can be 
explained when elements of the SDSA model are combined with elements from the DSB 
gap repair model (Fig. 2C) [160]. One way of obtaining crossovers is the following. One 
DSB end primarily invades the homologous duplex DNA and starts DNA synthesis, for 
example via a migrating D-loop (Fig. 2C2, 3). Then the other DSB end anneals to the 
displaced strand of the homologous DNA and two Holliday junctions are formed (Fig. 
2C4). Resolution of the Holliday junctions can lead to crossover events (Fig. 2C5). 
DSB repair via gene conversion in yeast strongly requires the presence of Rad52 
(Table 1) [226, 324, 496]. During mitotic chromosomal gene conversion, Rad51, Rad54, 
Rad55, and Rad57 also play an important role, whereas for gene conversion reactions in 
plasmids, these proteins are much less important [226, 322, 471, 496]. The difference is 
probably due to the chromatin structure which complicates strand invasion in 
chromosomal sequences. DNA unwinding is much easier in plasmid DNA, and the 
activity of Rad52 in stimulating annealing might be sufficient to result in strand invasion 
of the 3' ssDNA tail. Rad59 is also important for Rad51-independent plasmid DSB 
repair, especially when the homology length is limited and nonhomologous tails are 
present [16, 23, 495]. rad59 mutants are, however, hardly impaired in chromosomal DSB 
repair by heteroallelic gene conversion [471]. 
In vertebrate cells, as far as the different mutants have been tested, DSB repair by 
gene conversion is reduced in BRCAJ, BRCA2, XRCC2, XRCC3, and RAD54 mutant cells 
and in cells expressing dominant negative alleles of RAD51 (Table 1) (Chapter 2) [40, 64, 
144, 240, 280, 362, 365, 405]. Gene targeting is affected in BRCAJ, BRCA2, RAD52, 
RAD54, and RAD51 paralog mutant cells, while ELM mutant cells show increased gene 
targeting frequencies [40, 154, 317, 362, 365, 478, 509, 511, 555]. 
4.2 Break-induced replication 
In S. cerevisiae, an alternative form of homologous recombination is break-induced 
replication (BIR) [39, 53, 322, 359, 550]. In mammalian cells, direct evidence for the 
presence of BIR in DSB repair has not been obtained [425]. In wild-type yeast, BIR 
mainly occurs when the telomere-proximal part of the broken chromosome is lost, thereby 
preventing the occurrence of gene conversion. During BIR, the centromere-proximal end 
of a DSB is processed to a 3' ssDNA tail and invades homologous dsDNA (Fig. 3.1, 2). 
The one-ended invasion leads to DNA synthesis to the end of the chromosome, thereby 
producing a nonreciprocal translocation event (Fig. 3.3) [322]. The Holliday junction 
formed can either be resolved directly, resulting in semi-conservative DNA synthesis (Fig. 
3.4), or by branch migration to the end of the chromosome, resulting in conservative DNA 
synthesis. A telomere-proximal part of a broken chromosome cannot induce a BIR event, 
as DNA repair synthesis cannot pass the centromere. 
BIR ensures that a broken chromosome that cannot rejoin with its telomere-proximal 
end, gains a new telomere to prevent chromosomal degradation. A chromosome that has 
lost its telomere can obtain a new telomere by recombination in two ways, suggesting that 
there are two subpathways ofBIR [92, 289, 521]. One way involves recombination with 
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FIG. 3. Pathways for DSB repair via break-induced 
replication. The black and white DNA duplexes 
represent sister chromatids, homologous chromo-
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ends are nucleolytically processed yielding long 3' 
ssDNA tails. (2) The centromere-proximal DNA end 
invades homologous duplex DNA, forming a joint 
molecule. (3) A replication fork is set up, for leading 
and lagging strand DNA synthesis to the end of the 
chromosome. The centromere-distal part of the 
chromosome is lost. (4) The Holliday junction formed 
by strand invasion is resolved by branch migration to 
the end of the chromosome or by vertical or horizontal 
incisions (as depicted here). 
the long, homologous Y elements that lie proximal of the telomeres. This pathway is 
dependent on Rad52, Rad51, Rad54, and Rad57, like most gene conversion events. 
Alternatively, recombination occurs within the telomeric TG repeat tracts and depends on 
Rad52, Rad59, and Rad50 [92, 520]. Rdh54 also plays a minor role in BIR, partially 
redundant with the role ofRad54 [471]. 
In wild-type yeast cells, BIR is a rare event for the repair of a DSB, due to the 
efficient gene conversion process [322, 471]. In rad51 and rad54 mutant cells, that 
cannot perform gene conversion, BIR is found more often [322, 471]. The required strand 
invasion could then be performed by Rad52, but only at special sites on the cbromosome 
[323, 471]. When homologous sequences are present only for the centromere-proximal 
Homologous recombination 27 
part of the DSB, and normal gene conversion therefore is impossible, the DSB is repaired 
by BIR in about 70% of wild-type cells, which is completely Rad52 dependent [53]. 
4.3 Single-strand annealing 
One of the simplest ways of homologous recombination is SSA [307]. SSA can only 
occur between two stretches of directly oriented homologous DNA sequences and causes 
deletion of one of the repeats and the sequence in between the repeats. The minimal 
length of homology to allow for SSA in a plasmid containing a DSB is around 30 bp in 
yeast, but SSA is much more efficient when at least 200 bp are homologous [163, 423, 
494, 495]. A biologically relevant role of SSA could be resolving recombination 
intermediates in the repair of DNA interstrand cross-links (Chapter 4) [146]. DSB repair 
by recombination between repeated sequences, like the Alu repeats in mammalian cells, 
could also occur by SSA. However, similar to gene conversion, SSA is inhibited when 
the two repeated DNA sequences are not completely homologous, which reduces the 
inappropriate use of SSA [ 497]. In recombination assays, directly repeated DNA 
sequences are used frequently to test homologous recombination pathways, conditions, 
and genes involved, which makes SSA an important pathway in these assays. 
The first step of DSB repair in SSA is nucleolytic processing of the DSB ends 
yielding 3' ssDNA tails (Fig. IBI) [164]. Once resection has uncovered complementary 
sequences on both DSB ends, these sequences anneal (Fig. IB1.2). Rad52 and Rad59 
could be involved in this annealing step [360, 401, 495]. Annealing does not necessarily 
occur with the other end of the DSB. Haber and Leung induced two DSBs in different 
chromosomes in yeast, that could be repaired by two intrachromosomal or two 
interchromosomal SSA events [199]. Both events were equally frequent, suggesting that 
the DSB ends search the whole genome for homology. Nonhomologous sequences 
present at the end of the ssDNA are removed and the nicks are ligated (Fig. IB 1.3). In 
yeast, the removal of the nonhomologous tails could be performed by Polymerase 8, when 
the tails are shorter than 30 bp [385]. Longer tails are usually removed by Radl-Rad!O 
[163, 385, 411]. SSA between homologous sequences shorter than I kb is also dependent 
on Msh2 and Msh3 when long nonhomologous tails are present [ 446, 497]. The MMR 
proteins probably stabilize the annealed sequence and thereby enable Radl-Rad!O to 
cleave the tails. An increasing distance between the repeated DNA sequences slows the 
rate of SSA, probably due to rate-limiting resection of the DSB ends needed to expose the 
complementary DNA [164, 411]. Nevertheless, SSA can occur efficiently between 
repeated DNA sequences that are 15 kb apart [437]. 
Alternative events can give rise to the same genotypic outcome, consisting of the 
deletion of intervening sequences between directly oriented repeats. One of the 
alternatives is intrachromatid gene conversion with cross-over (Fig. 5A2). This event 
yields a circular DNA containing the deleted sequence as a second product. As this 
second product is either not found or found in a low frequency, intrachromatid gene 
conversion with cross-over is not very frequent compared to SSA [164, 172, 280, 420]. 
Other alternative events are unequal sister chromatid gene conversion with crossover (Fig. 
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5A3), or unequal sister chromatid gene conversion with deletion of the intervening 
sequences [2, 11, 411]. 
SSA in yeast depends on Rad52, but much less than gene conversion (Table 1) [263, 
377, 383, 495]. For SSA events, RAD52 is synergistic with RADJ, indicating the presence 
ofRad52-independent, Radl-dependent SSA events [450, 526]. Rad59 seems to function 
in the Radl-dependent SSA pathway and is possibly involved in annealing the ssDNA and 
stabilizing the intermediate for tail removal, independent of the MMR proteins [228, 495]. 
Mutations in the MREJJ group genes cause mainly a delay but hardly a reduction in 
product formation during SSA, probably due to slower processing of the DSB ends [226, 
494]. Rad51, Rad54, Rad55, and Rad57 are not needed for SSA [226]. On the contrary, 
RAD51- and RAD54-deficient cells show an increase in SSA events, probably due to the 
impairment of gene conversion in these cells (Chapter 2) [144, 226, 280, 465]. 
5 DSB REP AIR ASSAYS 
DSB repair assays are often based on the presence of two homologous, repeated 
sequences on plasmids or in chromosomes. The two repeats can be placed in direct or 
inverse order on the same molecule allowing measurement of intrachromatid and sister 
chromatid recombination (Fig. 4a, b, c). Alternatively, when present on homologous 
chromosomes, they measure heteroallelic recombination (Fig. 4d). Ectopic recombination 
can be assessed when they are placed on nonhomologous chromosomes (Fig. 4e ). A 
plasmid containing a DSB that recombines with chromosomal homologous DNA yields a 
gene targeting event. 
FIG. 4. Types of homologous recombination, defined by the position of the homologous 
sequence used to repair the DSB. The thick arrows represent repeated sequences. A 
white block in the arrow represents a restriction site where a DSB can be induced. 
Centromeres are indicated by circles. The chromosome shown at the top is homologous to 
the chromosome in the middle. Only for the chromosome in the middle both sister 
chromatids are indicated. The chromosome at the bottom is nonhomologous. (a) 
lntrachromatid recombination, (b) equal sister chromatid recombination, (c) unequal sister 
chromatid recombination, (d) heteroallelic recombination, (e) ectopic recombination. a, b, 
and c together constitute intrachromosomal recombination. 
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Usually, one of the repeats contains a recognition site for a restriction enzyme, that 
cuts only rarely elsewhere in the genome. In yeast, the HO-endonuclease is used most 
often [386]. The endogenous function of HO-endonuclease is creating a DSB in one of 
the mating-type loci of S. cerevisiae, causing gene conversion leading to mating-type 
switching [ 197]. The HO-endonuclease is often integrated into the yeast genome, placed 
behind a galactose-inducible promoter. When the cells are grown in the presence of 
galactose, expression of the HO-endonuclease leads to DSBs in more than 90% of the 
cells [564]. In mammalian cells, other rare cutting enzymes like !-See! and Pacl are used 
[230]. Usually, the restriction enzyme, or a plasmid that can express the enzyme, is 
transfected transiently into the cells. Transfection efficiency is far below 100%, the 
enzyme is not always expressed efficiently, and it does not always find its recognition site. 
The percentage of cells getting a DSB may therefore be only about 1%, depending on the 
cell type and the transfection procedure [426]. 
The DSB can be repaired by direct ligation of the ends by NHEJ, which recreates the 
restriction site [293]. The result is indistinguishable from the original, noncut DNA and 
the restriction site can be cut again. On continuous expression of the restriction enzyme, 
the site is removed by imprecise NHEJ resulting in deletion or insertion of one or more 
base pairs [293]. Homologous recombination in the G2 phase of the cell cycle using the 
same repeat on the sister chromatid will lead to a gene conversion event that recreates the 
restriction site and cutting can be repeated (Fig. 4b). Homologous recombination using a 
repeat that does not have the restriction site leads to a gene conversion event removing the 
site (Fig. 4a, c, d, e). A joint molecule that is formed between the invading DNA and the 
intact donor DNA, can be resolved in two ways. One leads to recovery of the original 
molecules, with a gene conversion at the position of the DSB (Fig. 2A5a), the other leads 
to crossover, with a reciprocal translocation between the two molecules (Fig. 2A5b). 
The design of the DSB repair assay determines which events can be recovered. After 
introduction and repair of the DSB, the whole population of cells can be analyzed by PCR 
or DNA blot analysis [239]. However, usually a selection procedure is used to prevent the 
recovery of uncut molecules and often it also prevents recovery of NHEJ events. By 
using selection markers, the frequencies of different events can be determined without the 
need for sequencing all recombined molecules. The positioning of the repeats and the 
selection procedures used determine which homologous recombination pathways are 
feasible for the cell, and which pathways yield a selectable event (Fig. 5). It should be 
kept in mind that the frequencies of different events measured do not always represent the 
frequencies of those events in normal DSB repair. For example, only unequal sister 
chromatid recombination can be assessed, while in normal DSB repair, this will be a 
relatively rare event, compared to equal sister chromatid recombination. 
The introduction of heterologies between repeats enables a determination of the 
amount of DNA that is transferred from the intact to the broken repeat, the gene 
conversion tract length. It has been shown, however, that the differences between the 
repeats change the use of different homologous recombination pathways and the length of 
gene conversion tracts. Nevertheless, in this way it has been determined that gene 
conversion tracts usually are short, smaller than I 00 bp, depending on the type of assay 
and the cell type used [98, !50, 372, 506, 562]. Very long tracts have also been found 
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[364]. These long tract gene conversion events cannot readily be distinguisted from 
crossover events, when the restriction site used to distinguish gene conversion from 
crossover on a DNA blot is positioned relatively close to the DSB [239]. Although the 
DSB repair assays using reporter genes have been highly informative, all the artificial 
aspects of these assays should be borne in mind when interpreting their results. 
A totally different kind of assay to measure the efficiency of homologous 
recombination in DSB repair is the observation of SCEs. SCEs occur mainly due to gene 
conversion events that are accompanied by crossovers [ 482]. A low level of SCEs can 
already be found without any treatment of the cells, as a result of repair of spontaneously 
occurring damage. The frequency of SCEs increases by DNA-damaging treatments, like 
UV, DSB-inducing agents, and DNA interstrand cross-linking agents. Cells deficient in 
genes involved in gene conversion, show a lower frequency of SCEs (Chapter 2) [144, 
509, 511]. The advantage of the measurement of SCEs is that no artificial sequences 
possibly influencing the frequency of different DSB repair processes have to be 
introduced into the cells. The disadvantage is that only gene conversion events associated 
with crossovers large enough to be cytologically detected can be measured and no 
knowledge concerning other DSB repair pathways is obtained. 
6 THE CHOICE BETWEEN HOMOLOGOUS RECOMBINATION 
PATHWAYS 
All homologous recombination repair pathways for DSBs start by nucleolytic 
processing of the ends, resulting in 3' ssDNA tails. These tails search the genome to find 
a homologous sequence. This sequence can be found at the other end of the DSB on the 
same chromatid, on the sister chromatid, the homologous chromosome, or a heterologous 
chromosome. The choice for the recombination partner is influenced by a number of 
factors. Important factors are homology length, sequence divergence, cell type, cell cycle 
phase, the chance of finding the homologous sequence, and the presence of proteins that 
regulate recombination, like the MMR proteins [219]. In meiosis, there is a preference to 
use the homologous chromosome. This preference is dependent on a number of proteins 
including the recombination proteins Dmcl and Rdh54 [10, 46, 453]. In mitosis, most 
gene conversion reactions in G2 phase take place using the sister chromatid, due to the 
perfect, long homology between sister chromatids and to sister chromatid cohesion [239, 
250, 352]. In Gl, in mammalian cells, the homologous chromosome is preferred above 
ectopic homologous sequences [426]. Factors influencing this frequency could be 
frequent, transient interactions between homologous chromosomes, as has been found in 
yeast, and the fact that centromeres tend to cluster, increasing the chance to find the 
homologous sequence on the homologous chromosome [69, 70]. Furthermore, the length 
of homology shared with the homologous chromosome is larger than the homology shared 
with heterologous chromosomes. During gene conversion reactions using a heterologous 
chromosome, the gene conversion tract length is shorter than using the homologous 
chromosome, and the frequency of crossovers is reduced [220, 364, 426]. 
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FIG. 5. Outcomes of homologous recombination repair of a DSB in substrates containing 
intrachromosomal repeats. Different positions of the repeat enable the distinction of 
different recombination repair pathways by selection markers. Centromeres are indicated 
by circles, the selection markers are indicated by arrows. Sister chromatids are indicated 
by the brackets. 
S1, selection marker that contains a restriction site, shown as a small black box, that can 
be cut resulting in a DSB, shown as a gap in the arrow. ~5'81, selection marker S1 
containing a deletion of the 5' end. ~5'~3'81, selection marker S1 containing a deletion of 
the 5' end and the 3' end. S2, second selection marker. 
(A) Outcomes of homologous recombination repair of a DSB in S1 in a directly oriented 
repeat substrate. (1) Gene conversion without crossover, using ~5'81 on the same or the 
sister chromatid as the donor for repair results in intact S1 and S2. (2) lntrachromatid gene 
conversion with crossover results in a chromosomal intact 81 and in a circular molecule 
containing ~5'81 and S2. This circle will be lost, unless it integrates elsewhere in the 
genome. (3) Unequal sister chromatid gene conversion with crossover results in one 
chromatid containing an intact S1 and the sister chromatid containing two copies of A5'S1, 
S2, and an S1 with the restriction site still present, unless a DSB has occurred there as 
well. After cell division, each chromatid will be found in a different cell. (4) SSA results in a 
single intact S1 with a deletion of S2. Usually, this event cannot be distinguished from (2) 
and (3) after selection for S 1. 
(B) Outcomes of homologous recombination repair of a DSB in S1 in a directly oriented 
repeat substrate, designed to measure gene conversion only. (1, 2, 3, 4) See above for 
the repair pathways depicted. Only gene conversion without crossover (1) leads to an 
intact S1. 
(C) Outcomes of homologous recombination repair of a DSB in S1 in a directly oriented 
repeat substrate, designed to measure sister chromatid recombination. The exchange of 
S 1 containing the restriction site with Ll5'S 1 results in different selection marker properties 
for the different repair pathways. (1) Gene conversion without crossover using ~5'81 on 
the same or the sister chromatid results in intact S 1 and S2. (2) lntrachromatid gene 
conversion with crossover results in a chromosomal Ll5'S1 and in a circular molecule 
containing intact S1 and S2. This circle will be lost, unless it integrates elsewhere in the 
genome. Due to loss of the intact S 1, this event cannot be selected for via S 1. (3) 
Unequal sister chromatid gene conversion with crossover results in an intact S1 in one of 
the chromatids, and can therefore be selected for. (4) SSA results in ~5'81 and cannot be 
selected for. 
(D) Outcomes of homologous recombination repair of a DSB in S1 in an inversely oriented 
repeat substrate. While substrate (C) specifically selects for sister chromatid 
recombination, this substrate selects for intrachromatid recombination. (1) Gene 
conversion without crossover using ~5'81 on the same or the sister chromatid results in 
intact S1 and S2. (2) lntrachromatid gene conversion with crossover results in intact S1 
and S2, with an inversion of S2. (3) Unequal sister chromatid gene conversion with 
crossover results in an acentric and a dicentric chromatid, which will lead to loss of the 
chromosome. SSA is not possible. 
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Apart from this competition between different repair templates, there is also 
competition between the different homologous recombination pathways, When a DSB 
can be repaired by either gene conversion or SSA, as with a directly oriented repeat, the 
ratio of the events varies widely for different repair assays (Chapter 2) [144, 164, 390, 
508, 574], Factors influencing this ratio are the cell type, the homology length, the 
distance between the repeats, and the position of the DSB. In cells mutant for one or more 
of the recombination repair genes, the ratio will change, Mutations in for example RAD51 
and RAD54 will reduce gene conversion frequencies and increase SSA, while RAD52 
mutants show a larger decrease in gene conversion than in SSA (Chapter 2) [144, 226, 
280, 377, 383, 465], A similar competition occurs between gene conversion and BIR 
[322, 471, 550], A mutation in one of the genes involved in homologous recombination 
may not only lead to a shift in recombination pathways, it may also lead to increased 
lethality, even when the broken chromosome or plasmid is not essential for cell survival 
[265, 322], This may be due to the formation of recombination intermediates that cannot 
be resolved anymore and lead to cell death, 
7 CONCLUSIONS 
Cells contain an intricate network of DSB repair pathways to protect the integrity of 
the DNA, The proteins involved in DSB repair work together in a number of different 
complexes, often performing functions in different repair pathways, Some of the protein 
interactions are very stable, others are much more dynamic (J. Essers, personal 
communication). Apart from repair proteins, replication and cell cycle checkpoint 
proteins are also involved in the cellular reaction to DSBs. Repair is localized to the sites 
of the DSBs, but the DSB ends can search the whole genome to find homologous DNA 
The in vitro biochemistry of gene conversion and strand annealing reactions is currently 
being elucidated, However, how the cellular repair proteins are able to find first the 
DSBs, and then homologous sequences in the large excess of DNA present is still a 
mystery, Similarly, future research should provide further clues as to how cells regulate 
DSB repair and decide which pathway is most suitable to prevent chromosomal 
instability, 
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Cells can achieve error-free repair of DNA double-strand breaks (DSBs) by homologous 
recombination through gene conversion with or without crossover. In contrast, an 
alternative homology-dependent DSB repair pathway, single-strand annealing (SSA), 
results in deletions. In this study, we analyzed the effect of mRAD54, a gene involved in 
homologous recombination, on the repair of a site~specific I~Scei-induced DSB located in 
a repeated DNA sequence in the genome of mouse embryonic stem cells. We used six 
isogenic cell lines differing solely in the orientation of the repeats. The combination of 
the three recombination-test substrates used discriminated among SSA, intrachromatid 
gene conversion, and sister chromatid gene conversion. DSB repair was most efficient for 
the substrate that allowed recovery of SSA events. Gene conversion with crossover, 
which was indistinguishable from long tract gene conversion, preferentially involved the 
sister chromatid rather than the repeat on the same chromatid. Comparing DSB repair in 
mRAD54 wild-type and knockout cells revealed direct evidence for a role of mRad54 in 
DSB repair. The substrate measuring SSA showed an increased efficiency of DSB repair 
in the absence of rnRad54. The substrate measuring sister chromatid gene conversion 
showed a decrease in gene conversion with and without crossover. Consistent with this 
observation, DNA damage-induced sister chromatid exchange was reduced in mRAD54-
deficient cells. Our results suggest that mRad54 promotes gene conversion with 
predominant use of the sister chromatid as the repair template at the expense of error-
prone SSA In promoting error-free DSB repair, mRad54 will contribute to the 
maintenance of genomic stability. 
INTRODUCTION 
DNA double-strand breaks (DSBs), induced for example by endogenously produced 
radicals or ionizing radiation, form a major threat to the integrity of chromosomes and 
viability of cells. Unrepaired or incorrectly repaired DSBs may lead to translocations or 
loss of chromosomes, which could result in cell death or uncontrolled cell proliferation. 
Eukaryotes have developed several mechanisms to repair DSBs, including 
nonhomologous DNA end-joining (NHEJ) and homologous recombination. In 
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Saccharomyces cerevisiae, DSBs are efficiently repaired through homologous 
recombination by the RAD52 group genes, while a contribution ofNHEJ to DSB repair is 
only observed in the absence of homologous recombination [20, 173, 270, 355, 386, 398, 
469]. In mammalian cells, NHEJ plays a major role in DSB repair [233]. More recently, 
it has become clear that in addition to NHEJ, homologous recombination can play an 
important role in DSB repair in mammalian cells as well [28, 224, 253, 300, 399]. 
Several pathways of homology-dependent DSB repair have been described for S. 
cerevisiae (Chapter I) (386]. One of these pathways, single-strand annealing (SSA), 
specifically occurs when a DSB is made between directly repeated DNA sequences. The 
DSB is processed by removal of part ofthe 5' strand on each side of the break, exposing 
long 3' overhangs [263]. The single-stranded DNA (ssDNA) overhangs anneal to a long 
complementary stretch of DNA and nonhomologous ssDNA ends are removed. As a 
result, one of the repeats and the intervening sequence are deleted. In vertebrates, a 
similar pathway has been described [75]. 
An alternative homology-dependent DSB repair pathway, mediated by the RAD52 
group genes, is gene conversion [386, 489, 507]. DSB repair through this pathway also 
requires the DNA around the DSB to be degraded to produce 3' ssDNA overhangs. One 
or both of these ends invade a homologous DNA sequence, which can be found either on 
the homologous chromosome or, in the S and G2 phases of the cell cycle, on the sister 
chromatid. Several models for this invasion have been described, including DSB gap 
repair and synthesis-dependent strand annealing (See Chapter I) [160, 370, 387]. In a 
model for DSB gap repair, both ends invade the homologous duplex and the gap is filled 
by semi-conservative DNA synthesis. The resulting Holliday junctions are resolved either 
with or without crossover [507]. For reasons of brevity, we will use the term 'crossover' 
for events involving gene conversion with crossover, and 'gene conversion' for gene 
conversion without crossover. In the simplest model for synthesis-dependent strand 
annealing, only one end invades the homologous sequence. After DNA synthesis primed 
from the invading end, the newly-synthesized strand reanneals with the other end of the 
DSB. Then the second strand is synthesized, resulting in conservative DNA synthesis and 
a strong bias towards noncrossover events (See Figure 2 in Chapter 1) (160]. However, if 
a long tract of DNA is synthesized, the result of gene conversion without crossover may 
appear similar to a crossover event. 
RAD52 is important for almost all gene conversion and crossover pathways in S. 
cerevisiae (386]. Other genes involved include RAD51, RAD54, RDH54/TIDI, RAD55, 
and RAD57 (Chapter 1) [162, 264, 386]. RAD51, RAD54, RAD55, and RAD57 are 
required for gene conversion. RDH54, a homolog of RAD54, is mainly required for gene 
conversion using the homologous chromosome, while RAD54 is involved in gene 
conversion with both the sister chromatid and the homologous chromosome (10, 264, 
465]. Mutations in MREII, RAD50, and XRS2 cause a slower repair of DSBs by SSA, 
gene conversion and crossover, most likely because the 5' to 3' degradation of the DNA is 
slowed down in these mutants [226, 292, 494]. In mammalian cells, similar gene 
conversion and crossover pathways have been found, but very little is known about the 
genetic requirements of the different pathways. Most of the above-mentioned genes have 
a homolog in mammals (Table I in Chapter I) [253, 399]. Nevertheless, the importance 
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of each gene can differ in mammalian and S. cerevisiae cells. For example, the mouse 
RAD52 (mRAD52) gene can be mutated without a major effect on recombination, while it 
is the most important gene inS. cerevisiae [428]. 
One of the other RAD52 group genes, RAD54, is clearly important in mammalian 
cells. The Rad54 protein belongs to the Swi2/Snf2 protein family whose members 
modulate protein-DNA interactions in an ATP-dependent manner [148, 259, 395]. The S. 
cerevisiae and human Rad54 proteins are double-stranded DNA-dependent ATPases that 
interact with Rad51, a key player in the search for homologous template DNA [102, 185, 
235, 400, 505, 513]. Compared to wild-type cells, RAD54-deficient mouse embryonic 
stern (ES) cells are two- to four-fold more sensitive to ionizing radiation, the alkylating 
agent methyl rnethanesulfonate, and the DNA interstrand cross-linking agent mitomycin C 
[154]. In addition, homologous recombination in mRAD54-deficient cells is 5- to 10-fold 
reduced, as measured by targeted integration of exogenous DNA [154]. This reduction in 
homologous recombination can explain the sensitivity of cells lacking mRad54 to DSB-
inducing agents, although a direct involvement of mRad54 in DSB repair has not yet been 
demonstrated. 
Much information concerning the mechanisms of DSB repair in S. cerevisiae has 
been obtained using a site-specific DSB induced by the rare-cutting HO-endonuclease. 
Recently, rare-cutting enzymes suitable for site-specific DSB induction in mammalian 
cells have become available [230]. One of these is the S. cerevisiae mitochondrial 
enzyme !-See!, which recognizes and cuts a nonpalindrornic 18-bp site leaving 4-bp 3' 
overhangs [106]. Transfection of an 1-Scel-expressing plasmid into mouse or hamster 
cells induces a DSB at I-Scel sites present on a plasmid or integrated in a chromosome, 
but is not toxic to these cells [99, 436]. Analysis of the repair products of the site-specific 
DSB allows quantitation of the relative conttibution of NHEJ and different homology-
dependent pathways of DSB repair in mammalian cells [140, 240, 300, 301, 436, 447, 
508]. 
In this study, we have investigated the relative contribution of different homology-
dependent pathways to the repair of an 1-Scel-induced chromosomal DSB in mouse ES 
cells. The repair of the DSB induced in different recombination-test substrates that 
discriminate among gene conversion, crossover using the homologous sequence on the 
sister chromatid or the same chromatid, and SSA was monitored through genetic 
selection. Importantly, the different recombination-test substrates were integrated at the 
same site in the genome, which excludes differences due to local effects of DNA 
sequences or chromatin and allows a direct comparison between the results obtained with 
different substrates. In addition, we analyzed the effect of mRAD54, by comparing the 
distribution of repair events from the different recombination-test substrates in mRAD54+!-
and mRAD541- mouse ES cells that were otherwise isogenic. The effects of mRAD54 on 
DSB repair were compared with its effect on the number of both spontaneous and DNA 
damage-induced sister chromatid exchanges (SCEs) observed in mRAD54-proficient and-
deficient cells. 
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MATERIALS AND METHODS 
Construction of mRAD54 targeting vectors. Targeting vectors were constructed to 
integrate three different recombination-test substrates into the mRAD54 genomic locus. 
The substrates were cloned into the unique Sful site of exon 4, thereby disrupting 
mRAD54. The first targeting vector was made by inserting the DRneo construct [301], 
linearized with Xhol, into the Sfol site of a 9-kb EcoRI fragment from mRAD54 
encompassing exons 4, 5, and 6 (Fig. !A) [!54]. The 5' ssDNA overhangs of both 
restriction sites were removed by incubation of the digested DNA with the Klenow 
fragment of E. coli DNA polymerase I. The resulting mRAD54 allele is referred to as 
mRAD54°R"" (Fig. !A). The second and third targeting vectors were made by inserting 
the !Rneo and SCneo recombination-test substrates in a similar manner [240]. The 
resulting mRAD54 alleles are referred to as mRAD541Rneo and mRAD54SCneo, respectively 
(Fig. lA). The presence of an intact !-See! restriction site was tested by digestion of the 
targeting vectors with the purified enzyme. 
ES cell culture and electroporation. Heterozygous mRAD54 ES cells of the genotype 
mRAD54+!JOlpur were electroporated with the different targeting vectors and cultured on 
gelatinized dishes as described previously [154, 595]. The cells were split 24 h after 
electroporation, and hygromycin B was added to a final concentration of 200 fig/ml. After 
7 to I 0 days, colonies were isolated and expanded. Genomic DNA from individual clones 
was digested with Stu! and analyzed by DNA blotting using a flanking probe (Fig. !B). 
The blot was rehybridized with a 700-bp 3' neomycin (neo) fragment to confirm a single 
integration of the targeting vector. 
Immunoblot analysis. The expression of mRad54 protein was checked for all cell lines 
used in this study by immunoblot analysis of whole cell extracts. Blots were hybridized 
with a polyclonal a-hRad54 antibody [254]. 
Cell survival after gamma ray treatment. To determine whether integration of the 
recombination-test substrates into the mRAD54 locus resulted in mRAD54 deficiency, the 
sensitivity of mRAD54+JDRneo and mRAD54-IDRneo ES cells towards increasing doses of 
ionizing radiation was determined by measuring their colony-forming ability. ES cells 
were trypsinized and counted. Various cell dilutions were aliquoted onto gelatinized 60-
mm dishes, and after 12 to 24 h, cells were irradiated by a 137Cs source. They were grown 
for 7 to 10 days, fixed, stained, and counted. All measurements were performed in 
triplicate. 
I-Scel transfections. ES cells containing the recombination-test substrates were cultured 
in medium containing hygromycin at a concentration of 200 )J.g/ml. Transfection of 
3.2xl06 cells was done by electroporation with 6 fig of either pPGK3xnlsl-Scel or 
pCBA3xnls-I-Scel, which transiently express 1-Scel from the phosphoglycerate kinase I 
(PGK) and the chicken ~-actin promoter, respectively [150, 426]. The pCBA3xnls-I-Scel 
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construct was slightly more efficient in the introduction of a DSB than pPGK3xnlsi-Scel, 
as was apparent from the number of 0418-resistant colonies obtained. However, no 
differences in the ratio of 0418-hygromycin-resistant colonies to 0418-resistant colonies 
were found (data not shown). To determine the transfection efficiency, 6 !Lg of 
pPGKCAS-eGFP, containing the green fluorescent protein (GFP) gene under the control 
of a PGK promoter, was cotransfected in a number of experiments. In parallel, cells were 
electroporated without DNA, with pBluescript II KS, or pPGKCAS-eGFP alone. After 
electroporation, 103 cells were plated without selection to determine the cloning 
efficiency. The remaining cells were grown for one day without selection before they 
were split and cultured in medium containing 0418 (200 f.Lg/ml) or 0418 (200 f.Lg/ml)-
hygromycin (200 f.Lg/ml). When pPGKCAS-eGFP had been cotransfected with the 1-
Scei-expressing plasmid, a portion of the cells was subjected to fluorescence-activated cell 
sorting analysis one day after transfection to detennine the percentage of cells positive for 
GFP expression. After 8 to 11 days, cells were fixed, stained, and counted. The number 
of clones from the cells transfected with the 1-Scel-expressing plasmid was corrected for 
the number of clones from the mock-transfected cells. To enable comparison between the 
number of clones from different cell lines and experiments, the absolute number of clones 
was divided by the cloning efficiency and transfection efficiency. Recombination 
frequencies can then be calculated by dividing the corrected number of clones by the 
number of cells transfected. The data on the number of 0418- and 0418-hygromycin-
resistant clones is based on three to seven independent experiments, using two or three 
independent cell lines for each genotype. In several of the experiments, colonies were 
isolated and expanded. Genomic DNA from individual clones was analyzed for 
recombination events by digestion with either Neal or EcoRI and DNA blotting using the 
700-bp 3' neo fragment as a probe. Colonies from all recombination substrates that had 
aberrations in the hybridization pattern which were difficult to interpret, were not included 
in the analysis. Inclusion of these aberrant clones did not alter the conclusions. To 
determine the influence of a low dose of gamma rays from a 137Cs source on the 
distribution of recombination events, ES cells were irradiated with 1 or 2 Gy just before or 
4 h after electroporation ofpCBA3xnls-1-Scel. After one day without selection, the cells 
were split and grown in medium containing 0418 or 0418-hygromycin and processed as 
described above. 
Sister chromatid exchanges. SCEs in ES cell lines of the genotype mRAD54+1~, 
mRAD54"1-, mRAD541-, and a derivative of the same mRAD541- line expressing the 
hRAD54 eDNA were analyzed [154, 505]. The mRAD54 knockout allele in these lines 
was mRAD54307neo. The cell lines were coded to prevent bias in the analysis. The code 
was revealed only after the SCE analysis of all cell lines was completed. Cells were 
seeded in 60-mm dishes and after 24 h, the medium was removed and replaced with 
medium containing 10 ~M bromodeoxyuridine (BrdU) with or without 0.2 ~g mitomycin 
C/ml. After 1 to 2 h, cells were washed with phosphate-buffered saline (PBS) and fresh 
medium supplemented with 10 f.LM BrdU was added. Cells were cultured for two rounds 
of DNA replication (23 to 26 h), collected by mitotic shake off 2 h after the addition of 
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colcemid to a final concentration ofO.l ~g/ml, and treated with trypsin/EDT A for 5 min. 
Cells were treated with cold hypotonic solution (0.075 M KCI) immediately followed by 
centrifugation. Subsequently, cells were fixed with three changes of methanol/acetic acid 
(3:1) and metaphase preparations were made. To visualize the SCEs, slides were stained 
in diluted acridine orange for 5 min, mounted in 0.07 M Na2HP04/KH2P04 (pH 6.5) with 
a coverslip, and exposed to UV light of 265 nm for I 0-15 min. SCEs were observed 
through a fluorescence microscope (Leitz Orthoplan) using an IOOx objective. At least 40 
metaphases per cell line were analyzed for both the number of chromosomes and SCEs. 
Metaphase spreads were also analyzed for the presence of gross chromosomal 
abnormalities. 
RESULTS 
The recombination-test substrates. The three different recombination-test substrates 
that were used to measure recombination frequencies in mouse ES cells are schematically 
depicted in Fignre lA. They contain a hygromycin-selectable marker gene, flanked by 
two inactive neomycin-selectable marker genes, S2neo and 3' neo. For brevity, we will 
FIG. 1. Generation of mRAD54•t- and mRA054-t- ES cells containing recombination-test 
substrates. 
(A) Structure of the genomic mRAD54 locus and targeting vectors containing the 
recombination-test substrates. The two upper lines represent the wild-type (mRAD54+) 
and the puromycin-targeted knockout (mRAD54307P"') alleles, respectively. The 18 exons 
that encode mRad54 are indicated by boxes. The dashed line above exons 7 and 8 
indicates the position of the probe used to distinguish the different mRA054 alleles after 
digestion of the genomic DNA with Stul. The arrow shows the position of the puromycin 
(pur)-selectable marker gene. The locations of selected restriction sites are shown; E, 
EcoRI; N, Ncol; Sf, Sful; St, Stu!. The third line shows a generic representation of the 
targeting vectors. The three lower lines show the three different recombination-test 
substrates inserted into the mRAD54 locus in more detail. The black arrow indicates the 
hygromycin-selectable marker gene (hyg). The gray arrow on the left represents the 700-
bp 3' neomycin-selectable marker gene (3' neo). The gray arrow on the right represents 
the full-length S2neo gene, which contains a 4-bp deletion at the 18-bp 1-Scel site insertion 
(indicated in black). Recombination between the S2neo and 3' neo genes can lead to 
restoration of the original Neal site, resulting in an intact neo gene. The targeting 
constructs differ solely in the orientation of the 3' neo and S2neo genes. 
(B) DNA blot of ES cells containing wild-type(+) and knockout(-) mRAD54 alleles in 
addition to alleles with recombination-test substrates. mRAD54+1307pur ES cells were 
electroporated with the mRAD54DRneo, mRAD541Rneo, and mRAD54SCneo targeting vectors. 
After selection, genomic DNA was isolated from individual clones and digested with Stu!. 
The DNA blot was hybridized with the probe indicated in panel A. Phage fi. DNA 
digested with Psti was used as a size marker. The lengths of marker fragments are 
indicated in kilo bases on the right and the positions of the different mRAD54 alleles are 
shown on the left. 
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hereafter refer to these selectable marker genes as the hyg and neo genes, respectively. 
One of the crippled neo genes, 3' neo, consists of the 3' 700 bp of the neo gene. The 
other, S2neo, is a full-length neo gene, which contains a 4-bp deletion and the 18-bp 
insertion of the !-See! site at the position of the Neal site at bp 576 of the neogene [301]. 
Expression of the I -See I enzyme can create a DSB in the S2neo gene. By recombination 
between the S2neo and 3' neo gene, the original Neal site of the Slneo gene, which is 
present in the 3' neo gene, can be restored, creating an intact neo gene. The three 
recombination-test substrates differ solely in the relative orientation of the two crippled 
neogenes (Fig. !A). One substrate, DRneo, contains both crippled neogenes in a directly 
repeated orientation. Transcription of the S2neo gene occurs towards the 51 end of the 3' 
neo gene. The second substrate, IRneo, contains both genes in an inversely repeated 
orientation, because the 3' neogene has been inverted relative to its orientation on DRneo. 
The third, SCneo, contains the genes in a directly repeated orientation, but in contrast to 
DRneo, transcription of the S2neo gene occurs away from the 31 end of the 3' neogene 
[240]. 
Homologous integration of the recombination-test substrates in the mRAD54 locus. 
We targeted the recombination-test substrates to the mRAD54 gene of mouse ES cells to 
obtain single integration of the substrates at a defined and transcriptionally active position 
in the genome. Consequently, the targeted cell lines are isogenic and differ only in the 
presence of an mRAD54+ or an mRAD54- allele and the orientation of the crippled neo 
genes of the recombination-test substrates. To achieve this, the recombination-test 
substrates were subcloned into ex on 4 of the mRAD54 gene to create targeting vectors that 
would result in disruption of the gene [154]. The resulting mRAD54 alleles are referred to 
as mRAD54DRneo, mRAD5lRneo, and mRAD54SCneo, respectively. The targeting vectors 
were transfected into mRAD54+!- ES cells of the genotype mRAD54+1307'"' [154]. After 
selection with hygromycin, targeted clones were identified by DNA blotting with a unique 
probe outside the targeting construct (Fig. 1). To confirm single integration, the blots 
were rehybridized with a 700-bp 3' neo probe (data not shown). Targeting efficiencies to 
the mRAD54+ allele were around 13% and to the mRAD54307P"' allele around 5%. 
The disruption of mRAD54 by the recombination-test substrates was confirmed by the 
hypersensitivity of mRAD54307pur!DRneo ES cells to gamma irradiation (data not shown). 
The survival curve of the mRAD54 ... !DRneo cell line after gamma irradiation was similar to 
that of wild-type cells, as expected, because heterozygote mRAD54 cells show no obvious 
phenotype [154]. Immunoblot analysis using a-hRad54 showed that mRad54 protein was 
present in all mRAD54+ cell lines containing the recombination-test substrates, but could 
not be detected in any of the mRAD54 knockout cell lines (data not shown). 
The DRneo substrate: DSB repair events. For clarity, we first describe possible 
pathways of DSB repair on the DRneo recombination-test substrate and their resulting 
molecular outcomes. Subsequently, we will present the results obtained with this 
recombination-test substrate in wild-type ES cells, in mRAD54-deficient ES cells, and the 
effect of ionizing radiation on 1-Seel-induced DSB repair. 
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Transfection of an 1-Scel-expressing plasmid in cells containing the DRneo substrate 
can result in a DSB in the S2neo gene (Fig. 2). The DSB can be repaired by NHEJ with or 
without a deletion or insertion [300]. NHEJ will not result in the restoration of an intact 
neo gene, and therefore NHEJ events will not be recovered on selection with G418. An 
alternative repair patbway is SSA (Fig. 2). During SSA within the DRneo substrate, 
complementary strands of the S2neo gene and the 3' neo gene will anneal, resulting in an 
intact neo gene and deletion of the intervening hyg gene. A third pathway to repair the 
DSB is homologous recombination by gene conversion (Fig. 2). Gene conversion by 
recombination with the S2neo gene on the sister chromatid will result in restoration of the 
nonfunctional S2neo gene, and therefore, these events will not be recovered. To obtain an 
intact neo gene by gene conversion or crossover, the S2neo gene containing the DSB 
needs to pair with either the 3' neo gene on the same chromatid or, in the S and G2 phases 
of the cell cycle, with the 3' neo gene on the sister chromatid. These modes of 
homologous pairing are referred to as intrachromatid and sister chromatid pairing in 
Figure 2. If the intermediate is resolved without a crossover, the resulting clone will 
contain intact neo and hyg genes and a 3' neo gene, and the cell will be resistant to 0418 
and hygromycin. On the other hand, if a single crossover takes place, the resulting clone 
will contain an intact neogene without a hyg gene and will only be resistant to 0418. At 
the DNA level, the outcome of crossover is therefore identical to the outcome of SSA 
(Table 1). The reciprocal product for intrachromatid crossover, a circular DNA molecule 
containing a hyg and a 3' neo gene, will usually be lost. The reciprocal product for sister 
chromatid crossover, that contains a duplication of the hyg and 3' neo genes, will 
segregate from the intact neo gene on cell division and be lost on selection with G418 
(See Figure SA in Chapter 1). 
In summary, the different ways of processing the 1-Scel-induced DSB in the DRneo 
recombination-test substrate result in differences in the 0418 and hygromycin resistance 
of the cells. NHEJ results in resistance to hygromycin only, which is identical to the 
original resistance of the cells before induction of a DSB and therefore, these events 
cannot be detected. SSA and crossover result in resistance to 0418 only, while gene 
conversion results in resistance to G418 and hygromycin (Table 1). 
The DRneo substrate: relative efficiency of DSB repair events. The relative 
contribution of the different homology-dependent DSB repair pathways was investigated 
by transfection of the 1-Scel-expressing plasmids pPGK3xnlsl-Scel or pCBA3xnls-1-Scel 
into mRAD54+!DRneo ES cells. All transfections were carried out at least three times with 
two independently obtained mRAD54+!DR"'" cell lines. As a control, a mock transfection 
was performed with either no DNA, pBluescript II KS or pPGKCAS-eGFP. Before 
transfection, the cells were grown on hygromycin selection to reduce the background due 
to spontaneous recombination events. After transfection, the cells were grovm for one day 
without selection. Subsequently, they were divided over multiple dishes and cultured in 
either 0418-containing medium or 0418-hygromycin-containing medium. After 8 to 11 
days, the cells were fixed and the number of colonies on each dish was counted. 
The frequency of spontaneously arising G418-resistant colonies varied between 1 o-5 
and 10-6 No significant differences in the induction of G418-resistant colonies were 
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FIG. 2. Model of possible mechanisms for homology-dependent DSB repair on the DRneo 
recombination-test substrate. The DSB induced at the 1-Scel site and indicated by the gap 
in the S2neo gene can be repaired by different repair pathways that are depicted 
schematically. Only repair events yielding an intact neo gene are shown. The repair 
products that do not contain an intact neo gene are shown in Figure 5 of Chapter 1. A 
summary of all possible outcomes of DSB repair is given in Table 1. Symbols are the 
same as used in Figure 1. The DSB in the DRneo substrate can be repaired by SSA. The 
annealing of the complementary ssDNA is indicated by thin vertical lines. SSA results in 
the generation of one intact neo gene, while the other parts of the neo genes and the 
intervening hyg gene are deleted. Alternatively, homologous recombination of the S2neo 
with the 3' neo gene on the same chromatid (indicated by intrachromatid pairing) or the 
sister chroma!'1d (indicated by sister chromatid pairing) can occur, wh'1ch is indicated by the 
cross. If the intermediate of this gene conversion (GC) event is resolved without a 
crossover (-CO), an intact neo gene containing the Ncol site is recovered flanked by the 
original hyg and 3' neo gene. After crossover (+CO), the result is an intact neo gene, 
while the hyg gene is lost. Only the crossover (CO) product that results in an intact neo 
gene is shown. The locations of selected restriction sites used for DNA blot analysis are 
shown; E, EcoRI; N, Neal. 
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found between transfection of a control plasmid or no DNA. The recombination 
frequency was increased a 100- to 1,000-fold after transfection of an 1-Scel-expressing 
plasmid. This frequency of around 1 o·' is an underestimate of the actual recombination 
frequency after induction of a DSB, because only part of the cells receive the 1-Scel-
expressing plasmid DNA and only part of the cells containing !-See! will suffer a DSB 
[426]. 
G418-resistant colonies are obtained after all likely recombination events: SSA, gene 
conversion, and crossover. In contrast, G418-hygromycin-resistant colonies are only 
obtained after gene conversion (Fig. 2). Therefore, the ratio of the number of G418-
hygrornycin-resistant colonies to G418-resistant colonies is an indication of the 
contribution of gene conversion to all homologous recombination events. The advantage 
of this ratio is that it is an internal measure that can be compared directly among different 
cell lines and separate experiments. In addition, the ratio is not dependent on the 
transfection or the cloning efficiency of the cell line. In mRAD54+!DR"'" ES cells that have 
no defect in homologous recombination [154], this ratio of G418-hygromycin- to G418-
resistant colonies was 0.15 ± 0.01, when all experiments in which the number of colonies 
had been counted were taken into account. Thus, around 15% of all recombination events 
consist of gene conversion. There were no significant differences between the 
independently obtained mRAD54+!DR"" cell lines tested (data not shown). The 
contribution of crossover to the repair of a DSB is usually equal to or lower than the 
contribution of gene conversion [51, 240, 386]. Therefore, it is likely that SSA accounts 
for the majority of recombination events recovered from the DRneo substrate. 
The DRneo substrate: the effect of mRAD54 on DSB repair. Next, we determined the 
effect of mRAD54 on the repair of a DSB induced by 1-Scel in the DRneo substrate by 
using mRAD541DR"" ES cell lines. The ratio of G418-hygromycin-resistant to G418-
resistant colonies shifted from 0.15 ± 0.01, observed for mRAD54-proficient cells, to 
0.077 ± 0.007 for mRAD54-deficient cells. There were no significant differences between 
TABLE 1. Possible outcomes of repair events for the different recombination-test 
substrates after induction of a DSB by !-See!. 
Possible outcomes for recombination-test substrates 
DRneo IRneo SCneo 
Viabilitf Resulting Viabilitf Resulting Viabilitl Resulting 
DSB repair event resistance resistance resistance 
geneb geneb geneb 
NHEJ + hyg + hyg + hyg 
Single-strand annealing + neo + none 
Gene conversion + neo, hyg + neo, hyg + neo, hyg 
Intrachromatid crossover + neo + neo, hyg + none 
Sister chromatid crossover + neo + neo, hyg 
a Plus and minus signs indicate whether repair through these pathways results in viable or 
inviable cells, respectively. 
b neo and hyg indicate the expected expression of the neo and hyg genes, respectively. 
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the independently obtained mRAD54 knockout cell lines tested. Thus, the contribution of 
gene conversion (0418-hygromycin-resistant clones) to the total number of recombination 
events (0418-resistant clones) was reduced in the absence of mRad54 protein. We 
conclude that mRad54 is involved in repairing DSBs in vivo. 
To confirm these results at the DNA level, we isolated DNA from both 0418-
resistant mRAD54+!DRneo and mRAD541DRnea ES cell colonies. The DNA was digested 
with either Nco I or EcoRI and analyzed by DNA blotting and hybridization with a 3' neo 
probe (Fig. 3). Most clones showed a hybridization pattern consistent with either gene 
conversion or SSA and/or crossover (Table 2). 20% of the clones showed, in addition to 
those banding patterns, (part of) the hybridization pattern of the original construct. These 
clones could have resulted from events involving a (partial) duplication of the 
recombination substrate. 2% of the colonies showed a different hybridization pattern, 
which could be explained by an event consisting of a combination of long tract gene 
conversion and NHEJ (Table 2) [37, 239, 364, 425]. In these events, only one DSB end 
invades the 3' neogene and starts DNA synthesis continuing beyond the end of the 3' neo 
gene. After unwinding, the elongated end is joined to the other DSB end by NHEJ. 
The ratio of gene conversion to all recombination events was 0.175 for 
mRAD54+!DRneo and 0.095 for mRAD541DRneo ES cells using the data obtained after DNA 
blotting (Table 2). Thus, an approximately two-fold reduction in the proportion of gene 
conversion in the absence of mRAD54 was again observed. However, the ratio for each 
genotype was slightly higher when analyzed by DNA blotting, compared to the colony 
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FIG. 3. DNA blot analysis of 1-Scel-induced 
DSB repair events in ES cells containing 
the different recombination-test substrates. 
mRA054-proficient ES cells conlaining 
either the DRneo, IRneo, or SCneo 
recombination-test substrate were trans-
fected with an 1-Scel-expressing plasmid. 
After selection with G418 or G418-
hygromycin, genomic DNA from individual 
clones was digested with EcoRI. The 
outcome of repair of the 1-Scel-induced 
DSB was analyzed by DNA blotting using a 
700-bp 3' neo probe. Only a selection of 
the clones listed in Table 2 is shown. As 
shown in Figures 2 and 5, the sizes of the 
EcoRI fragments labeled with the neo probe 
indicate whether the DSB has been 
repaired by gene conversion (GC) or 
crossover (CO). With the DRneo substrate, 
SSA results in the same molecular outcome 
as crossover. Phage A DNA digested with 
Pstl was used as a size marker. The 
lengths of marker fragments are indicated 
on the left. 
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formation assay. This increase was not significant (P > 0.2), due to the relatively low 
number of events ( 60 to 1 00) analyzed by DNA blotting. 
We wished to determine whether the decrease in the contribution of gene conversion 
to all recombination events observed in the absence of rnRad54 was due to a decrease in 
the number of gene conversions, to an increase in SSA, or to both. Therefore, the 
experiments described above were repeated three times with the inclusion of additional 
controls, measuring the cloning efficiency and transfection efficiency, as described in the 
Materials and Methods section. These controls allowed the comparison of the number of 
colonies obtained with different cell lines and separate experiments. The decrease in the 
proportion of gene conversion events appeared to be due to both a significant increase (P 
< 0.05) in the recombination events yielding only G418 resistance, of which SSA is 
probably the most common, and a very slight, nonsignificant, decrease (P > 0.1 0) in the 
number of gene conversion events (Fig. 4A and B). These results suggest that in the 
absence of mRad54 and the presence of direct repeats, ES cells shift their repair process 
from gene conversion to SSA. 
Tile DRneo substrate: the effect of ionizing radiation on the distribution of repair 
events. We determined whether the simultaneous introduction of randomly distributed 
DSBs by ionizing radiation and the site-specific DSB by I-Scei would influence the repair 
of the I-Scei-induced DSB in mRAD54+-IDRneo and mRAD5riDRneo ES cells. For this 
TABLE 2, Relative contribution of different homology-dependent repair events of I-
Scei-induced DSBs in mRAD54-proficient and -deficient cells containing the 
recombination-test substrates. 
Distribution ofDSB repair eventsa 
Genotype GC CO GC+NHEJ Other Total 
(SSA) 
mRAD54+ "" 17 80 1 0 98 
mRAD54-IDR"w 6 57 2 1 66 
mRAD54+!IR"'" 124 2 1 3 130 
mRAD54-11R"w 112 0 3 5 120 
mRAD54+!SC"" 50 54 9 15 128 
mRAD5415c"" 55 50 11 26 142 
a The distribution of DSB repair events was determined by expanding colonies obtained 
after transfection of an l-Scel-expressing plasmid to ES cells of the indicated genotypes 
and selection with either G418 (DRneo) or G418-hygromycin (!Rneo, SCneo). DNA 
from the colonies was analyzed by DNA blotting after digestion with EcoRI or Neal. The 
clones were classified according to their restriction pattern as resulting from gene 
conversion (GC), crossover (CO), or long tract gene conversion starting frorne one DSB 
end coupled with NHEJ at the other DSB end (GC+NHEJ). For DRneo, SSA was 
recovered in the same class as crossover (CO-S SA). VVhen the restriction pattern and/or 
the intensity of the bands was different from the expected pattern of homologous 
recombination events, the clone was counted in the category 'Other'. 
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FIG. 4. Homologous recombination frequencies for the recombination-test substrates. 
1.6x1 06 mRAD54-proficient and -deficient ES cells containing the different recombination-
test substrates (DRneo, IRneo, or SCneo) in the identical genomic location were 
transfected with pCBA3xnls-I-Scel and grown in G418- and/or hygromycin-containing 
media. After 8 to 11 days, colonies were fixed, stained, and counted. The number of 
colonies obtained was normalized for the cloning efficiency and the transfection efficiency 
(see Materials and Methods). Shown is the normalized number of G418- or G418-
hygromycin-resistant colonies ± standard error of the mean for three independent 
experiments with two cell lines from all six genotypes. 
(A) Homologous recombination frequency of mRAD54+/DRoeo (+/-)and mRAD54'0R"" (-/-) 
ES cells. Colonies containing an intact neo gene were obtained after repair of the 1-Scel-
induced DSB by SSA, gene conversion (GC), or crossover (CO). 
(B) Frequencies of gene conversion and crossover events for ES cells containing the 
recombination-test substrates. For all three recombination-test substrates, neo- and hyg-
containing colonies were obtained after repair of the 1-Scel-induced DSB by intrachromatid 
gene conversion and sister chromatid gene conversion. The IRneo- and SCneo-containing 
cell lines each have one additional possibility to yield G418-hygromycin-resistant colonies. 
In the IRneo-containing lines, these clones can be formed by intrachromatid crossover (CO 
intra). In the SCneo-containing lines, they can be formed by crossover after pairing with 
the sister chromatid (CO sister). 
purpose, mRAD54+!DRneo and mRAD541DRneo cells were irradiated with 2 and 1 Gy of 
gamma rays, respectively, either just before or 4 h after transfection ofpCBA3xnls-!-SceL 
These radiation doses induce 30-100 DSBs per cell and give about 50% survival of the 
cells [!54, 413]. As a control, unirradiated cells were transfected with pCBA3xnls-I-Scel 
or pB!uescript II KS. The irradiated cells showed no significant difference in the ratio of 
G418-hygromycin-resistant colonies to G418-resistant colonies, compared to unirradiated 
cells transfected with pCBA3xnls-1-Scel (data not shown). Thus, a relatively high level of 
randomly-introduced DSBs does not saturate one of the DSB repair pathways that lead to 
G418- and G418-hygromycin-resistant colonies. 
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The IRneo and SCneo substrates: DSB repair events. The experiments with DRneo-
containing cell lines yielded useful information on the frequency of gene conversion. 
However, because SSA and crossover result in clones that are identical at the DNA level, 
the relative frequencies of these repair events could not be determined. To obtain 
information on the usage of crossover, either within the same chromatid or with the sister 
chromatid, we constructed mRAD54+!- and mRAD54_1_ cell lines containing the IRneo 
and SCneo recombination-test substrates (see above). First, we describe the pathways of 
DSB repair on these recombination-test substrates and their resulting molecular outcomes. 
Then, we will describe the contribution of the different repair pathways to DSB repair in 
these substrates and the effect of mutations in mRAD54. 
The IRneo recombination-test substrate contains the S2neo and the 3' neo gene in an 
inversely repeated orientation (Fig. SA). The DSB that is made in the S2neo gene after 
transfection of an 1-Scel-expressing plasmid can be repaired by NHEJ with or without a 
deletion or insertion. As with the other recombination-test substrates, this will not result 
in an intact neo gene and therefore, these events will not be recovered. In contrast to the 
DRneo substrate, the 1-Scel-induced DSB in the !Rneo substrate cannot be repaired 
through SSA. Due to the inverse orientation of the crippled neo genes, nucleolytic 
processing of the DSB will expose identical rather than complementary ssDNA tails. 
However, repair of the DSB by recombination is possible through several different routes 
(Fig. SA and Table 1). Both gene conversion and crossover can occur using the 3' neo 
gene on either the same chromatid or the sister chromatid as a template. Both gene 
conversion events will result in G418-hygromycin-resistant cells. In contrast, crossover 
involving the sister chromatid results in a dicentric chromosome and an acentric 
chromosome, which is incompatible with cell survival (See Figure SD in Chapter 1). DSB 
repair through crossover after pairing with the 3' neo gene on the same chromatid results 
in G418-hygromycin-resistant cells. The orientation of the hyg gene will be inverted by 
the crossover event. Thus, crossover can be distinguished from gene conversion at the 
DNA level (Fig. 3). 
The SCneo recombination-test substrate contains the S2neo and the 3' neo gene in a 
directly repeated orientation (Fig. 5B). In contrast to the DRneo substrate, transcription of 
the S2neo gene occurs away from the 3' end of the 3' neo gene, which has implications 
for the outcome ofDSB repair. Expression ofi-Scel in a cell containing SCneo can result 
in a DSB in the S2neo gene. Repair by NHEJ will not be recovered in the assay, because 
this does not result in an intact neo gene. SSA is a possible repair event, and will pair the 
5' end of the 3' neogene to the 3' end of the S2neo gene. As a result, the DSB is repaired 
and a 3' neo gene is recovered, which will not be detected because the cell will remain 
sensitive to G418. Similar to the other recombination-test substrates, gene conversion can 
occur by pairing with the 3' neo gene on the same chromatid or the sister chromatid. In 
this way, an intact neo gene will be obtained and the hyg gene will be retained. Crossover 
after pairing with the 3' neo gene on the same chromatid will yield the same outcome at 
the DNA level as SSA, namely a single 3' neo gene which will not be recovered (See 
Figure SC in Chapter 1 ). On the other hand, crossover after unequal pairing with the 3' 
neo gene on the sister chromatid will result in an intact neo gene with a partial duplication 
of the rest of the construct resulting in two intact hyg genes (Fig. 5B and Table 1). The 
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FIG. 5. Schematic representation of possible homology-dependent DSB repair pathways 
for the IRneo and SCneo recombination-test substrates. Only repair events yielding an 
intact neo gene are depicted. The repair products that do not contain an intact neo gene 
are shown in Figure 5 of Chapter 1. A summary of all possible outcomes of DSB repair is 
given in Table 1. Symbols are the same as in Figure 1. Expression of 1-Scel can create a 
DSB, indicated by the gap in the S2neo gene. Recombination between the S2neo and the 
3' neo gene, indicated by the cross, can lead to restoration of the original Neal site 
resulting in an intact neo gene. Concerning the crossover events, only the product that 
results in an intact neo gene is shown. The locations of selected restriction sites, used for 
DNA blot analysis are shown; E, EcoRI; N, Neal. 
(A) Outcomes of DSB repair events on the IRneo recombination-test substrate. After 
induction of a DSB by 1-Scel, a recombination event resulting in an intact neo gene is gene 
conversion (GC) with either intrachromatid or sister chromatid pairing as indicated. If the 
intermediate is resolved without crossover (-CO), the only change in the substrate will be 
the replacement of the 1-Scel site by the original Neal site. If the intermediate is resolved 
with crossover (+CO), the orientation of the hyg gene is reversed by the crossover event. 
Crossover events will only result in normal chromosomes after intrachromatid pairing. 
(B) Outcomes of DSB repair events on the SCneo recombination-test substrate. After 
induction of a DSB by 1-Scel, an intact neo gene is obtained by gene conversion with 
intrachromatid or sister chromatid pairing (GC, -CO), or by crossover after pairing with the 
3' neogene of the sister chromatid (GC, +CO). In this case, the hyg gene and the S2neo 
gene will be duplicated. 
same outcome may, however, be obtained by long tract gene conversion without crossover 
[239]. These events can be distinguished from gene conversion by DNA blotting (Fig. 3). 
In summary, with both the IRneo and SCneo recombination-test substrates, gene 
conversion events are detected by G418-hygromycin resistance, similarly to the DRneo 
substrate. With the !Rneo substrate, G4!8-hygromycin resistance is also obtained by 
crossover after pairing with the 3' neo gene on the same chromatid. In contrast, with the 
SCneo substrate, crossover events after pairing with the 3' neo gene on the sister 
chromatid are recovered (Table 1 ). 
The IRneo and SCneo substrates: relative efficiency of DSB repair events. To 
investigate the relative efficiency of the different homologous recombination repair 
pathways, mRAD54+!IRneo and mRAD54+!SCnr?o ES cells were transfected v.rith the I-Scel-
expressing plasmid pCBA3xnls-I-Scel, as described above for the DRneo-containing cell 
Jines. For both genotypes, two independently obtained cell Jines were used in three 
different experiments. The spontaneous recombination frequency was 1 o-5 to 1 o-6 and did 
not differ significantly between different cell lines (data not shown). The number of 
colonies on the pCBA3xnls-I-Scel transfected dishes was normalized for the number of 
colonies on the mock transfected dishes, the cloning efficiency, and the transfection 
efficiency. The resulting recombination frequency was about 10·2 In the SCneo-
containing cell lines, not all recombination events are recovered, as SSA, gene conversion 
using the S2neo gene on the sister chromatid, and crossover after pairing with the 3' neo 
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gene on the same chromatid do not result in G418 resistance (Table 1). Nevertheless, 
transfection of the I-Scel-expressing plasmid into mRAD54+!SCneo cells resulted in three 
times more colonies than transfection into mRAD54+IIRneo cells (Fig. 4B). The number of 
G418-hygromycin-resistant colonies obtained after transfection of mRAD54+!IRneo cells 
with pCBA3xnls-I -Scel was comparable to the number obtained after transfection of 
mRAD54+!DR'" cells (Fig. 4B). 
Since both gene conversion and crossover result in G418-hygromycin resistance of 
the !Rneo and SCneo recombination-test substrates, we investigated the distribution of 
these events by DNA blotting. Gene conversion and crossover can be discriminated 
because they result in a different restriction pattern after digestion with EcoRl (Fig. 5 and 
3). The !Rneo recombination-test substrate almost exclusively showed gene conversion, 
which implies that crossover within the same chromatid between inversely oriented 
repeats is a rare event in ES cells (Table 2). A few of the recovered events showed a 
restriction pattern consistent with long tract gene conversion starting from one DSB end 
combined with NHEJ of the other DSB end [239, 418]. In the SCneo recombination-test 
substrate, gene conversion and crossover and/or long tract gene conversion contributed 
equally to the recovered homologous recombination events (Table 2). Thus, crossover or 
long tract gene conversion after pairing with the sister chromatid, which usually do not 
lead to deleterious chromosome rearrangements, are common events. A relatively high 
number of SCneo-derived clones showed restriction patterns that could not be explained 
by gene conversion or crossover. The restriction pattern of about one third of these clones 
was consistent with long tract gene conversion starting from one DSB end combined with 
NHEJ ofthe other DSB end. The other cases were difficult to interpret. They might have 
been caused by a more complex homologous recombination event, maybe also combined 
with NHEJ. 
The IRneo and SCneo substrates: the effect of mRAD54 on DSB repair. With the 
DRneo recombination-test substrate, we observed a change in the relative contribution of 
different DSB repair events in mRAD54 knockout ES cells. Especially, in the absence of 
mRad54 protein, a significant increase in SSA with a concomitant very slight reduction of 
gene conversion was observed. Therefore, we investigated the effect of mRAD54 on 
homologous recombination in the other recombination-test substrates. We transfected 
pCBA3xnls-I-Scel into mRAD54-11R"" and mRAD5r5c"'" cells and analyzed the colonies 
obtained as described above. DNA blot analysis revealed that there was no difference in 
the relative distribution of homologous recombination events between mRAD54-proficient 
and -deficient ES cell lines containing the !Rneo or SCneo substrates (Table 2). mRAD54 
IIRneo cells showed only gene conversion events, and mRAD541scneo cells showed an equal 
number of gene conversion and crossover events. The proportion of long tract gene 
conversion coupled with NHEJ was also similar between mRAD54-proficient and -
deficient ES cells. 
The number of colonies obtained from mRAD5411R"" cells did not differ from the 
number of colonies from mRAD54'11R"" cells (Fig. 4B). Thus, no indication was obtained 
for an involvement of mRAD54 in the repair of a DSB between inversely oriented repeats 
by gene conversion. However, mRADS~SCneo ES cells gave rise to fewer colonies than 
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mRAD54+!sc," ES cells after transfection of an I-Scei-expressing plasmid (Fig. 4B). 
There was a consistent, statistically significant (P < 0.05) decrease to approximately 70% 
of the number of colonies obtained with mRAD54-proficient cell liues containing the 
SCneo substrate. This indicates a role for mRAD54 in gene conversion and crossover with 
the sister chromatid in DSB repair in this substrate. 
Influence of mRAD54 on the induction of sister chromatid exchanges. To obtain 
independent evidence for a role of mRAD54 in sister chromatid recombination, we 
measured the spontaneous and DNA damage-induced levels of SCEs in mRAD54-
proficient and -deficient ES cells. ES cells of the genotypes mRAD54'1', mRAD5~1-, and 
mRAD54_1_ were analyzed. The spontaneous level of SCEs found in the mRAD541- cell 
line was slightly reduced compared to that observed in the mRAD54-proficient control cell 
lines (Fig. 6). In all cell lines, no numerical or gross structural chromosomal 
abnormalities were observed. DNA damage inflicted by the DNA interstrand cross-
linking agent mitomycin C increased the number ofSCEs. Treatment of the cells with 0.2 
~g mitomycin C/ml for 1 h increased the number of SCEs 2.6-fold in the mRAD5~1' and 
mRAD54'1- ES cell lines. In the mRAD54'- cell line, the increase in SCEs was only 1.8-
fold. The difference in the average number of SCEs among mRAD54'1', mRAD54+1-, and 
mRAD54_1_ cells was significant (Fig. 6; P < 0.05). In addition, we included a derivative 
of the mRAD54_1_ cell line that expressed the hRAD54 eDNA in the SCE analysis as a 
control. Expression of this eDNA rescues the DNA damage sensitivities of mRAD541-
cells [505]. The expression of hRAD54 returned the number of SCEs in the mRAD541-
ES cell line to wild-type levels, both spontaneously and after treatment with mitomycin C. 
In all cell lines treated with mitomycin C, no apparent chromosomal changes were 
observed. 
+I+ +I- -1- -/-
+ hRAD54 
mRAD54 Genotype 
FIG. 6. Induction of SCEs by mitomycin C in 
mRA054-proficient and -deficient ES cells. 
ES cells of the genotypes mRAD54'1', 
mRAD54'1-, mRAD54-I-, and mRA054'-
containing a hRAD54 eDNA expression 
construct were analyzed for the frequency of 
SCEs. Cells were either mock treated or 
treated with 0.2 !19 of mitomycin C/ml for 1 to 
2 h, in the presence of BrdU. Fresh medium 
with BrdU was added and the cells were 
cultured for two rounds of DNA replication, 
and collected 2 h after addition of colcemid. 
Metaphase preparations were made and 40 
to 95 metaphases per sample were scored 
for the number of SCEs per cell. The 
frequency of spontaneous SCEs is shown in 
black, while the frequency of SCEs after 
treatment with mitomycin C is shown in gray. 
The error bars indicate the 95% confidence 
intervals (CI). 
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DISCUSSION 
In this study, we have analyzed the repair of a single site-specific DSB located in a 
repeated DNA sequence in the genome of mouse ES cells. Three recombination-test 
substrates have been used, all integrated in the same genomic location, but different in the 
orientation of the repeated sequences, allowing optimal comparison. DSB repair 
involving homologous recombination was found to be most efficient, when the DSB can 
be healed through SSA. The second most efficient homology-dependent repair pathway is 
gene conversion from the sister chromatid. We have determined the effect of the mouse 
Rad54 protein on homology-dependent DSB repair using these substrates in mRAD54-
proficient and -deficient cells. Our data provides the first evidence for involvement of 
mRad54 in repairing DSBs. The DSB repair phenotype of mRAD541- cells differs 
depending on the type of recombination-test substrate. mRAD541- cells display a hyper-
recombination phenotype for DSB repair between directly oriented DNA sequences and 
no phenotype when the DSB is located between inversely oriented repeats. For a 
recombination-test substrate that measures repair by gene conversion and crossover using 
the sister chromatid, a hypo-recombination phenotype is observed. Consistent with this 
observation, we find that lack of mRAD54 results in less efficient induction of sister 
chromatid exchanges in response to DNA damage. 
A site-specific DSB in mouse ES cells induces homologous recombination. In this 
study, we have analyzed homologous recombination in mouse ES cells. These cells have 
two major advantages over other mammalian cell types. First, they are nontransformed 
and therefore, all DNA damage and cell cycle checkpoints are likely intact [ 440]. Second, 
efficient protocols for gene targeting in these cells have been developed. This allows the 
generation of series of isogenic cell lines, which differ solely in defined genetic loci. 
The analysis of homologous recombination after induction of a site-specific DSB 
between repeated DNA sequences requires a low level of spontaneous recombination 
between the repeats. We find that the spontaneous frequency of recombination in mouse 
ES cells is in the order of 10-5 to 10·6 for all three recombination-test substrates used in 
this study. Similar frequencies of spontaneous recombination between directly oriented 
repeats have been observed in Chinese hamster ovary (CHO) cells [240, 301, 376]. 
Induction ofi-Scei expression in the ES cells containing the recombination-test substrates 
increases the frequency of homologous recombination at least 100- to 1000-fold. Similar 
increases in DSB-induced recombination have been observed in a number of different cell 
lines including ES cells [150, 240, 301, 364, 426, 447, 508]. In this study, we find that, 
after correction for cloning and transfection efficiencies, 3.6 to 4.8% of the DRneo-
containing cells undergo homologous recombination upon DSB induction (Fig. 4). This 
percentage of cells undergoing homologous recombination is still an underestimate, 
because not all transfected cells will receive a DSB [426]. Furthermore, homologous 
recombination using the S2neo gene on the sister chromatid will not be detected. The 
contribution of homology-dependent processes towards DSB repair can be as high as the 
one by DNA end-joining, as was recently demonstrated using the DRneo and SCneo 
substrates randomly integrated in the genome of CHO cells [240, 300]. 
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The major homology-dependent DSB repair pathway for the Dllneo substrate is 
SSA. Using the DRneo substrate, a distinction can be made between DSB repair through 
SSA and crossover on one hand and gene conversion on the other hand (Fig. 2). Our 
results show that approximately 15% of all homology-dependent DSB repair events 
within the DRneo substrate in mouse ES cells occur through recombination between the 
directly oriented repeats via gene conversion. These results appear not to be specific for 
mouse ES cells, because 25% of the DSB repair events in CHO cells containing the 
integrated DRneo substrate occur through gene conversion [300]. The separate 
contributions of SSA and crossover to DSB repair cannot be determined with the DRneo 
substrate. However, a comparison to the results with the SCneo substrate, which also 
contains directly oriented repeats, suggests that gene conversion and crossover occur at 
similar frequencies (Table 2). This implies that SSA accounts for 70% of aU homology-
dependent DSB repair events within the DRneo substrate in mouse ES cells. 
Consistent with our results, recombination between directly repeated sequences 
through gene conversion, when compared to SSA, accounts for the minority of detected 
events in a number of other assay systems, including DSB-induced events on plasmids 
and in chromosomes in S. cerevisiae and vertebrate cells [164, 234, 300, 377, 437]. 
However, there are a number of exceptions, both in S. cerevisiae and mammalian cells, in 
which gene conversion accounts for the majority of spontaneous and DSB-induced events 
[51, 184, 376, 420, 508]. For example, after induction of a DSB with 1-Scel between 
directly oriented repeats containing restriction fragment length polymorphisms, spaced by 
100 bp, more than 90% of the DSB repair events in CHO cells are gene conversions [508]. 
This shift in repair pathways could be due to the heterology in the repeats. Other variables 
that might contribute to observed differences among assay systems include the length and 
sequence context of the repeats, the distance between the repeats, the position of the DSB 
and heterology at the ends [164, 184, 377, 385]. Both gene conversion and SSA use 3' 
ssDNA tails as intermediates. Gene conversion requires search for homology followed by 
joint molecule formation actively mediated by Rad51-coated ssDNA. On the other hand, 
SSA involves the more passive process of annealing of complementary single strands, 
although it does also, at least partially, depend on Rad52. Depending on the presence of 
nonhomologous ends and the length and sequence context of the repeat, these two 
processes might be affected differentially. Finally, the distribution of repair events may 
also be dependent on the stage of the cell cycle, as gene conversion using the sister 
chromatid is only possible inS and 02. 
DSB repair associated with DNA crossovers occurs mostly from the sister chromatid. 
DSB repair products of both the !Rneo and SCneo recombination-test substrates differ 
depending on whether they have been generated through gene conversion or crossover 
(Fig. 5). While the !Rneo substrate detects intrachromatid crossovers, the SCneo substrate 
detects unequal crossovers between sister chromatids. It should be noted, however, that if 
a long tract of DNA is synthesized during gene conversion, the result appears similar to a 
crossover. With the IRneo substrate, DSB repair through crossover occurs only in 1.5% 
of the analyzed repair events, while gene conversion accounts for over 95% of the events 
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(Table 2). This also indicates that gene conversion tracts are generally shorter than 2.7 kb, 
because otherwise, the outcome would have been scored as a crossover. In contrast to the 
lack of crossovers with IRneo, we find that gene conversion and crossover contribute 
equally to DSB repair using SCneo. Thus, it appears that crossovers preferably arise 
when the sister chromatid, instead of a homologous sequence on the same chromatid, is 
used as the repair template. A similar preference for crossover events using the sister 
chromatid has been observed in mouse L cells during spontaneous recombination between 
repeated sequences [51]. A somewhat lower contribution of crossovers using SCneo has 
been found in CHO cells after induction of a DSB [239]. In addition, evidence has been 
obtained for a restriction of gene conversion to the S and G2 phases of the cell cycle after 
induction of a DSB in the DRneo substrate in CHO cells, again indicating a preference for 
pairing with the sister chromatid to perform gene conversion [300]. In contrast, in S. 
cerevisiae a preference for intrachromatid interactions has been found, as indicated by a 
low percentage of crossover events in an SCneo-like substrate [262]. A high percentage 
of crossovers after intrachromatid interactions has been found in the repair of an induced 
DSB on a plasmid or spontaneous DSBs on chromosomes using inversely oriented repeats 
inS. cerevisiae [3, 419,437, 497]. 
Using the SCneo substrate in CHO cells, the nature of the crossover events after 
induction of a DSB has been investigated [239]. All crossover events in these cells 
appeared to be due to long tract gene conversion without crossover, as the reciprocal 
product that should be formed during crossover could not be found in unselected colonies, 
while the second product of long tract gene conversion, an unchanged SCneo substrate, 
was found (See Figure 5 in Chapter 1 ). Due to our selection procedures, we have not been 
able to discriminate between actual crossover and long tract gene conversion. Long tract 
gene conversion requires a gene conversion tract length of 3.1 kb in the SCneo substrate, 
which contrasts with the shorter gene conversion tract lengths we have found for the 
!Rneo substrate in ES cells. Half of the long tract gene conversion events found in CHO 
cells are actually the result of gene conversion starting from one DSB end and NHEJ of 
the other DSB end [239]. In our study, these combined recombination and NHEJ events 
are detected as a separate class on DNA blots, and constitute about 7% of all analyzed 
repair events, while crossovers constitute 40%. If these combined events also accounted 
for half of the long tract gene conversion events in ES cells, 33% of all events would still 
be due to actual crossovers after pairing with the sister chromatid. 
The preference for sister chromatid interactions during homologous recombination in 
mammalian cells could have arisen because sister chromatid recombination is, in general, 
less prone to the generation of chromosomal rearrangements than intrachromatid 
recombination. A significant fraction of mammalian genomes consists of repetitive DNA 
sequences. Crossovers between these sequences will result in deleterious chromosomal 
rearrangements, except when the same sequence on the sister chromatid is used. Evidence 
thus far suggests that genome rearrangements are indeed suppressed during recombination 
between sequence repeats on nonhomologous chromosomes [ 425, 426]. Furthermore, the 
presence of mismatches between the repeats also prevents recombination, due to the 
mismatch repair system [ 150, 518]. S. cerevisiae contains hardly any repetitive sequences 
and will undergo less selection against allowing intrachromatid recombination. The 
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preference for the sister chromatid in mammalian cells might occasionally result in 
unequal crossover events between sister chromatids, but if those events occur in a limited 
region, their potential deleterious effects could be minimized. 
Comparison of the frequency of DSB repair events on the different substrates. We 
find that the frequency of gene conversion is comparable among the different 
recombination-test substrates. The estimated frequency of gene conversion between 
intrachromosomal repeats after induction of a DSB is 5.9 x 10·3 for DRneo, 6.6 x 10·3 for 
SCneo and 5.1 x 10·3 for IRneo (Table 2 and Figure 4). The frequency of crossover events 
for DRneo cannot be determined due to the occurrence of SSA events. With IRneo, we 
hardly find any crossover events compared to SCneo. It seems reasonable to assume that 
with all three recombination-test substrates, a similar fraction of the cells receives a DSB 
and that a similar fraction of these DSBs is channeled into a homology-dependent repair 
pathway. Therefore, it is striking that with the IRneo substrate, the number of events 
involving gene conversion is not higher than with the DRneo or SCneo substrate. Repair 
by SSA will result in correct DSB repair in cells containing DRneo and SCneo, but cells 
containing IRneo that attempt SSA will fail to repair the DSB. Apparently, these cells 
will not undergo gene conversion or crossover, but instead, the homologous repair event 
will be aborted and resolved by another pathway not resulting in an intact neo gene, or it 
will not be resolved at all and result in cell death. Cells that repair their DSB by gene 
conversion using the sister chromatid, which is the predominant route for recombination, 
can resolve the intermediate without a crossover in all three recombination-test substrates. 
However, if a cell attempts to resolve the intermediate by crossover in the IRneo substrate, 
this will result in chromosomal rearrangements and cell death. It seems that either finding 
the homologous repair template on the sister chromatid is more difficult with the IRneo 
substrate or cells containing the inversely oriented repeat fail to prevent crossovers with 
the sister chromatid and die. Othen:vise, more gene conversion events should have been 
recovered with the IRneo substrate. In S. cerevisiae. induction of a DSB by HO-
endonuclease in directly or inversely oriented repeats on a plasmid, results in a higher loss 
of the plasmid containing the inversely oriented repeats [437]. In mouse L cells 
containing thymidine kinase repeats in a direct or inverted orientation integrated in the 
chromosome, the frequency of spontaneous recombination is three-fold lower for the 
repeats in inverted orientation [50]. These results also indicate that recombinational repair 
between inversely oriented repeats is less efficient. 
mRad54 influences the repair of DSBs in the DRneo recombination-test substrate. A 
role for the mRad54 protein in the repair of DSBs has been postulated based on the 
ionizing radiation sensitivity and homologous recombination deficiency of mRAD541- ES 
cells [154]. The results of our study provide direct evidence that mRad54 is involved in 
DSB repair in vivo. The difference in DSB repair between mRAD54-proficient and -
deficient cells is most clearly seen when the DSB is induced between directly oriented 
repeated sequences, as is the case with the DRneo and SCneo recombination-test 
substrates (Fig. 4A and B). The absence ofmRad54 causes a very slight reduction in gene 
conversion during DSB repair of the DRneo substrate. This reduction is accompanied by 
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a statistically significant increase in the number of crossovers and SSA, the latter of which 
is the most frequent. In S. cerevisiae, a similar increase in homologous recombination is 
seen in rad54 mutants, both with directly oriented repeats on plasmids and in 
chromosomes [226, 303, 465]. The frequency of SSA (or crossover) is 2- to 27-fold 
higher in rad54 cells than in wild-type cells [303, 465]. With an HO-endonuclease-
induced DSB between chromosomal, directly oriented repeats, a decreased survival of 
rad54 mutant cells has been found compared to wild-type cells. Although this indicates a 
deficiency in DSB repair, the number of SSA events increased [226]. In addition to the 
increase in SSA events, a decrease in both spontaneous and DSB-induced gene 
conversions has been observed [226, 303, 465]. These results suggest that there might be 
a competition between SSA and gene conversion (see below). 
mRad54 influences recombination between sister chromatids. In cells containing the 
SCneo recombination-test substrate, the effect of mRAD54 on gene conversion is more 
pronounced than in cells containing the DRneo substrate. Repair of the DSB through SSA 
is possible in SCneo, although those events are not detected, because they do not yield an 
intact neo gene. A statistically significant 27% decrease in the frequency of gene 
conversion and crossover and/or long tract gene conversion is observed in the absence of 
mRAD54 (Fig. 4B). Since all crossover events take place after pairing with the sister 
chromatid, mRAD54 is clearly involved in sister chromatid recombination. This is also the 
case for S. cerevisiae RAD54 [10]. The contribution of gene conversion and crossover 
remains about equal in mRAD541- cells compared to mRAD54+!- cells, which indicates 
that mRAD54 is involved in both gene conversion and crossover recombination events 
(Table 2). In contrast to these results, S. cerevisiae RAD54 appears to be mainly involved 
in gene conversion, although this has been investigated only with inversely oriented 
repeats [ 419]. 
Crossovers resulting in restoration of the neo gene in the SCneo recombination-test 
substrate are the consequence of interactions with the sister chromatid and result in SCEs 
at the chromosomal level. Therefore, our results with the SCneo substrate predict a 
reduction in the level of SCEs in the absence of mRAD54. Indeed, we find a slight~ 
lower level of spontaneous SCEs in mRAD541- ES cells compared to that in mRAD54+ + 
ES cells (Fig. 6). Because SCEs are induced by DNA-damaging agents, we have also 
tested whether mRAD541- ES cells respond differently to mitomycin C treatment in the 
SCE assay than mRAD54+!+ or mRAD54+1- cells. Treatment of mRAD541- cells with 
mitomycin C yields a 1.5-fold lower induction of SCEs, compared to mRAD54+t+ cells 
(Fig. 6). This effect of RAD54 on spontaneous and DNA damage-induced SCEs 
corresponds to results obtained with chicken-derived cells, in which a reduction in the 
frequency of SCEs in RAD54- and RAD51-deficient chicken B-lymphocytes is observed 
[482]. From these results, we conclude that genes required for homologous recombination 
are also involved in promoting SCEs. The decrease in SCEs induced by DNA damage 
corresponds to the similar decrease in the number of crossover events during DSB repair 
on the SCneo recombination-test substrate. 
The observation that mRAD54 influences DNA damage-induced SCEs adds 
significantly to our results with the recombination-test substrates. The results of the SCE 
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experiments show that mRAD54 is involved in homology-dependent DNA repair of DNA 
damages that are present in naturally occurring genomic sequences. The SCE experiments 
overcome two restrictions of the experiments with recombination-test substrates. First, 
the restriction enzyme-induced DSB that initiates repair in the experiments involving the 
recombination-test substrates might be recognized differently from other types of DNA 
damages, including DSBs introduced by ionizing radiation or DNA interstrand cross-
linking agents. Second, in the experiments involving the recombination-test substrates, 
the introduction of repeated DNA sequences is necessary in order to select for successful 
DSB repair events. However, the presence of these repeated sequences -will influence the 
distribution of observed repair events. SSA relies especially on the presence of repeated 
sequences and will be used less frequently in a more physiological situation, 
The absence of mRad54 has no influence on recombination within the IRneo 
substrate. We find no change in the frequency of gene conversion after induction of a 
DSB in the !Rneo substrate in mRAD54-deficient cells compared to that in mRAD54-
proficient cells (Fig. 4B), With the !Rneo recombination-test substrate, the induced DSB 
can be repaired by gene conversion involving either the same chromatid or the sister 
chromatid, or by crossover after pairing with the 3' neo gene on the same chromatid (Fig. 
SA). The latter events are rare in mRAD54--r-IIRneo cells and have not been detected in 
mRAD5411R"" cells (Table 2), Similar to our results with chromosomal substrates in 
mouse ES cells, disruption of RAD54 in S. cerevisiae has no effect on the repair of an 
induced DSB in inversely oriented repeats located on a plasmid [226], In contrast, the rate 
of spontaneous gene conversion between chromosomal, inversely oriented repeats is 
decreased 25-fold in a rad54 S, cerevisiae strain [419], The frequency of gene conversion 
is severely reduced, while events involving crossovers are relatively less affected. The 
difference between the results obtained with rad54 S cerevisiae and mRAD54_1_ ES cells 
might be due to a difference between spontaneous and DSB-induced recombination 
events. Furthermore, because S. cerevisiae cells display a different distribution of events, 
with a predominance of crossovers during intrachromatid recombination, a direct 
comparison between S cerevisiae rad54 and mRAD541- ES cells is difficult, The lack of 
an effect of mRAD54 on DSB repair between inversely oriented repeats in mouse ES cells 
also contrasts with the effects of mRAD54 on DSB repair between directly oriented 
repeats (Fig, 4), As we will discuss below, this could be due to the possibility to repair a 
DSB in directly oriented repeats by SSA, which is not possible in inversely oriented 
repeats, 
Does mRad54 promote gene conversion at the expense of SSA? ssDNA tails are 
formed as a common intermediate in SSA and gene conversion with or without crossover. 
Because of this common intermediate, it is likely that a certain degree of competition 
exists between these two pathways [164]. rnRad54 could have a role in promoting gene 
conversion, either directly or indirectly by blocking DSBs from being processed through 
the SSA pathway, This would explain the increase in the number of 0418-resistant 
colonies in mRAD54-deficient cells with DRneo, which results from an increase in SSA. 
It would also explain the decrease in 0418-hygromycin-resistant colonies with SCneo, 
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because an increase in SSA, which is not recovered, would cause a decrease in the 
recovered gene conversion events. With IRneo, SSA is not possible, and therefore, lack 
of rnRad54 would not have any effect on DSB repair in this substrate. Manunalian 
chromosomes contain a significant amount of repetitive sequences that could be used to 
repair a DSB by SSA, thereby resulting in deletions. Inhibition of SSA by rnRad54 is 
therefore even more relevant in mammalian cells than in S. cerevisiae, where similar 
effects of Rad54 on SSA have been found. Direct stimulation of gene conversion 
pathways by rnRad54, possibly by its interaction with rnRad51, would decrease the 
contribution of SSA to DSB repair. It has been shown that the purified human and S. 
cerevisiae Rad54 proteins have ATP-dependent DNA supercoiling activity [403, 513]. 
This activity would be ideally suited for the the stimulation of mRad51-mediated 
homologous DNA pairing and strand exchange (See Chapter I) [ 400]. 
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3 Department of Radiation Oncology, University Hospital Rotterdam, The Netherlands 
Homologous recombination is one of the important pathways to repair DNA double-strand 
breaks. Central proteins involved are Rad51 and Rad54, which are conserved from yeast 
to human. Rad51 can perform DNA strand exchange, stimulated by Rad54 via a direct 
interaction. Upon ionizing radiation, colocalizing nuclear foci are formed by Rad51 and 
Rad54. In mammals, a second sequence homolog of Rad54 is present, called Rad54B. 
Mouse embryonic stem cells deficient for both mouse RAD54 (mRAD54) and mRAD54B, 
are more sensitive to ionizing radiation than mRAD54-deficient cells, suggesting a role for 
mRad54B in DSB repair, similar to mRad54. In this study, we show that mRad54B 
resides in the nucleus. In contrast to mRad54, we could not observe foci formation of 
mRad54B coupled to Yellow Fluorescent Protein (YFP) upon treatment with ionizing 
radiation. We performed immunoprecipitations from Chinese hamster ovary cells 
transfected with YFP-mRAD54B-Flag and from reticulocyte lysates containing in vitro 
translated hRAD51 and mRAD54B(-Flag) using a-hRad51, C<-mRad54B, and a-Flag 
antibodies. We observed an association between Rad51 and Rad54B both without 
treatment and after ionizing radiation, although at a low efficiency. Furthermore, we 
demonstrated homomeric association ofmRad54B, mediated by the carboxy-terminal 140 
amino acids. These results and the conservation betvveen mRad54 and mRad54B suggest 
a role for mRad54B in homologous recombination either together with mRad54 or in a 
different subpathway. 
INTRODUCTION 
Homologous recombination is one of the important pathways for the repair of DNA 
double-strand breaks (DSBs) that is conserved from Saccharomyces cerevisiae to human 
(See Chapter 1). This pathway is essentially error-tree by using homologous DNA as a 
template for DSB repair. Two of the central proteins in homologous recombination both 
in yeast and mammalian cells are Rad51 and Rad54 [253, 386]. In vertebrate cells, 
deletion of RAD51 is lethal, most likely due to defective repair ofDSBs that occur during 
DNA replication [114, 165, 198, 268, 305, 325, 434, 481, 536]. Deletion of vertebrate 
RAD54 makes cells sensitive to ionizing radiation, reduces the frequency of homologous 
recombination, and alters DSB repair, but is not lethal (Chapter 2) [40, 144, 154]. In 
vitro, Rad51 can form a nucleoprotein filament on a single-stranded DNA (ssDNA) 
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molecule and perform strand exchange using a homologous double-stranded DNA 
(dsDNA) molecule [27, 338, 472, 501, 504]. Human Rad54 (hRad54) is a dsDNA-
dependent ATPase that can induce supercoiling into DNA [430, 505, 513]. In vitro, it can 
bind to hRad51 on nucleoprotein filaments [185]. In vivo, binding of mouse Rad54 
(mRad54) to mRad51 is observed only after induction of DSBs [513]. Yeast Rad54 
(ScRad54) stimulates DNA strand exchange by ScRad51, possibly through its 
supercoiling ability [332, 400,403, 546]. 
The close cooperation between Rad51 and Rad54 in DSB repair identified 
biochemically, is also found at the cell biological level. The mammalian Rad51 and 
Rad54 proteins cannot be detected by immunofluorescence in untreated cells [513]. 
However, the majority of hRad51 fused to the green fluorescence protein (GFP) is 
localized in the cytosol in transfected Chinese hamster ovary (CHO) cells. In contrast, 
GFP-hRad54 is found in the nucleus (J. Essers, personal communication). After the 
induction of DSBs by ionizing radiation, mammalian Rad51 and Rad54 molecules form 
nuclear foci, that colocalize [513]. Rad51 foci can also be observed in S phase cells, 
probably due to DSB repair during replication [299, 515, 516]. 
Both in S. cerevisiae and in mammalian cells, a second homolog of RAD54 has been 
identified. The yeast homolog, called ScRDH54 or ScTIDJ, fimctions in different 
subpathways of homologous recombination compared to ScRAD54, although the function 
of ScRad54 and ScRdh54 is partially redundant [264, 402, 464, 465, 471]. The 
mammalian RAD54 homolog is called RAD54B [212]. 50% of the amino acids of 
mRad54B and mRad54 are similar. mRad54B is more homologous to ScRad54 than to 
ScRdh54. Mice deficient for mRAD54B are viable and show no gross abnormalities, 
similar to mRAD54-deficient mice (J.-M. Buerstedde, personal communication in [153]). 
The ionizing radiation sensitivity of mouse embryonic stem cells that are deficient for 
mRAD54B is between the sensitivity of wild-type and mRAD54-deficient cells (A. 
Wesoly, personal communication). Cells deficient for both mRAD54 and mRAD54B are 
viable but more sensitive to ionizing radiation than either mRAD54-deficient or 
mRAD54B-deficient cells (J. Essers and A. Wesoly, personal communication). Chicken 
DT40 cells, deficient for RAD54B, have a minor defect in homologous recombination 
[358]. 
In this study, we have investigated the cellular localization of mRad54B both in 
untreated cells and in cells treated with ionizing radiation. Furthermore, we have 
demonstrated that mRad54B and hRad51 interact by immunoprecipitation from CHO cell 
extracts and from reticulocyte lysates containing in vitro translated proteins. By the same 
methods, we have observed homomeric (di- or polymeric) interaction of mRad54B and 
determined the domain responsible for this interaction. 
MATERIALS AND METHODS 
eDNA constructs. The full length mRad54B eDNA was cloned using four overlapping 
PCR fragments. The following tags were added by PCR: an amino-terminal histidine tag 
(His6: single letter amino acid code: MGHHHHHHGGI) and a carboxy-terminal Flag tag 
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(DYKDDDDK). All PCR fragments were sequenced The His-mRAD54B-Flag eDNA 
was subcloned into pEYFPCl (Yellow Fluorescent Protein, Clontech), yielding YFP-
mRAD54B-Flag. The constructs were subcloned into the appropiate vectors for 
transfection and in vitro transcription and translation (IVTT). 
Generation of a-mRad54B antibodies. 390 bp encoding the carboxy terminus of 
mRad54B were subcloned into pRP261, derived from pGex2T. The fusion protein, 
mRad54B-Cterm, derived from this plasmid, contained amino acid 754 to 884 of 
mRad54B fused to a glutathione S-transferase tag. Similarly, a 386-bp Nhei-Pstl 
fragment was subcloned in pMalC2 and yielded a fusion protein containing amino acid 
100 to 229 fused to maltose binding protein. The fusion proteins were produced in E. 
coli strain BL21-codon+. The proteins were purified from the insoluble fraction by 
preparative SDS-polyacrylamide gel electrophoresis (PAGE) and used to immunize two 
rabbits. The antibody directed against the carboxy terminus is called o:-mRad54B-Cterm, 
the antibody against amino acid I 00 to 229 a-mRad54B-Nterm. The antibodies did not 
cross-react with mRad54 on immunoblots (data not shown). 
Transfection of mRAD54B into CH09 cells. YFP-mRAD54B-Flag was transfected 
using lipofectin into CH09 cells, grown in FlO-DMEM containing 10% fetal calf serum. 
To obtain stable transfectants, cells were split after one day and put on G418 selection (1 
mg/ml). Single colonies containing YFP-mRad54B-Flag protein were expanded. The 
cellular localization of the YFP signal was determined using an Olympus IX70 
microscope. The expression of full-length fusion protein was investigated with o:-YFP, o:-
mRad54B-Cterm and a-Flag antibodies on immunoblots of cell extracts from transfected 
CH09 cells, using untransfected cells as a control. 
Immunofluorescence. Cells were grown on glass slides for two days and treated with 12 
Gy of gamma irradiation or left untreated. Two to six hours after treatment, the slides 
were fixed in 2% paraformaldehyde and washed twice with 0.1% Triton-X 100 in 
phosphate-buffered saline. They were incubated with o:-hRad51, a-Flag (M2, Sigma), or 
a-mRad54B for 90 min, washed again with 0.1% Triton-X 100 and incubated for 90 min 
with the secondary antibodies (Alexa, Molecular probes). Nuclei were counterstained 
with 4' ,6-diamidino-2-phenylindole. 
IVTT and immunoprecipitation. In vitro transcription and translation of pcDNA-
mRAD54B, pcDNA-His-mRAD54B-FLAG, pRSET-His-mRAD54B-Cterm, pcDNA-
hRAD51 and pZeo-His-hRad54-HA in the presence of 35S methionine produced the 
corresponding mRad54B, hRad51 and hRad54 proteins (Promega TnT T7 coupled 
reticulocyte lysate system). The antibodies used for immunoprecipitation were a-
mRad54B-Cterm, a-Flag, o:-hRad51, and a-HA (3Fl0, Roche). Interactions of the in 
vitro translated proteins were investigated by mixing 5 ~1 of reticulocyte lysates 
containing the proteins with 5 ~1 NETT buffer (100 mM NaCI, 5 mM EDTA, 50 mM 
Tris-HCI (pH 8.0), 0.5% Triton-X 100) and incubating for 1 hat 30'C. 5 ~I antibody was 
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added, and incubation continued for 4 h on ice, Then, 20 fll ProtA- or, for a-HA 
antibodies, ProtG- sepharose beads (Amersham) were added and the mixture was rotated 
overnight at 4°C, After washing the beads with NETT buffer, the protein was eluted from 
the beads by heating to 95°C and analyzed by SDS-PAGE and autoradiography, 
Immunoprecipitation from cellular extracts. CH09 cells were either unirradiated or 
irradiated with 12 Gy of gamma rays and were lysed after 2 h by incubation with NETT 
buffer or RJPA buffer (50 mM Tris-HCl (pH 7,5), 150 mM NaCl, 1 mM EDTA, 1% 
NP40, 0,)% SDS, 0,5% Na-deoxycholate), both containing 1:250 Pefabloc, leupeptine 1 
!lgiml, antipain 1 !lgiml, pepstatin A 1 !lgiml, chymostatin 1 !lgiml for 30 min on ice. 
After centrifugation, the supernatant was precleaned by incubation with ProtA-sepharose 
beads. In one experiment, 5 mM MgC12, 0.1 mg DNase/ml and 0.1 mg RNase/ml were 
added for 30 min at room temperature to remove DNA and RNA from the extract. The 
removal of DNA and RNA was checked by agarose gel electrophoresis of part of the 
sample and ethidium bromide staining. Then the cellular extract was incubated overnight 
at 4°C with antibody and afterwards incubated for 3 h with 30 111 ProtA-sepharose beads. 
After washing the beads with buffer, the protein was eluted from the beads by heating to 
95'C and analyzed by SDS-PAGE and immunoblotting. 
RESULTS 
Subcellular localization of mRad54B. The subcellular localization of mRad54B was 
determined by transfection of YFP-mRAD54B-Flag into CHO cells. As a control, the 
pEYFP vector was transfected. In this case, YFP was present throughout the cell. On the 
contrary, YFP-mRad54B-Flag was diffusely present only in the nucleus both by direct 
observation in living cells and on immunofluorescence using either o:-rnRad54B-Cterm, 
a-mRad54B-Nterm, or a-Flag (Fig. !A and data not shown). Irradiation of the cells with 
12 Gy gamma rays did not change the localization of YFP-mRad54B (Fig. !B). As a 
positive control for foci formation, immunofluorescence of untransfected and transfected 
CHO cells with a-hRad51 showed normal radiation-induced Rad51 foci formation (data 
not shown). 
Interaction of mRad54B with Rad51. mRad54 coprecipitates with hRad51 after 
treatment of the cells with ionizing radiation [513]. To investigate potential interactions 
between mRad54B and Rad51, cell extracts were made from untransfected and YFP-
mRAD54B-Flag-transfected CHO cells. Immunoprecipitation from unirradiated cell 
extracts using immobilized a-hRad51 revealed precipitation of the endogenous hamster 
Rad51 and coprecipitation, albeit at a low efficiency, of the transfected and overexpressed 
YFP-mRad54B-Flag (Fig. 2A). The endogenous hamster Rad54B was not well visible in 
these coprecipitations probably due to a low expression level and competition with YFP-
mRad54B-Flag. The reciprocal experiment, immunoprecipitation with a-Flag or a-
mRad54B-Cterm to precipitate YFP-mRad54B-Flag, yielded coprecipitation of Rad51 
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FIG. 1. Subcellular localization of YFP-mRad54B-Fiag in CHO cells. Living CH09 cells, 
stably transfected with YFP-mRAD54B-Fiag were either treated with 12 Gy of gamma rays 
(B), or left untreated (A) before making the photograph on an Olympus IX70 microscope. 
(Fig. 2B, C). Treatment of the cells with 12 Gy gannna rays before lysis did not change 
the results for the different innnunoprecipitations (Fig. 2D, E, F). Coprecipitation of 
mRad54B and Rad51 occurred both in NETT buffer and in the more stringent RIP A 
buffer. Higher amounts of protein were precipitated in NETT buffer than in RIPA, but 
precipitation never was quantitative. This suggests that not all of the Rad54B and Rad51 
protein molecules in the cell are present in the same complex. Treatment of the cellular 
extract with DNase and RNase did not change the immunoprecipitation results, suggesting 
that the interaction is not mediated by DNA (Fig. 2F and data not shown). 
To test whether the interaction between Rad54B and Rad51 was direct, the 
innnunoprecipitation experiments were repeated with proteins generated through IVTT. 
In this case, mRad54B and hRad51 were used for the innnunoprecipitation reactions. 
Coprecipitation of hRad51 with mRad54B and vice versa were observed (Fig. 3A). 
Similar results were obtained using His-mRad54B-Flag (data not shown). There was no 
cross-reactivity of the antibodies. In these experiments, quantitative interactions were not 
observed. 
Homomeric interaction of mRad54B. In the immunoprecipitation experiments using 
cellular extracts from YFP-mRAD54B-Flag-transfected CHO cells, precipitation of YFP-
mRad54B-Flag with a-Flag also caused coprecipitation ofuntagged Rad54B (Fig. 2B, E). 
This indicates that mRad54B can form di- or multimers. To evaluate this result, 
innnunoprecipitation experiments using in vitro translated mRad54B and His-mRad54B-
Flag were performed. a-Flag precipitated both the untagged and the Flag-tagged 
mRad54B, when reticulocyte lysates containing either protein were mixed together in the 
innnunoprecipitation reaction (Fig. 3B). This confirms the results obtained using cell 
extracts and suggests that coprecipitation is not caused by indirect interactions. 
Irnmunoprecipitation reactions on parts of mRad54B were performed to investigate the 
domain of mRad54B involved in this homomeric interaction. The carboxy-terminal 
domain composed of 140 amino acid residues could be coprecipitated with His-
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FIG. 2. Co-immunoprecipitations of Rad54B and Rad51 in CHO cellular extracts. CH09 
cells stably transfected with YFP-mRAD548-Fiag (Y54B) or untransfected (Co) were 
irradiated with 12 Gy of gamma rays (right panel) or left untreated (left panel). After 2 h the 
cells were lysed in NETT buffer (A, B) or RIP A buffer (C. D. E, F). The cell extract used in 
the experiment shown in panel F was also treated with DNase and RNase. The proteins 
were precipitated using the indicated antibodies o:-hRad51 (o:-51 ), a-Flag (o:-FI), and o:-
mRad54B-Cterm (o:-548) on ProtA-sepharose beads as described in Materials and 
Methods. The supernatant of the beads (sup), and the immunoprecipitate (ip) were 
analyzed by SDS-PAGE and immunoblolting. The endogenous hamster Rad51 (51) was 
detected with o:-hRad51 in the lower panels. The endogenous hamster Rad54B (54B) and 
the transfected YFP-mRad54B-Fiag (Y54Bf) were detected with o:-mRad54B-Cterm in the 
panels A, B, D, and E. In the panels C and F, they were detected with the less sensitive o:-
mRad54B-Nterm. The position of the immunoprecipitated proteins is indicated between 
the blots. Protein size markers (in kD) are visible on the right side. 
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mRad54B-Flag using a-Flag (Fig. 3C), suggesting that the interaction occurs via the 
carboxy terminus of the protein. 
DISCUSSION 
In this study, we determined that mRad54B is a nuclear protein, similar to mRad54. 
mRad54B foci formation after ionizing radiation of the cells was not observed in contrast 
to mRad54 foci formation [513]. mRad54B interacts with hRad51, and shows homomeric 
interaction. This homomeric interaction is mediated by the carboxy terminus of the 
protein. The interactions are independent of ionizing radiation treatment. 
Nuclear localization and foci formation. Using a YFP-mRad54B-Flag fusion protein, 
overexpressed in CHO cells, we showed that the protein is uniformly distributed in the 
nucleus. The localization did not change on ionizing radiation (Fig. I). With the use of 
immunofluorescence, we could not observe the endogenous Rad54B protein, maybe due 
to a low expression level. On irnrnunoblots from CHO cell extracts, we could see the 
endogenous Rad54B using a-mRad54B-Ctenm. Using a different a-Rad54B antibody, 
the endogenous protein has also been observed on an immunoblot using a mouse 
embryonic stern cell extract, but in that cell line expression was very low as well [514]. 
The expression level did not change upon treatment with ionizing radiation. Focally 
concentrated mRad54B in the nucleus on immunofluorescence has been reported for 
several tumor cell lines, with an increase in cells containing foci from 71% to 89% after 
ionizing radiation. The foci colocalized with both Rad51 and Rad54 foci after ionizing 
radiation [514]. This focus formation is different from that observed for mRad54 and 
mRad51, where no foci are seen without irradiation of the cells [513]. We may have 
missed this focal pattern because the tags interfered with focus formation, due to the 
overexpression of our mRad54B fusion protein, or to the different cell type used. We also 
used a different immunofluorescence protocol and different antibodies. Radiation-
induced foci likely reflect protein relocalization events upon DNA damage. The Rad51 
foci co localize with sites of DNA damage, where repair proteins accumulate [516]. The 
high percentage of foci found in unirradiated cells by Tanaka et al. is difficult to reconcile 
with this hypothesis about the origin of foci formation and the relevance of the foci they 
observed is therefore unclear [514]. Whether or not Rad54B can be found in radiation-
induced foci at the sites of DNA damage remains to be determined. 
Interaction of mRad54B with bRadSl. Our finding of co-irnmunoprecipitation of 
Rad54B and the endogenous Rad51 from CHO cell extracts confirms previous findings on 
this interaction [514]. Contrary to the situation for Rad54, the interaction in vivo is not 
dependent on the previous induction of DNA damage (Fig. 2A, B, C) [513]. The lack of 
interaction between Rad51 and Rad54 in unirradiated cells could be due to the nuclear 
localization of Rad54, while Rad51 is predominantly located in the cytoplasm. In vitro, 
Rad54 and Rad51 readily interact (data not shown) [185]. Possibly, the Rad54B protein 
interacts with the small amount of Rad51 present in the nucleus. The interaction between 
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FIG. 3. Co-immunoprecipitations of reticulocyte lysates containing in vitro translated 
mRad54B and hRad51. By IVTT radioactive mRad54B (54B). His-mRad54B-Fiag (54Bf). 
mRad54B-Cterm (54Bc), and hRad51 (51) were produced. The IVTT reactions yielded 
secondary protein bands due to alternative translation start sites. The proteins were 
precipitated with the antibodies (indicated at the top) a-Flag, a-hRad51, and a-mRad54B(-
Cterm) in NETT buffer on ProtA-sepharose beads as described in Materials and Methods. 
The proteins, the supernatant of the beads (sup), and the immunoprecipitate (ip) were 
analyzed by SDS-PAGE and autoradiography. Protein size markers (in kD) are indicated 
on the left side. The immunoprecipitated proteins (Prot) are indicated on the right side. In 
panels B and C, to prevent overflow, the lanes were loaded in a different order, but on the 
same gel and then electronically rearranged. 
(A) mRad54B shows homomeric interaction. mRad54B and His-mRad54B-Fiag were 
immunoprecipitated with a-Flag. Lane 1, IVTT of mRAD54B; lane 2, IVTT of His-
mRAD54B-FLAG; lane 3, co-immunoprecipitate of mRad54B and His-mRad54B-Fiag by a.-
Flag. 
(B) The homomeric interaction of mRad54B is mediated by its carboxy terminus. 
mRad54B-Cterm alone (lanes 1, 3) or mixed with His-mRad54B-Fiag (lanes 2, 4) was 
precipitated with a-Flag. Lanes 1, 2, supernatant; lanes 3, 4, immunoprecipitate. 
(C) mRad54B and hRad51 interact as detected by precipitation with a-hRad51 and a-
mRad54B. mRad54B alone (lanes 1, 3) or mixed with hRad51 (lanes 2, 4) was 
precipitated with a-hRad51. hRad51 alone (lanes 5, 7) or mixed with mRad54B (lanes 6, 
8) was precipitated with a-mRad54B. Lanes 1, 2, 5, 6, supernatant; lanes 3, 4, 7, 8, 
immunoprecipitate. 
Rad54B and Rad51 was not quantitative (Fig. 2). Tanaka et a!. reported that the 
interaction was mediated by the amino terminus of hRad54B [514]. The interaction 
between hRad54 and hRad51 is also mediated by the amino terminus of hRad54 [185]. 
As hRad54B and hRad51 did not show any interaction in a yeast two-hybrid screen, the 
interaction was presumed to be indirect in contrast to the interaction between Rad54 and 
Rad51 [514]. The lack of interaction could, however, also be due to the fusion proteins 
used in this two-hybrid screen. The interaction is probably not mediated by DNA, 
because DNase and RNase treatment of the cell extracts did not inhibit the co-
immunoprecipitation of Rad54B and Rad51 (Fig. 2F). We also observed this interaction 
using reticulocyte lysates containing in vitro translated proteins, suggesting a direct 
interaction (Fig. 3A). Nevertheless, the interaction might be mediated by other proteins 
present in the reticulocyte lysate. The co-immunoprecipitation of in vitro translated 
RAD54B and RAD51 was weaker than that of RAD54 and RAD51 (data not shown). This 
is another difference between the interaction of Rad51 with Rad54 and Rad54B and 
suggests that Rad54 and Rad54B perform at least slightly different functions. 
Homomeric interaction of mRad54B. Apart from the interaction between mRad54B 
and hRad51, we also observed homomeric interaction ofmRad54B. This interaction was 
mediated by the carboxy terminus of mRad54B. Scanning force microscope observations 
on hRad54 suggest that hRad54 also has homomeric interaction and forms complexes on 
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DNA [430]. The carboxy-terminal homomeric interaction ofmRad54B probably does not 
interfere with the interaction with Rad51, which takes place via the amino terminus of 
mRad54B. 
Role of mRad54B. mRad54B has conserved the ATPase and helicase motifs 
characteristic for proteins belonging to the Swi2/Snf2 family of proteins [395]. These 
proteins are involved in chromatin remodeling. The homology between mRad54 and 
mRad54B suggests that the functions of both proteins are similar. The nuclear 
localization and the interactions observed for mRad54B are compatible with a role for the 
protein in homologous recombination. This is also suggested by the increased sensitivity 
of mRAD54B-mRAD54-deficient mouse cells to ionizing radiation compared to mRAD54-
deficient cells. Mutations in RAD54 and RAD54B have been observed in a low percentage 
oftumors [212, 331]. 
In yeast, the two Rad54 homologs function in different subpathways of 
recombination, but are also partially redundant. Both proteins can stimulate DNA strand 
exchange by ScRad51 [400, 402]. ScRad54 is more involved in mitotic recombination 
and interacts with ScRad51 (I 02, 235]. ScRdh54 on the other hand is more important for 
meiotic recombination and interacts with ScRad51 and Dmcl, the yeast Rad51 homolog 
only active during meiosis [462, 464]. Consistent with this, Scrad54 mutants are deficient 
in recombination using the sister chromatid or the homologous chromosome, while 
Scrdh54 mutants are only deficient in recombination using the homologous chromosome, 
which is more important during meiosis (10, 264, 465]. The defects in all these 
recombination reactions are more severe in Scrad54-rdh54 double mutants. 
On the basis of its sequence, mRad54B is expected to have similar ATPase and DNA 
supercoiling activities as mRad54. mRad54B might also stimulate Rad51-mediated DNA 
strand exchange. Similar to the situation in S. cerevisiae, the mammalian Rad54 
homo logs may have partially redundant roles. Such a redundancy is relatively common in 
mammalian DNA repair pathways. The nucleotide excision repair gene RAD23, the 
translesion repair gene RAD6, the recombination gene RAD51, and the DNA interstrand 
cross-link repair gene SNMJ all have more than one homolog/paralog in mammalian cells 
(Chapter 5) [145, 266, 330, 524]. mRad54B and mRad54 may be important for different 
subpathways of recombination. Alternatively, they could also work together in the same 
pathways, by interaction with each other or by common interactions with other 
homologous recombination proteins, like Rad5l. For further clues on the function of 
mRad54B, biochemical analysis of the protein, results on recombination assays, and on 
the phenotype of mRAD54-mRAD54B double knockout cells will be necessary. 
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REPAIR OF DNA INTERSTRAND CROSS-LINKS 
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DNA interstrand cross-links (ICLs) are very toxic to dividing cells, because they induce 
mutations, chromosomal rearrangements, and cell death. Inducers of ICLs are important 
drugs in cancer treatment. We discuss the main properties of several classes ofiCL agents 
and the types of damage they induce. The current insights in ICL repair in bacteria, yeast, 
and mammalian cells are reviewed. An intriguing aspect of ICLs is that a number of 
multi-step DNA repair pathways including nucleotide excision repair, homologous 
recombination, and postrephcation/translesion repair all impinge on their repair. 
Furthermore, the breast cancer-associated proteins Brcal and Brca2, the Fanconi anemia-
associated FA proteins, and cell cycle checkpoint proteins are involved in regulating the 
cellular response to ICLs. We depict several models that describe possible pathways for 
the repair or replicational bypass of ICLs. 
1 INTRODUCTION 
DNA interstrand cross-links (ICLs) are among the most toxic DNA damages. A 
single ICL can kill repair-deficient bacteria and yeast, and about 40 ICLs can kill repair-
deficient mammalian cells [287, 320]. Moreover, ICLs can induce mutations and 
rearrangements of DNA, possibly resulting in uncontrolled cell proliferation and tumor 
formation. Many different agents are capable of inducing ICLs into the genome. A well-
known class of ICL-inducers are chemotherapeutic agents like mitomycin C, cisplatin, 
nitrogen mustard, nitrosourea, and their derivatives. However, cells are also exposed to 
environmental ICL agents, like furocoumarins that are present in many plants and 
cosmetics [454]. Moreover, endogenous agents that are formed during lipid peroxidation, 
such as malondialdehyde, can lead to ICLs. However, the clinical relevance of these 
endogenous agents is unclear, because they are unstable and hardly form ICLs under 
physiological conditions [24, 86]. Organisms have developed strategies to deal with DNA 
damage in order to survive. A number of specialized repair pathways have evolved that 
each process specific kinds of DNA damage. An intriguing aspect of ICL repair is that 
several of these pathways have to work together in order to remove or bypass an ICL. 
While the major ICL repair pathway in bacteria is well-characterized, both genetically and 
biochemically, ICL repair in eukaryotes is less well understood. 
First, we will discuss a number of important properties of ICL agents and the DNA 
damage with which they confront the cells. Next, the clinical relevance of knowledge 
concerning ICL repair for the treatment of cancer will be surveyed, followed by a review 
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of the current insights in the mechanisms ofiCL repair in bacteria, yeast, and mammalian 
cells. 
2 CROSS-LINK FORMATION AND PROPERTIES OF DNA 
INTERSTRAND CROSS-LINKING AGENTS 
ICL agents have different toxicities depending on a number of factors, including 
cellular uptake aud metabolic activation. First, most ICL agents have to be trausported 
into the cell and then into the nucleus. Second, a number of ICL agents, such as the 
nitrosoureas, are metabolically activated in the cell, yielding an agent with a much higher 
activity [566]. Metabolism also yields other damaging agents. Mitomycin C, for 
example, undergoes a cycle of oxydation and reduction, thereby activating the agent and 
generating reactive oxygen species that cau cause additional damage to the cell [68, 414, 
529, 530]. Nitrogen mustard, cisplatin, and 8-methoxypsoralen also give rise to reactive 
oxygen species [15, 101]. On the other hand, metabolism also inactivates ICL agents, 
often via the cytochrome P450 reductase system [566]. Furthermore, intracellular thiols, 
such as glutathione and metallothionein, can detoxifY ICL agents [100]. 
ICL agents form a number of adducts with DNA. The adducts are not always 
produced randomly throughout the genome, because chromatin structure can influence 
adduct formation [222, 284, 552]. Mostly, ICLs only represent a small fraction of the 
adducts formed. Nevertheless, they are thought to be the main determinaut of the toxicity 
of ICL agents, due to their inhibition of DNA strand separation and therefore of DNA 
replication, transcription, and segregation. To adequately respond to the ICLs, cells have 
to recognize them. They could recognize the ICL itself by its distortion ofthe DNA helix. 
However, the three-dimensional structures of the ICLs are variable, which could influence 
the efficiency of!CL recognition and repair. Cells could also recognize the transcription 
or replication block induced by the ICLs. The damage response will lead to cell cycle 
arrest and, if repair fails, to cell death. The characteristics of a few classes of!CL agents 
are discussed below and summarized in Table 1. 
Psora/ens. Psoralens can be activated by UV A light to induce thymine monoadducts 
and ICLs between thymines at d(TpA) sequences in DNA. They are used in the treatment 
of several skin diseases like psoriasis, and belong to the group of furocoumarins, present 
in plants aud cosmetics [454]. The ratio of!CL to monoadduct can be influenced by the 
wavelength and dose ofUV A. In this way, up to 40% of the adducts can be converted to 
ICLs [63]. Compared to monoadducts, ICLs are more cytotoxic, mutagenic, and 
recombinogenic [15, 79, 189]. Psoralen-induced ICLs on an oligonucleotide induce 
relatively minor changes in the architecture of the DNA helix. There is no bend in the 
helix axis and only a 25' local unwinding of the helix [485, 486]. The cross-link is 
asymmetric, because it consists of a furan ring with one thymine and a pyrone ring with 
the other [63]. Repair of this ICL also shows asymmetry. Usually, there is a preference 
for incision of the furan side [21, 544]. 
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TABLE 1. Properties of a number of classes of!CL agents 
ICL agent 
class 
Psoralens 
Mitomycin C 
Platinum 
compounds 
Nitrogen 
mustards 
Representatives DNA sequence 
ofiCLs 
psoralen 
8-methoxypsoralen 
trimethylpsoralen 
mitomycin C 
cisplatin 
carboplatin 
trans-[PtC12(NH3) (quinoline)] 
or (thiazole)] 
transplatin 
nitrogen mustard 
melphalan 
chlorambucil 
5'-TA-3' 
' 3'-AT-5' 
5'-CG-3' 
3'-GC-5' 
5'-GC-3' 
3'-c'o-s· 
5'-G-3' 
3'-C-s· 
5'-GNC-3' 
3'-C'NG-5' 
Percentage 
ICLs' 
30-40% 
5-13% 
5-8% 
3-4% 
30% 
10-20% 
1-5% 
DNA 
distortionb 
minor 
minor 
major 
major 
Nitrosoureas BCNU'/carmustin 5'-G-3' <8% unknown 
CNU' ' 3'-C-5' 2.5% 
chlorozotocin 
'Percentage of all DNA adducts that are formed by the ICL agent. 
b Distortion of the DNA double helix by the ICL. Potential DNA distortions include 
kinks, bends, and unwinding of strands. 
'BCNU, bis-chloroethyl-nitrosourea; CNU, chloroethyl-nitrosourea. 
Mitomycin C. Mitomycin C, a natural antitumor antibiotic, forms adducts at the N-7 
and N-2 of guanine, intrastrand cross-links, and ICLs between the N-2 of guanines at 
d(CpG) sequences in the minor groove [274, 530]. ICLs constitute 5-13% of all adducts 
[558]. After injection in chicken embryos, the maximal adduct level is reached at 6 h due 
to the slow formation of ICLs from monoadducts [558]. Mitomycin C-induced ICLs 
cause relatively little DNA distortion [530]. 
Platinum compounds. Cisplatin forms many diadducts in DNA. It mainly reacts with 
guanines, forming 65% d(GpG) intrastrand cross-links, 25% d(ApG) intrastrand cross-
links and 5-8% ICLs between the guanines in the sequence d(GpC). The formation of an 
ICL from a cisplatin monoadduct takes a few hours, depending on the sequence context of 
the guanines. The ICLs are relatively unstable with a half-life of 29 h. The structure of a 
cisplatin ICL incorporated in an oligonucleotide has been solved and reveals a major 
distortion of the DNA. The platinum is located in the minor groove of the DNA. The 
helix displays a 47° bending towards the minor groove and a IJ0° unwinding, while 
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cytosines are extruded from the helix [321]. Carboplatin adducts are similar to cisplatin 
adducts, with 3-4% ICLs [47]. Transplatin forms different intrastrand cross-links and 
ICLs. The ICLs are formed between a complementary cytosine and guanine. Although 
the percentage of!CLs is higher, transplatin has a much lower cytotoxicity than cisplatin 
[57]. This difference could be due to the different structrue of the ICL allowing faster 
repair, slower conversion ofmonoadducts to ICLs, or lack of the toxic d(GpG) intrastrand 
adducts [321, 389]. Up to 30% of the adducts induced can be ICLs when cells are treated 
with trans-[PtC!,(NH3)(quinoline)] and trans-[PtC12(NH3)(thiazole)], which are derivatives 
of transplatin. These ICLs form between guanines in the sequence d(GpC), similar to 
cisplatin-induced ICLs [58]. 
Nitrogen mustards. ICLs constitute up to 5% of the DNA damage caused by nitrogen 
mustard and its derivatives. These ICLs cause a major DNA distortion [ 429]. Next to the 
N-7 guanine ICLs, formed in the sequence d(GpNpC), nitrogen mustards cause guanine 
monoadducts, DNA-protein cross-links and they also react with RNA. Melphalan and 
chlorambucil also cause N-3 adenine adducts [63, 410]. Nitrogen mustard ICLs are quite 
uustable with a half-life of 2 h, which decreases their toxicity compared to other, more 
stable ICLs [207]. 
Nitrosoureas. Nitrosoureas, for example bis-chloroethyl-nitrosourea (BCNU or 
carmustin), form guanine and cytosine monoadducts, guanine intrastrand cross-links, and 
guanine-cytosine ICLs after metabolic activation. ICLs constitute only a low percentage 
of total adducts. Nevertheless, the cytotoxicity of nitrosoureas is clearly linked to the 
number of ICLs formed [566]. Formation of the ICL from 0-6 guanine adducts takes 
several hours. Furthermore, DNA strand breaks and DNA-protein cross-links are formed 
by BCNU and proteins are also attacked by its carbamoylating activity. 
3 CLINICAL RELEVANCE OF DNA INTERSTRAND CROSS-LINKS 
As mentioned above, many ICL-inducing agents are used in the treatment of cancer. 
Knowledge about the formation and repair of these ICLs enables us to understand the 
clinical effectiveness and side-effects of these agents and to improve cytostatic therapy. 
Knowledge about ICL repair is also relevant for Fanconi anemia patients, whose cells are 
specifically sensitive to ICL agents. Fanconi anemia will be discussed later. 
Cytostatic therapy is based on selective killing of tumor cells, while normal cells are 
spared as much as possible. For example, the activation of mitomycin C is stimulated in 
the hypoxic environment in many solid tumors, while the well-oxygenated cells in the rest 
of the body show less mitomycin C activation [ 530]. Part of the selectivity of all ICL 
agents for tumor cells is achieved by interfering with DNA transcription and replication. 
These processes are more active in rapidly dividing cells and in general, tumor cells divide 
more rapidly than nontumorigenic cells. ICLs inhibit DNA metabolism, they cause 
mutations and chromosomal damage, and can induce apoptosis. Unfortunately, tumors 
can be intrinsically resistant to certain agents, or become so after treatment [161]. For 
example, intrinsic resistance to cisplatin occurs in hereditary nonpolyposis colorectal 
carcinomas which are mismatch repair deficient. The reason is that mismatch repair-
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deficient cells can tolerate cisplatin adducts better than repair-proficient cells. This is not 
true for all platinating agents, so some of them can still be used in treating these tumors 
[ 161, 540]. Mismatch repair deficiency is often induced in ovarian tumors, also yielding 
cisplatin-resistant cells [ 67]. 
Resistance to ICL agents can be caused by many mechanisms, which often operate 
together, increasing resistance even more. In many cases, there is a clear correlation 
between the level of ICLs formed or the repair activity on ICLs and the sensitivity of 
tumor cells [244, 488, 566, 591]. In some cases, though, resistance is not correlated to the 
ICL level, but to other adducts formed [540]. In many tumors, overexpression of multi-
drug transport proteins causes resistance to chemotherapeutic agents by increased export 
of the agents from the cell [285]. Tumor cells often have a different metabolism than 
nontumorigenic cells, reducing the formation of active metabolites, or increasing 
deactivation of the drug. A higher level of glutathione or metallothionein can increase the 
detoxification of!CL agents [6, 397, 470]. Increased base excision repair can remove, for 
example, the 0-6 guanine monoadducts formed by BCNU, thereby preventing ICL 
formation, which takes a few hours [566]. Conversely, inactivation of the responsible 
alkyltransferase can make tumors more sensitive to certain ICL agents [156, 204, 412]. 
Finally, repair of the ICLs can be increased in resistant tumors [6, 244, 379, 488, 582, 
591]. Some of these mechanisms cause cross-resistance to ICL agents of several classes, 
while others are agent-specific [59, 161, 204, 566]. Knowledge of the mechanisms by 
which a tumor has become resistant to treatment may guide the development of additional 
treatments that could still be effective. 
4 DETECTION OF DNA INTERSTRAND CROSS-LINKS AND REPAIR 
INTERMEDIATES 
It is important to be aware of the methods used to assess the level of ICLs and their 
repair intermediates to correctly interpret the data that are obtained. It has to be kept in 
mind that ICLs form only a small fraction of the induced DNA damage, except when one 
ICL has been produced at a specific position on a plasmid. The damage response, repair 
activity, and survival of the cell are also determined by the other types of damage. The 
main difference between an ICL and any other DNA damage is that ICLs covalently bind 
the two strands of the DNA double helix together. Thereby, separation of the two strands 
by denaturation is made impossible. This property yields different sedimentation rates of 
native versus cross-linked DNA in alkaline sedimentation methods and causes different 
mobility in agarose and polyacrylamide gels. After incision in at least one DNA strand 
near the ICL, the DNA strands can be separated again by denaturation. This step of repair 
can thus be followed in time by measuring the fraction of DNA that can be denatured. A 
drawback of these methods is their relatively low sensitivity and therefore they require a 
high level of ICLs, which is lethal for almost all cells and may saturate repair pathways. 
Furthermore, the nature of the incision, on one or both sides of the ICL, in one or both 
DNA strands, cannot be determined. The recovery of the ability to denature cross-linked 
DNA is often used to compare the repair proficiency in sensitive and resistant cell lines, 
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although it only measures the first step of repair. Sometimes DNA double-strand breaks 
(DSBs) are formed during repair. They can be observed in yeast as relatively low-
molecular weight DNA during alkaline or neutral sucrose sedimentation and as a smear 
during pu!sed-f1eld gel electrophoresis of the chromosomes. Recovery of high-molecular 
weight DNA and disappearance of the smear can indicate repair of the DSBs over time. 
5 DNA INTERSTRAND CROSS-LINK REPAIR IN ESCHERICHIA COLI 
!CL repair in E. coli has been characterized both genetically and biochemically. In 
the major pathway of ICL repair, nucleotide excision repair (NER) and homologous 
recombination work together to remove the ICL [104, 544]. The biochemical work has 
mainly made use of psoralen ICLs and resulted in a model for ICL repair that is 
schematically presented in Figure lA In vitro, repair starts with incisions around the ICL 
in one DNA strand (Fig. IA2). When a psoralen ICL is present, this is usually the strand 
with the furan ring. The incisions are made by the NER enzymes UvrABC at the ninth 
phosphodiester bond 5' and the third bond 3' to the ICL [545]. The result is an !!-base 
oligonucleotide which is covalently bound to the complementary DNA strand by the ICL 
Then, the 5' -exonuclease activity of DNA polymerase I makes a gap at the 3' end of the 
ICL (Fig. IA3) [105, 476]. This yields a single-stranded DNA (ssDNA) region which is 
necessary for RecA to initiate recombination. RecA is the central protein in homologous 
recombination in E. coli. It performs strand exchange with intact homologous DNA 
FIG. 1. ICL repair pathways in E. coli. The black and white DNA duplexes represent sister 
chromatids and the vertical lines represent base pairs. Newly-synthesized DNA is 
indicated in gray. The ICL is indicated by the thick diagonal line connecting the DNA 
strands. 
(A) Repair of the ICL by excision repair and homologous recombination. (A1) Introduction 
of an ICL into the DNA (A2) The NER enzymes UvrABC make incisions in one DNA 
strand both 5' and 3' to the ICL. (A3) The exonuclease activity of DNA polymerase I 
produces a ssDNA gap on the 3' side of the ICL. This enables RecA to form a 
nucleoprotein filament on the ssDNA (A4) The RecA nucleoprotein filament pairs with 
intact homologous dsDNA and performs strand exchange past the cross-linked 
oligonucleotide. Strand invasion of the damaged DNA into the homologous dsDNA 
initiates DNA synthesis. (A5) The resulting Holliday junctions are resolved to separate the 
two DNA molecules. To excise the cross-linked oligonucleotide, UvrABC incises the 
complementary DNA strand on both sides of the ICL. (A6) The remaining ssDNA gap in 
the chromosome is filled in by DNA polymerase I and ligated, resulting in the release of a 
cross-linked oligonucleotide. 
(B) Repair of the ICL by excision repair and translesion DNA synthesis. (81) Introduction 
of an ICL into the DNA (82) The NER enzymes UvrABC make incisions in one DNA 
strand both 5' and 3' to the ICL. (83) Translesion DNA synthesis is performed by DNA 
polymerase II. (84) To excise the cross-linked oligonucleotide, UvrABC incises the 
complementary DNA strand on both sides of the ICL. (85) The remaining ssDNA gap in 
the chromosome is filled in by DNA polymerase I and ligated, resulting in the release of a 
cross-linked oligonucleotide. 
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resulting in heteroduplex DNA encompassing the region containing the cross-linked 
oligonucleotide (Fig. 1A4) [476]. As a result, a three-stranded region occurs with 
predominantly base pairing of the full-length strands. This enables UvrABC to incise the 
other DNA strand, containing the pyrone ring (Fig. lAS). Thereby, UvrABC enables the 
release of the ICL-containing DNA fragment [96, 476]. The resulting gap can be filled in 
by DNA polymerase I and ligated (Fig. 1A6). 
In a RecA-deficient strain, repair of psoralen ICLs decreases to 2% of wild-type 
repair, while repair of a nitrogen mustard ICL decreases only to 30% [36, 406]. This 
suggests that the stmcture of the ICL is important for the repair efficiency of different 
pathways. Repair in RecA-deficient strains is dependent on NER and DNA polymerase II 
(Fig. lB) [35]. Repair is once again inititated by UvrABC incising one strand of the 
cross-linked DNA (Fig. 1B2). But because recombination is impaired, DNA polymerase 
II synthesizes DNA across the region spanning the cross-linked oligonucleotide (Fig. 
1B3). Then, UvrABC removes the ICL by incisions in the complementary DNA strand 
(Fig. IB4). Thus, besides the major RecA-dependent recombination repair, a minor DNA 
polymerase ll-dependent translesion repair pathway is capable of repairing ICLs. 
In vivo, more proteins are involved in the repair process. Bacteria deficient in one of 
a number of recombination proteins, such as RecB, C, D, F, G, 0, R, are sensitive to ICL 
agents [216, 589]. RecFOR promotes the binding of RecA to ssDNA and facilitates 
homologous pairing by RecA, especially in the absence of a DSB [538, 559]. RecBCD is 
necessary when a DSB is formed during ICL repair. DSBs can be formed by the direct 
action of nucleases. Alternatively, when a nick has been made next to an ICL, the 
encounter of a replication fork will yield a DSB. Finally, a replication fork that is stalled 
by an ICL can also result in a DSB without a pre-existing nick. RecBCD resects DSBs 
producing a 3' ssDNA overhang and it loads RecA onto the ssDNA [8]. RecG or 
RuvABC are responsible for the resolution of the recombination intermediates [113, 268]. 
Finally, some ICL repair is seen in uvr mutants, which are unable to follow either of the 
pathways mentioned above. After replication is stalled due to the adduct, recombinational 
repair or bypass may be induced without the need for UvrABC in the process, possibly 
using other nucleases [553]. 
6 DNA INTERSTRAND CROSS-LINK REPAIR IN SACCHAROMYCES 
CEREVISIAE 
ICL repair inS. cerevisiae has not been characterized in as much detail as repair in E. 
coli. A significant amount of information is available about the genes involved in ICL 
repair, but not specifically about their involvement in ICL repair (Table 2). Most ofthese 
genes belong to one of the DNA repair pathways that process other types of lesions as 
well: NER, homologous recombination, and postreplication/translesion repair [63]. 
Survival after treatment with ICL agents is also affected by mutations in base excision 
repair and mismatch repair. Base excision repair can prevent the formation of ICLs by 
repair of precursor lesions [336]. Mismatch repair sensitizes cells to ICL agents as it 
interferes with translesion synthesis past monoadducts and intrastrand cross-links [147]. 
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TABLE 2. Glossary of eukaryotic genes mentioned in this review'. 
S. cerevisiae Mammals S. cerevisiae Mammals 
Nucleotide excision repair Post-replication/translesion repair 
RADI XPFIERCC4 (continued) 
RAD2 XPGIERCC5 RAD30 RAD30/XPV/POL 1] 
RAD30B/POL t 
POLe 
RAD3 XPDIERCC2 
RAD4 XPC 
RADIO 
RADI4 
RAD23 
RAD25 
ERCCI 
XPA 
RAD23A 
RAD23B 
XPB/ERCC3 
Homologous recombination 
RAD50 RAD50 
RAD5I RAD5I 
RAD55 RAD5IB 
RAD57 RAD5IC 
RAD52 
RAD59 
RAD54 
RDH54/TIDI 
MREII 
XRS2 
RAD51D 
XRCC2 
XRCC3 
RAD52 
RAD54 
RAD54B 
MREJI 
NBSI 
BRCAI 
BRCA2 
PostreplicationJtranslesion repair 
RAD6 HHR6AIUBCHI 
RADI8 
POL30/PCNA 
RAD5/REV2/SNM2 
MMS2 
UBCJ3 
REV3/PSOI 
REVI 
REV7 
HHR6B/UBCH2 
RADI8 
PCNA 
(only Arabidopsis 
thaliana RAD5) 
MMS2 
CROC-I 
UBE2N 
REV3 
REVI 
REV7 
DNA interstrand cross-link repair 
Non-homologous end joining 
KU70/HDFI KU70 
KU80/HDF2 KU80 
Other genes 
SNMI/PS02 
DNA-PKc, 
SNMI 
SNMIB 
SNMIC/ARTEMIS 
PS03/WHI2 
PS04/PRPI9 NMP200 
FA genes 
Cell cycle checkpoint genes 
RAD9 
RAD17 
DDCI 
MEC3 
RAD24 
MECI 
TELl 
CHKI 
RAD53 
RADISp 
RAD9 
HUSI 
RADI7 
ATM 
ATR 
CHKI 
CHK2 
a The genes are assigned to the different 
repair or checkpoint pathways according to 
genetic and biochemical data. They are 
mentioned in one group, also when there 
are indications for a function in other 
groups as well. Sequence homology 
between S. cerevisiae and mammalian 
genes is indicated. When different 
homologs/paralogs of certain genes exist, 
they are listed, slightly indented, below 
each other. 
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Next to the genes that were already known for a role in DNA repair, some genes involved 
in ICL repair have been identified by searching for mutations that sensitize yeast cells to 
ICL agents, namely SNMJ, SNM2, PSOJ, PS02, PS03, and PS04 [208, 210, 439]. 
SNM2 and PSOI later appeared to be allelic to RAD5/REV2 and REV3, respectively, and 
therefore belong to the postreplication/translesion repair group of genes [82, 468]. The 
other genes, PS03, PS04, and SNMI which is allelic to PS02, do not clearly belong to 
one of the abovementioned DNA repair pathways and will be dealt with separately below 
[82]. 
6.1 Cell cycle effects of DNA interstrand cross-links 
DNA damage induces cell cycle arrest to allow DNA repair and prevent genetic 
instability. This arrest is achieved by activating cell cycle checkpoint pathways (for 
reviews see [166, 316, 561, 594]). The intricate network of proteins involved in DNA 
damage-induced cell cycle checkpoints recognizes the presence of damage, arrests the cell 
cycle after signal transduction, affects transcription of repair genes and post-translational 
modifications of repair proteins, and influences DNA repair processes. It is not yet known 
how the cell achieves recognition of all different kinds of DNA lesions. The so-called 
sensor proteins in S. cerevisiae, including Rad9, Ddcl, Mec3, Radl7, and Rad24 may 
recognize lesions directly, or after processing to a common intermediate such as ssDNA. 
Alternatively, they may sense changes in chromatin structure or interact with DNA repair 
proteins. Different damages may be recognized by different sensor proteins, thereby 
affecting the type of checkpoint response. During S phase, the replication complex is also 
involved in signaling damage. The damage response signal is transduced by Mecl, 
Rad53, and Chkl, which activate proteins further downstream that affect cell cycle 
progression and DNA repair. 
Although much is known about the response of cells to 254-nm UV light (UV254 mn) 
or ionizing radiation, little is known about cell cycle arrest after treatment with ICL 
agents. Different ICL agents trigger different cell cycle responses. 8-methoxypsoralen 
plus UV A in a high dose, inducing three ICLs per replicon, causes G2 delay after 
treatment in S or G2 phase. Cells treated in G l show G l arrest [345]. In contrast, after 
treatment with cisplatin, no G l arrest is found. This might be due to differences in the 
detection of cisplatin and psoralen DNA lesions. At a relatively low dose of cisplatin, 
40% survival and less than one ICL per replicon, wild-type yeast cells show only a G2 
delay after treatment in Gl [192, 193]. Repair-deficient cells treated with a low dose of 
cisplatin and wild-type cells treated with a high dose show a permanent G2 arrest [193]. 
This G2 arrest is not directly dependent on the number of adducts induced, but may 
depend on repair or replication intermediates. Apparently, replication can tolerate or 
bypass a low number of cisplatin ICLs. Nevertheless, at a high dose, cisplatin also 
induces S phase delay [193]. This S phase delay and the G2 arrest depend on MECJ, one 
of the cell cycle checkpoint genes [192, 193]. 
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6.2 Processes during DNA interstrand cross-link repair 
6.2.1 Recognition and incisions 
The first step in the repair of a DNA lesion is recognition. Up to now, no specific 
proteins involved in ICL recognition have been found. Recognition could occur when the 
replication or transcription machinery encounter an ICL and become blocked. 
Alternatively, or in addition, the NER DNA damage recognition proteins or other ICL 
structure-specific DNA binding proteins could recognize the ICLs and initiate repair. 
Shortly after ICLs are formed in yeast as measured by the inhibition of DNA 
denaturation, this inhibition is overcome [229, 320, 344, 348]. This indicates either that 
incisions surrounding the ICL are made in one strand, as in E. coli, or that incisions are 
made in both strands resulting in DSBs. Formation of DSBs during ICL repair is much 
more prominent in S. cerevisiae than in E. coli, indicating an important difference in the 
processing ofiCLs in bacteria versus fungi [119, 120, 229, 320]. 
The first incision near the ICL is supposed to be made by NER enzymes, since in 
radl, rad2, and rad3 cells, cross-linked DNA cannot be denatured after incubation of the 
cells to allow repair, in contrast to the situation in mutants defective in homologous 
recombination or postreplicationltranslesion repair [344, 348]. It is not known whether 
the NER nucleases are also responsible for incisions made later in the process of ICL 
repair. NER is known for the repair ofUV 254 nm-induced lesions and bulky adducts, which 
damage only one strand. A structure-specific endonuclease consisting of a heterodimer of 
the Radl and RadiO proteins makes an incision on the 5' side of the lesion. A second 
endonuclease involved in NER, Rad2, makes the incision on the 3' side of the lesion. 
Together, they facilitate the removal of an oligonucleotide containing the lesion. NER 
consists of two subpathways, global genome repair and transcription-coupled repair. The 
latter subpathway provides fast repair of transcriptionally active genes [169]. ICL repair 
in transcriptionally active genes is also often faster than the repair in transcriptionally 
inactive chromatin regions [21, 344, 345]. This could be due to the presence of more 
accessible chromatin in transcriptionally active regions or to a potential transcription-
coupling activity associated with the NER enzymes acting early in ICL repair. The latter 
hypothesis is supported by the finding that mutations induced by psoralen-induced ICLs 
are most often found at the position of the thymine in the nontranscribed strand [21]. 
The NER nucleases are supposed to make incisions in only one of the strands of 
double-stranded DNA ( dsDNA). DSB formation could be caused either by two closely 
separated incisions on opposite strands or by replication of nicked DNA This would 
explain the observation that in exponentially growing cells, usually a higher level of DSB 
formation is found than in stationary cells [119, 337]. However, some DSB formation has 
been found in cells deficient for the NER proteins Rad1, Rad2, and Rad4, suggesting there 
are other ways of making incisions [33 7]. 
6.2.2 Recombination 
The DSBs formed after incision of the ICL have to be repaired by one of the DSB 
repair pathways. The major pathway inS. cerevisiae is homologous recombination using 
either the sister chromatid or the homologous chromosome. Some of the key genes 
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involved in homologous recombination are RAD51, RAD52, and RAD54 (Table 2) (See 
also Chapter I) [253]. Yeast cells mutant for one of these genes are sensitive to ICL 
agents, and they show a decrease in the recovery of high-molecular weight DNA after 
DSB formation during the repair of ICLs [14, 229, 337]. Homologous recombination is 
less important for ICL repair in haploid yeast treated in stationary phase, as only few 
DSBs are formed and there is no homologous DNA available for recombination [337, 
467]. It should be noted, however, that treatment of yeast cells in stationary phase is 
followed by proliferation of the cells when survival is assessed. On cell proliferation, 
homologous recombination is feasible again. Therefore, survival is also reduced in 
homologous recombination-deficient cells, treated in stationary phase. The second DSB 
repair pathway is nonhomologous end-joining (NHEJ) in which for example the yKU70 
andyKU80 are involved. Mutants in NHEJ are not sensitive to ICL agents and ku70rad52 
double mutants are as sensitive as rad52 mutants, suggesting that NHEJ cannot 
compensate for a defect in homologous recombination [337]. Nevertheless, while rad52 
mutants perform some DSB repair during nitrogen mustard ICL repair, in a ku70rad52 
double mutant no DSB repair is fouud [337]. NHEJ may therefore still have a minor role 
in processing ICL repair intermediates. 
In some cases, homologous recombination was found to be epistatic to NER with 
regard to ICL repair, suggesting that they participate in one pathway as described above 
[209]. In most cases, however, synergism is observed, with double mutants being more 
sensitive than either single mutant, which suggests that they are involved, at least 
partially, in alternative routes of repair [85, 319]. This means that other pathways 
supplement NER and recombination, as it is difficult to imagine complete repair of ICLs 
by just the one or the other pathway. 
6.2.3 Postreplication/translesion repair 
Postreplication/translesion repair provides at least one additional route for repair of 
ICLs. Postreplication/translesion repair mutants usually are synergistic with both NER 
and recombination repair mutants [85]. The mechanism of postreplication/translesion 
repair is less well known than that of NER or homologous recombination. Mostly, this 
pathway does not repair a lesion, but helps the cell to tolerate or bypass the lesion. The 
major genes in postreplication/translesion repair are RAD6, encoding a ubiquitin-
conjugating enzyme that is also involved in other cellular pathways, and RAD18 [288]. 
These two genes take part in most routes of postreplication/translesion repair. 
Postreplication/translesion repair consists of several subpathways, which are either error-
free or error-prone [288, 575]. One error-free pathway involves Pol30/PCNA and DNA 
Polymerase 8, the other Rad5/Rev2/Surn2 [5, 242, 468, 575]. The mechanisms of the 
error-free pathways are still unknown. Rad5 and Rad!S are both ssDNA-dependent 
ATPases, bind DNA, and can form a complex with each other and the ubiquitinating 
proteins Ubcl3-Mms2 and Rad6, respectively [17, 243, 537]. The error-prone pathway 
consists of the trans!esion DNA polymerase<; (zeta) complex, formed by Rev3/Psol and 
Rev7, but the translesion synthesis of this complex also depends on Rev! [82, 288, 357, 
373, 374]. RAD5 plays a role in the error-prone pathway as well [304]. RAD30, which 
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encodes DNA polymerase 11 (eta), is also part of the postreplication/translesion repair 
pathway [334]. 
rad6 and rad18 mutants are sensitive to ICL agents both after treatment during 
exponential growth and during stationary phase followed by exponential growth [209, 
337]. The induction of DSBs after ICL formation is normal, but they are slowed down in 
the restitution of high-molecular weight DNA [80, 119]. In contrast to NER and 
homologous recombination mutants, which show an increase in ICL-induced mutagenesis, 
rad6 and radl8 mutants show a decrease in mutagenesis in response to JCL agents [22, 
80]. Mutagenesis induced by ICLs formed during stationary phase is probably mainly 
dependent on translesion DNA synthesis by DNA polymerase c;, that can efficiently 
bypass UV254 om and bulky adducts but at the expense of a high mutation rate [30, 288, 
304, 374, 431]. A DNA polymerase c; mutant, rev3, is not sensitive to ICL agents when 
the cells grow exponentially [337]. rev3 mutants are also less sensitive to DNA-damaging 
agents than rad6 or rad18 mutants [288]. This implies that the error-free subpathways of 
the postreplicationltranslesion repair pathway also have an important function in ICL 
repmr. 
6.3 Additional genes involved in DNA interstrand cross-link repair 
SNMI. Some genes that are involved in ICL repair do not quite fit into one of the 
major repair pathways. One of them is SNMI/PS02 [427]. snml mutants are sensitive to 
JCL agents, but in contrast to the abovementioned genes, they are only slightly or not 
sensitive to UV254 nm' ionizing radiation, and monofunctional alkylating agents [63, 208, 
439]. The relative sensitivity of snml cells compared to wild-type cells is much higher for 
nitrogen mustard than for psoralens, suggesting some ICL agent specificity [81]. 
Expression of SNMI is induced by JCL agents and UV254 om in exponentially growing cells 
[570]. In stationary cells, the expression level is two times lower and is not induced by 
DNA damage [570]. There are no indications for a role of Snml in cell cycle 
checkpoints, as the cell cycle arrest after cisplatin treatment of snml cells is similar to the 
arrest of wild-type cells [193]. 
SNMI encodes a nuclear protein, that is a member of the NER epistasis group with 
respect to monoadducts and ICLs and shows the same preference for repair of 
transcriptionally active genes [207, 209, 344, 467]. However, with respect to treatment of 
cells with ICL agents, the SNMI gene also appears to be epistatic to REV3, a 
postreplication/translesion repair gene that is synergistic to the NER genes [209]. snml 
cells show a reduced mutagenesis after ICL agent treatment, which also suggests that 
Snml is involved in an error-prone repair pathway [78, 80, 81]. Nevertheless, snml 
shows synergism with the other postreplication/translesion repair mutants rad5 and rad6 
[ 467]. Similar to postreplication/translesion repair mutants but in contrast to NER 
mutants, snml cells are able to incise lCLs and produce DSBs, but they are not able to 
reconstitute high-molecular weight DNA [193, 320, 567]. Similar to the recombination 
mutants, they do not show the increased resistance in 02 or in diploid yeast cells that is 
observed in wild-type cells [78, 208]. Damage-induced recombination is also decreased 
in snml cells after treatment with 8-methoxypsoralen plus UV A, but not after nitrogen 
DNA interstrand cross-link repair 89 
mustard treatment [ 441]. The repair of a psora! en ICL on exogenous plasmid DNA is not 
impaired in snml mutants in contrast to NER and recombination mutants [319]. This 
suggests that Smnl could be involved in some chromatin modulation activity. Snml 
could function in a mutagenic, recornbinogenic repair pathway that is specific for ICL 
repair and does not belong to the recombination or postreplication/translesion repair 
pathways. It might also link incision of the ICL by NER to recombination or trans lesion 
synthesis. Alternatively, it could have a role in the regulation of!CL repair. 
PS03. Another gene involved in ICL repair is PS03. pso3 mutant yeast cells are 
sensitive to both psoralen monoadducts and ICLs, but also to H20 2• They are, however, 
not sensitive to UV254 nm, ionizing radiation, or alkylating agents [62, 207]. With regard to 
ICL repair, PS03 is epistatic to RAD3, SNMI, and REV3, but synergistic with RAD6 [32, 
207]. Compared to wild-type cells, pso3 cells show reduced mutagenesis and gene 
conversion frequencies, but an increased number of crossovers after ICL agent treatment, 
both in haploid and diploid cells [62, 78, 123, 342]. These features are similar to those of 
snml cells. PS03 may be allelic to WHI2, a gene involved in the regulation of cell 
growth and cell division [207, 415, 449]. Therefore, it might form one ofthe connections 
between repair and cell growth regulation. 
PS04. PS04 is another gene identified by sensitivity of mutant cells to treatment 
with psoralens [210]. It is allelic to PRP19, an essential gene that is involved in pre-
rnRNA splicing [97, 190]. The pleiotropic DNA repair defective phenotype ofpso4 cells 
could be explained by a requirement for Pso4 function in different repair pathways and in 
splicing. Alternatively, its involvement in DNA damage repair could be explained by 
inhibited splicing ofpre-rnRNAs of DNA repair genes inpso4 mutant cells. 
6.4 Conclusions on Saccharomyces cerevisiae DNA interstrand cross-link 
repair 
Surveying the data available, there is no single pathway responsible for all ICL repair. 
Different ways of dealing with ICLs are used, dependent on position and type of the ICL, 
the cell cycle phase, ploidy, chromatin structure, and availability of ICL repair proteins. 
In Figures I, 2, and 3, we have depicted models showing different hypothetical pathways 
by which ICLs could be repaired or bypassed in yeast in accordance with the genetic and 
biochemical data described above. The first two pathways described are similar to the E. 
coli ICL repair pathways (Fig. lA, B). Repair starts with incisions next to the ICL in one 
DNA strand. These incisions could be made by the NER enzymes and they may occur 
preferentially in transcriptionally active genes. When a sister chromatid or homologous 
chromosome is available, homologous recombination could continue the repair reaction, 
similar to the situation in the major E. coli ICL repair pathway, without the need for a 
DSB (Fig. !A). Resolution ofthe homologous recombination intermediate leads to a gene 
conversion event with or without a crossover. Only the latter outcome is depicted. NER 
enzymes could finally remove the ICL by incisions around it in the complementary DNA 
strand. This repair route is principally error-free. 
In the absence of homologous DNA, recombination repair is not possible. A more 
error-prone postreplication/translesion repair route might then take over. After incision 
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next to the ICL in one DNA strand by the NER enzymes or some other nuclease, DNA 
polymerase S could bypass the base on the other strand which is bound to the cross-linked 
oligonucleotide (Fig. 1B3). Subsequently, a second round of NER activity could remove 
the cross-linked oligonucleotide leading to restoration of intact DNA (Fig. 1B4, 5). Base 
pair substitutions are expected to occur frequently dming translesion synthesis. When 
NER is eliminated, ICL repair becomes more error-prone, not only yielding base pair 
substitutions but also insertions [22]. Other nuclease(s) might incise the DNA near the 
ICL, or breaks could occur upon a replication block. They could be processed either by a 
recombinational pathway or a translesion synthesis pathway. 
In yeast, DSBs are often found after the induction of ICLs. These DSBs, either 
formed by NER or other nucleases, could be the intermediate for initiating recombination 
(Fig. 2). DSBs might occur on both sides of the ICL, thereby immediately removing the 
ICL (Fig. 2Al). Homologous recombination could then continue the repair reaction 
similar to the repair of DSBs induced by other damaging agents, like restriction enzymes 
or ionizing radiation (See Chapter 1). After nucleolytic processing, strand invasion of one 
or both ends takes place, leading to DNA synthesis to bridge the gap (Fig. 2A2, 3). 
Formation and resolution of Holliday junctions or reaunealing of the elongated DSB ends 
result in two intact DNA molecules (Fig. 2A4, 5). In Figure 2, we have only depicted the 
outcome after gene conversion without crossover, but crossovers could equally well occur. 
When DSBs are formed, as described here, on both sides of the ICL, the DSBs could also 
be repaired by NHEJ. This would result in deletion of the sequences around the ICL. 
However, yeast cells mutant for NHEJ are not sensitive to ICL agents, which leads to the 
conclusion that this pathway cannot play a major role in ICL repair [337]. 
Alternatively, ICL repair could proceed via a single DSB (Fig. 2B, C). Only the DSB 
end that does not contain the ICL can be exonucleolytically processed and invade 
homologous DNA on the sister chromatid or homologous chromosome (Fig 2B2, B3, C2, 
C3). The continuity of the chromosome with the ICL could be restored by break-induced 
replication initiated from the invaded end (Fig. 2B4) (See also Figure 3 in Chapter 1) 
[386]. Break-induced replication cannot pass the centromere, so for this pathway the DSB 
has to be made on the centromere-proximal side of the ICL. The result is replacement of 
the centromere-distal part of the chromosome, including the ICL, by homologous DNA 
(Fig. 2B5). The chromosome fragment containing the ICL will be lost. As an alternative 
to break-induced replication, the invading end could, after being extended by DNA 
synthesis, unwind again from the homologous DNA molecule. This model requires the 
introduction of an additional nick in one DNA strand on the other side of the ICL (Fig. 
2C3). Resection or unwinding of the 5' end of the nick would result in a ssDNA region. 
The unwound newly-synthesized DNA strand could anneal with this ssDNA (Fig. 2C4). 
Cleaving off the unpaired tails or flaps including the ICL, and DNA synthesis and ligation 
ofthe remaining gap would result in intact DNA molecules (Fig. 2C5). The Radl-RadlO 
heterodimer is known to remove unpaired tails during homologous recombination, and 
could therefore also be responsible for the removal of these unpaired tails during ICL 
repair [ 18]. 
An alternative to removing ICLs is to bypass them during DNA replication. Two 
pathways that could lead to ICL bypass after replication stalling and formation of a DSB 
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are depicted in Figure 3A and B. In both pathways, an incision in one DNA strand in 
front of the ICL is necessary to enable the unwinding of the DNA needed for DNA 
recombination and replication. Due to this incision, a DSB occurs in the sister chromatid 
that does not contain the ICL (Fig. 3Al, Bl). This DSB can be repaired by homologous 
recombination using the homologous chromosome in diploid yeast cells (Fig. 3A). The 
DSB in the sister chromatid that does not contain the ICL is nucleolytically processed and 
the 3' ssDNA tail invades the homologous chromosome (Fig. 3A2). After DNA 
synthesis, the tail unwinds again from the homologous chromosome (Fig. 3A3). The 
elongated tail end is homologous to the sequence behind the ICL on the cross-linked sister 
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FIG. 2. Putative ICL repair pathways in S. cerevisiae. This figure shows repair pathways 
starting from a DSB. ICL repair pathways starting from incisions in one DNA strand are 
depicted in Figure 1. The black and white DNA duplexes represent homologous 
sequences, usually sister chromatids or homologous chromosomes, and the vertical lines 
represent base pairs. Newly-synthesized DNA is indicated in gray. The ICL is indicated by 
the thick diagonal line connecting the DNA strands. 
(A) Repair of an ICL by homologous recombination after incisions producing two DSBs. 
(A1) DSBs are formed on either side of an ICL, removing the ICL and yielding a gap. (A2) 
The DSB ends are nucleolytically processed producing 3' ssDNA tails. (A3) The ssDNA 
tails invade homologous dsDNA, usually the sister chromatid or homologous chromosome. 
DNA is synthesized starting from the ends to Jill the gap. (A4) By DNA synthesis and 
ligation of the ends, a four-stranded DNA intermediate is formed containing two Holliday 
junctions. (A5) Resolution of the Holliday junctions results in two intact DNA duplexes with 
gene conversion of the region that contained the lCL. Holliday junction resolution can also 
lead to a crossover. As an alternative to Holliday junction formation, the two newly-
synthesized DNA strands can unwind from the homologous DNA and anneal according to 
a DSB repair model that is called synthesis-dependent strand annealing. A number of 
variations on this model have been described (Chapter 1) [386]. 
(B) Repair of an ICL by the formation of one DSB and homologous recombination resulting 
in break-induced replication. (B1) Incisions produce a DSB on the centromeric side of an 
ICL. (B2) The DSB end that does not contain the ICL is nucleolytically processed resulting 
in a 3' ssDNA tail. (B3) The ssDNA tail invades homologous dsDNA. The ICL-containing 
telomeric part of the chromosome is degraded. (B4) In a process called break-induced 
replication, a replication fork is formed with both leading and lagging strand DNA synthesis 
to elongate both strands of the invading DSB end. DNA synthesis is continued up to the 
end of the chromosome. (B5) The Holliday junction formed by the DNA strand invasion is 
resolved. Alternatively, but not depicted here, the Holliday junction could branch migrate 
up to the end of the chromosome. 
(C) Repair of an ICL by the formation of one DSB and homologous recombination resulting 
in single-strand annealing. (C1) On one side of the ICL, incisions produce a DSB. (C2) 
The DSB end that does not contain the ICL is nucleolytically processed resulting in a 3' 
ssDNA tail. (C3) The ssDNA tail invades homologous dsDNA. DNA is synthesized 
starting from the invading strand. An incision is made in one DNA strand on the other side 
of the ICL. (C4) The newly-synthesized DNA unwinds from the homologous DNA 
molecule. The nick on the other side of the ICL is processed into a ssDNA region by 
resection or unwinding of the DNA. This ssDNA region can anneal with the newly-
synthesized DNA strand. As a result, the ICL-containing DNA is displaced and forms a 
flap. Depending on the position of the ssDNA region and the length of newly-synthesized 
DNA strand, a ssDNA flap is produced on the other side of the annealing region as well. 
(C5) The flaps are removed by an endonucleolytic incision. The remaining gaps are filled 
in by DNA synthesis and ligation. 
chromatid. Invasion of the tail into the cross-linked sister chromatid, followed by DNA 
synthesis and Holliday junction resolution yields a new replication fork, with successful 
bypass of the !CL (Fig. 3A4, 5). In haploid yeast cells, the DSB could be repaired by 
strand invasion of the DSB end into the cross-linked DNA (Fig. 3B2). A second incision 
behind the ICL facilitates temporary displacement of the cross-linked oligonucleotide. 
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FIG. 3. Putative pathways to bypass an ICL during replication in S. cerevisiae. The black 
and white DNA duplexes represent homologous chromosomes and the vertical lines 
represent base pairs. Newly-synthesized DNA is indicated in gray. The ICL is indicated by 
the thick diagonal line connecting the DNA strands. 
(A) Bypass of an ICL at a stalled replication fork by recombinational mechanisms. This 
pathway is only feasible in diploid cells. (A 1) The presence of an ICL causes arrest of a 
replication fork. An incision in the leading strand DNA template nex1 to the ICL produces a 
nick nex1 to the ICL in the lagging strand and a DSB on the DNA containing the leading 
strand. Repair is similar when the first incision is made in the lagging strand template. 
(A2) The DSB is nucleolytically processed, forming a 3' ssDNA tail, that invades the 
homologous chromosome. DNA is synthesized from the DSB end to bridge the region of 
the ICL. (A3) The newly-synthesized DNA unwinds from the homologous chromosome. 
The DNA could be made double-stranded again by DNA synthesis. (A4) The elongated 3' 
ssDNA end can now invade the cross-linked DNA molecule behind the ICL. Both leading 
and lagging DNA synthesis are started. (A5) Resolution of the Holliday junction formed by 
the second invasion step results in the recovery of a normal replication fork with successful 
bypass of the ICL. 
(B) Bypass of an ICL at a stalled replication fork by recombination and translesion 
synthesis. This pathway is feasible in both haploid and diploid cells. (B1) The presence of 
an ICL causes arrest of a replication fork. Incisions in the lagging strand template next to 
the ICL produce nicks on both sides of the ICL in the leading strand and a DSB on the 
DNA containing the lagging strand. Repair is similar when the first incisions are made in 
the leading strand template. (B2) The DSB is nucleolytically processed, forming a 3' 
ssDNA tail, that invades the sister chromatid in front of the ICL. (B3) The cross-linked 
oligonucleotide is displaced and DNA is synthesized from the invading end past the ICL by 
translesion DNA synthesis. (B4) The newly-synthesized DNA ligates to the parental 
lagging strand. The DNA unwinds, and the cross-linked oligonucleotide can come back 
into the helix. (B5) The cross-linked oligonucleotide is ligated to the rest of the leading 
strand and the replication fork is restored. 
The invading end can perform translesion synthesis past the ICL and upon unwinding 
restore the replication fork (Fig. 3B3, 4, 5). Up to now, there is no direct evidence for 
these pathways, and several other solutions for bypass or repair ofiCLs during replication 
are feasible. 
Proteins exclusively involved in ICL repair, like Snml and Pso3, may play a role in 
one or several of these repair routes by assisting other repair proteins in overcoming 
specific ICL-related difficulties. NER-mediated incision ofiCLs could be hindered by the 
covalent bond between the DNA strands, that impairs unwinding of the DNA. 
Recombination could be more difficult as well, if there is only a DSB on one side of the 
ICL and the ICL persists, while translesion synthesis requires displacement of an 
oligonucleotide containing the ICL. Adaptations in repair to deal with difficulties like 
these, could also require additional unknown proteins. 
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7 MAMMALIAN DNA INTERSTRAND CROSS-LINK REP AIR 
7.1 Finding genes involved in mammalian DNA interstrand cross-link repair 
Knowledge about ICL repair in mammalian cells is mainly derived from two sources. 
The first of these is knowledge of yeast ICL repair. DNA repair pathways have been 
conserved in eukaryotes from S. cerevisiae to human (Table 2). Similar to the situation in 
S. cerevisiae, genes required for NER, homologous recombination, and postreplication/ 
translesion repair are involved in mammalian ICL repair. A number of genes involved in 
mammalian ICL repair, including RAD6, RAD18, RAD54, SNMJ, REV3, and REV7 have 
been identified by their sequence homology to yeast genes [181, 254, 266, 367, 369, 517, 
576, 578]. However, differences exist in the importance of certain pathways for the repair 
of certain damages. To repair DSBs, yeast cells mainly use homologous recombination, 
while NHEJ plays an important role in many mammalian cell types [169, 253]. 
Furthennore, mammalian DNA repair is often more complex than DNA repair in yeast, 
which is reflected in the increase in the number of proteins involved. Many yeast DNA 
repair proteins, such as RAD6, RAD23, RAD30, RAD51, and SNMJ, have more than one 
homolog/paralog in mammals (Chapter 5) [145, 266, 329, 330, 335, 369, 524]. 
A second way in which mammalian genes involved in ICL repair have been identified 
is the analysis of mutant cell lines for their sensitivity to ICL agents. Most ICL-sensitive 
mammalian cell lines are derived from hamster cell lines. For a number of the highly 
ICL-sensitive cell lines, the gene responsible for the DNA repair defect has been 
identified (Table 3). For others, the genetic defect is still unknown [107, 247]. Many cell 
lines show a moderate sensitivity to ICL agents, probably not due to a repair defect of 
ICLs, but to a defect in the repair of other adducts induced by ICL agents. A striking 
contrast exists between the involvement of NER in yeast and in mammalian cells. Yeast 
NER mutants all show a similar, rather severe, sensitivity to ICL agents [169]. Most 
mammalian NER mutant hamster cell lines show only a moderate sensitivity to ICL 
agents, while cell lines with a mutation in the mammalian homologs of RADJ 0 and RAD 1, 
ERCCJ and ERCC4/XPF, respectively, are very sensitive to ICL agents [107]. An 
explanation for this difference between yeast and mammals has not yet been found (see 
below). Apart from the ICL-sensitive hamster cell lines, the Fanconi anemia patient cell 
lines are also sensitive to ICL agents. Fanconi anemia will be discussed separately below. 
Finally, Drosophila melanogaster mus308 mutant cell lines are sensitive to ICLs among 
other types of damage [4, 56]. The gene involved appeared to be a DNA polymerase, that 
also contains helicase motifs [202, 381]. The human homolog was recently cloned and 
named DNA polymerase 6 (theta) [459]. 
In addition to the molecular biological and genetic approaches mentioned above, a 
number of biochemical attempts have been made to unravel the mechanisms of 
mammalian ICL repair. A few groups have undertaken the formidable challenge to set up 
a system to measure aspects of ICL repair in vitro using cell extracts or purified proteins. 
To date, the results obtained are difficult to interpret in the context of the available genetic 
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TABLE 3. Hamster cell lines, sensitive to ICL agents 
Mutant Gene ICL agent Characteristics 
cellline sensitivit/ 
UV20 ERCCJ MMC 90x 
DEB 30x 
UV41 ERCC41XPF 
cis-Pt SOx 
MMC90x 
DEB 30x 
NER enzyme 
involved in recombination 
ICL incision reduced 
NER enzyme 
involved in recombination 
irs 1 XRCC2 
cis-Pt IOOx ICL incision reduced 
MMC 60x RAD51 paralog 
irs! SF XRCC3 
UV40 XRCC91FANCG 
cis-Pt lOx 
HN2 12x 
MMC !OOx 
cis-Pt I Ox 
HN2 26x 
MMC llx 
chromosomal instability 
sensitive to UV 254 nm• EMS 
RAD51 paralog 
chromosomal instability 
sensitive to UV 254 nm• EMS 
Fanconi anemia protein 
chromosomal instability 
sensitive to UVzs4nm• EMS, X-rays 
References 
[107, 118, 
218, 282] 
[107, 118, 
282] 
[77, 107, 
116,118, 
249, 512] 
[107, 116, 
118,519] 
[72, 130, 
311] 
' MMC, mitomycin C; DEB, 1,2,3,4-diepoxybutane; cis-Pt, cisplatin=cis-diammine-
dichloroplatinum(II); HN2, nitrogen mustard=2-2 '-dichloro-N-methyl diethylamine 
hydrochloride; EMS, ethyl methane sulfonate 
data. The results vary with respect to the kind of incisions found, the influence of 
undamaged (non)homologous DNA on repair DNA synthesis, and the proteins involved 
[38, 275, 276, 298, 366, 557]. 
7.2 Transcription-coupled repair of DNA interstrand cross-links in 
mammalian ce1ls 
Mammalian ICL formation may differ among genomic regions, probably depending 
on chromatin structure. The level ofiCLs in transcriptionally active regions is sometimes 
higher than in inactive regions [222]. The same is true for ICL repair, at least for the first 
incision step that is monitored, which may occur earlier in transcriptionally active genes 
[171, 221, 222, 284, 552]. Sometimes equal repair is found in transcriptionally active and 
inactive regions, especially at high levels of ICLs, maybe due to saturation of some 
transcription-dependent ICL pathway or induction of a bulk ICL repair pathway at high 
ICL levels [246, 284]. Repair in active rRNA genes, transcribed by RNA polymerase I, is 
slower than repair of an active dihydrofolate reductase gene, transcribed by RNA 
polymerase II [552]. The base pair substitutions induced by psoralen ICLs also suggest 
transcription-coupled repair of ICLs, because most are found at the position of the 
thymine in the nontranscribed strand [281, 442, 556]. 
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7.3 Cell cycle effects of DNA interstrand cross-links 
The organization of DNA damage-induced cell cycle checkpoints in mammalian cells 
is comparable to the situation in yeast cells [594]. A number of proteins, like Radl, Rad9, 
Husl, and Radl7, are present to detect DNA damage or repair intermediates. One of the 
signal transduction proteins is Atm, a homolog of the yeast checkpoint protein Mec 1, and 
responsible for the human genome instability and cancer predisposition syndrome ataxia 
telangiectasia [286]. Together with other transducer proteins, like Atr, Chkl, and Chk2, it 
phosphorylates a number of effector proteins like p53, Nbs!, and Brcal, that induce cell 
cycle arrest, apoptosis and DNA repair [594]. A number of proteins, including Nbs!, 
Brcal, and Brca2, are supposed to play a role both in cell cycle checkpoint responses and 
in DNA repair [87, 136, 326, 592]. NBSJ is the gene involved in Nijmegen breakage 
syndrome. The cellular phenotypes of NBSJ and ATM mutations are similar, including 
chromosomal instability, radiosensitivity, defective cel1 cycle checkpoints, and reduced 
p53 responses [136]. Nbs! forms a complex with Mrell and Rad50 that is involved both 
in homologous recombination and NHEJ. Nbs 1 targets Mre 11 and Rad50 to repair sites 
for DSBs [73]. Brcal and Brca2 are involved in familial breast and ovarian carcinomas 
[133, 592]. Apart from its role in damage-induced cell cycle checkpoints, Brcal is 
involved in transcription and DSB repair. After ionizing radiation, Brcal can be fotmd in 
association with Mrell-Rad50-Nbsl, Rad51, and Brca2 [88, 89, 455, 593]. 
The role of cell cycle checkpoints in the cellular response to ICL agents has hardly 
been investigated. Similar to the situation in yeast, the induction of cell cycle checkpoints 
depends on the ICL agent used. After treatment with mitomycin C, Chinese hamster 
ovary (CHO) cells continue to replicate [283]. On the other hand, treatment with cisplatin 
induces G2 arrest, followed by either apoptosis or continuation of cell cycling [283, 484]. 
Mutations in ATM, BRCAJ, BRCA2, and NBSJ cause sensitivity to ICL agents, but it is 
not known, whether this is due to their role in cell cycle checkpoints or in DNA repair [ 41, 
176, 363, 586]. 
7.4 Processes during mammalian DNA interstrand cross-link repair 
7.4.1 Recognition and incisions 
The proteins responsible for recognition of ICLs in mammalian cells are not known. 
There could be specific DNA damage recognition proteins, or recognition could occur 
when transcription or replication are blocked. While NER enzymes probably make many 
of the incisions required during ICL repair in yeast, their role in mammalian ICL repair is 
unclear. Mammalian cells may use other enzymes to make the incisions, because most 
NER mutant cell lines are only moderately sensitive to ICL agents, and therefore are 
thought to be defective only in the repair of monoadducts and intrastrand cross-links. In 
some assays, an ICL repair deficiency is found in NER mutants, suggesting they could 
play a minor role in ICL repair [556, 557, 590]. The only NER genes that have a major 
influence on mammalian ICL repair are ERCCJ and ERCC4/XPF, the homo logs of S. 
cerevisiae RADIO and RADJ [169]. 
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Erccl and Ercc4/Xpf form a complex that functions as an endonuclease that nicks 
dsDNA near the transition between dsDNA and ssDNA, when the ssDNA forms a 3' 
ssDNA tail [18, 126, 474]. InNER, Erccl-Xpf incises the DNA at the 5' side of the 
lesion, while Xpg incises at the 3' side, thereby removing an oligonucleotide containing 
the lesion [169]. Furthermore, Erccl-Xpf and RadlO-Radl are involved in removing 
nonhomologous ssDNA tails during homologous recombination [1, 18, 223, 448]. 
Mammalian ERCCJ knockout mice show a much more severe phenotype than other NER 
mutant mice. They are not only UV254 run-sensitive, but have a severe growth failure, 
many mice die before birth, and their maximal age is around 80 days. The mice are 
infertile, show nuclear abnormalities in liver cells, renal dysfunction, and no subcutaneous 
fat [340, 560]. Cells from ERCCJ knockout mice show early senescence and genomic 
instability [343, 560]. They are also very sensitive to mitomycin C and other ICL agents. 
The role of the Erccl-Xpf complex in ICL repair may differ from its function inNER, as 
some ERCCJ and ERCC4 mutant CHO cells that have been characterized, are only mildly 
sensitive to mitomycin C, but still are sensitive to UV 254 nm [71]. 
Incision of ICLs is reduced in ERCCJ mutant cells, but normal in XPG mutants [118, 
282]. In vitro, Erccl-Xpfcan cut a Y-shaped oligonucleotide with an ICL in the dsDNA 
near the transition between dsDNA and ssDNA. The incisions occur both at the 5' and 3' 
side of the ICL [279]. Such a Y shape could be formed in vivo by a stalled replication 
fork, a transcription complex, or a helicase. If the in vivo incision activity ofErccl-Xpfis 
the same as the in vitro activity, Erccl-Xpfincisions next to the ICL in one strand will 
create a similar situation to that after the first incisions in E. coli (Fig. 1A2). Homologous 
recombination could then continue the repair reaction. Erccl-Xpf could also perform 
incisions later during ICL repair. One of its additional roles could be the removal of 
nonhomologous DNA tails during homologous recombination in ICL repair (see Figure 
2C). The loss ofErccl-Xpffunction in this late step of!CL repair may therefore be the 
cause of the extreme sensitivity of ERCCJ mutant cells, compared to cells mutant in other 
NER genes. Maybe, the repair intermediate formed by strand invasion after the 
occurrence of a DSB next to an ICL is preferentially resolved by break-induced 
replication in yeast, but by single-strand annealing in mammalian cells (Fig. 2B, C). This 
could be an explanation why loss of the yeast hornologs of Ercc1-Xpf does not lead to a 
higher lethality than loss of other NER proteins. 
7.4.2 Recombination 
The extent ofDSB induction during the repair of!CLs in mammalian cells is not well 
known, because their formation and disappearance are much more difficult to monitor 
than in yeast cells. Some data suggest that DSBs are indeed formed [118, 549]. While 
ionizing radiation-induced DSBs in many mammalian cell types are often repaired via 
NHEJ, mutations in NHEJ do not cause sensitivity to ICL agents [42]. Whether or not 
DSBs play an important role, homologous recombination genes are important for ICL 
repair. After treatment with ionizing radiation or ICL agents, proteins involved in 
homologous recombination, like Rad51 and Rad54, form nuclear foci, which could be 
centers for the repair of DNA damage [194, 513, 516]. Vertebrate cells mutant for 
mRAD54 and the RAD51 paralogs are known for their sensitivity to ICL agents [107, 154, 
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176, 509, 511]. Sensitivity to ICL agents is also found in BRCA I mutant tumor cells, and 
in Brcal- and Brca2-deficient mouse cells [41, 176, 363, 586]. Brcal and Brca2 associate 
with each other and Rad51 and they are required for the formation of damage-induced 
Rad51 nuclear foci [41, 455, 458, 587, 592]. Furthermore, Brcal- and Brca2-deficient 
cells are deficient in homologous recombination [362, 365, 478]. The proteins could have 
a regulatory role in coupling the DNA damage response, cell cycle checkpoints, and DNA 
repair. 
Another indication for the importance of recombination during ICL repair is the 
recombinogenicity of ICLs. Short tract gene conversions sometimes accompanied by 
crossover have been observed after induction ofiCLs [158, 445]. Treatment of cells with 
ICL agents induces sister chromatid exchanges (SCEs), another measure for 
recombination, while SCEs are hardly induced by monofunctional agents [49]. The 
toxicity of several types of ICL agents is correlated with the number of SCEs that are 
induced by the ICLs formed [49, 566]. SCEs induced by mitomycin C are found only 
after the first replication, suggesting that these ICLs cannot be bypassed efficiently during 
replication, causing cell death when repair has failed [569]. Psoralen ICLs are also hardly 
found in replicated DNA, in contrast to psoralen monoadducts [551]. The induction of 
SCEs by ICL agents is reduced in cells mutant for RAD54, RAD51, or its paralogs 
(Chapter 2) [144, 482,509, 511]. 
Mutations in the vertebrate RAD51 paralogs yield a higher sensitivity to ICL agents 
than mutations in the other genes from the homologous recombination pathway, 
suggesting different subpathways of recombination that are not equally important for ICL 
repair [154, 509, 511]. Therefore, the RAD51 paralogs will be discussed here in more 
detail. Both yeast and human Rad51 play a central role in homologous recombination and 
can perform DNA strand exchange in vitro [27, 501]. In yeast, two RAD51 paralogs are 
known, RAD55 and RAD57, that stimulate the Rad51-mediated DNA strand exchange 
reaction [255, 315, 503]. In mammalian cells, three mitotically active paralogs of RAD51 
have been identified by their amino acid sequence, RAD51B, RAD51C, and RAD5JD [7, 
76, 142, 258, 408, 422]. Two other paralogs were identified as the genes responsible for 
the ICL sensitivity of the mutant CHO cell lines irs! and irslSF, and they are called 
XRCC2 and XRCC3, respectively [77, 310, 512, 519]. The Rad51 paralogs interact with 
each other and with Rad51 [60, 142, 310, 451, 524]. RAD51 deficiency leads to cellular 
lethality, while chicken cells deficient in any one of the RAD51 paralogs are viable. 
Nevertheless, both chicken and mammalian cells deficient for a RAD51 paralog show 
chromosomal instability [116, 191,509,511, 519]. Mice deficient for RAD51, RAD51B, 
RAD5ID, and XRCC2 show embryonic lethality, signifying the importance of 
homologous recombination for genomic integrity and cell proliferation [131, 305, 407, 
466, 536]. The unhooking of ICLs is not affected in XRCC2 and XRCC3 mutant cells, as 
expected for homologous recombination mutants [118]. Repair ofDSBs by homologous 
recombination is affected in mutant XRCC2 and XRCC3 cells, but NHEJ is not affected 
[64, 240, 405]. ICL-induced Rad51 nuclear foci formation is impaired in XRCC3-
deficient cells [45]. 
The Rad51 paralogs could play a supporting role in Rad51-mediated DNA strand 
exchange. The RecA-mediated DNA strand exchange reaction in E. coli is stimulated by 
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RecBCD when starting from a DSB intermediate and by RecFOR in the absence of a DSB 
[8, 268, 538]. Homologous recombination in mammalian cells probably needs some 
adaptations during ICL repair compared to DSB repair, because there may be repair 
pathways in which only one end of a DSB is available for strand invasion (Fig. 2B, C and 
Fig. 3) and others in which strand invasion is required in the absence of a DSB (see Figure 
lA). Cells with a mutation in the Rad51 paralogs are much more sensitive to ICL agents, 
than to DSB-inducing agents [107, 248, 519, 525]. This may be explained by a specific 
role of these paralogs, like the role of RecBCD and RecFOR, in adapting the strand 
invasion reaction by Rad51 to the requirements ofiCL repair. 
7.4.3 Postreplicationltranslesion repair 
Little is known about the influences of the mammalian postreplicationltranslesion 
repair group of enzymes on the cellular response to ICL agents. Human Rad6/UbcHI can 
rescue yeast rad6 sensitivity to 8-methoxypsoralen plus UVA [251]. RADJ8-deficient 
vertebrate cells are very sensitive to cisplatin and have increased levels of SCEs, 
suggesting a switch from postreplication/translesion repair to homologous recombination 
(Y.M. Yamashita, S. Takeda, personal communication). Expression of a dominant-
negative mutant of human RAD18 makes cells sensitive to mitomycin C [517]. Human 
RAD30/XPV mutant cells show a decreased mutagenesis and replication bypass of ICLs 
compared to wild-type cells [351, 417]. The mutagenicity of ICLs compared to 
monoadducts differs per species and cell type, suggesting different preferences for certain 
ICL repair pathways [15, 61, 281, 583]. 
7.5 Mammalian Snml homologs 
The mammalian homolog of the yeast Smnl/Pso2 protein is also involved in the 
response to ICL agents. SNMI-deficient mouse embryonic stem cells are sensitive to 
mitomycin C, but not to 8-methoxypsoralen plus UV A, melphalan, or cisplatin (Chapter 
5) [145]. SNMJ knockout mice show a two-fold higher sensitivity to mitomycin C, which 
is similar to the sensitivity of the homologous recombination-deficient RAD54 knockout 
mice (Chapter 5) [145, 155]. SCE induction by mitomycin Cis similar in SNMJ-deficient 
and wild-type cells, suggesting that Snml plays no role in the homologous recombination 
pathway of ICL repair (Chapter 5). In mammalian cells, at least two other proteins that 
display similarity to Snml are present (Chapter 5) [145]. They could have redundant 
functions in the cellular response to different ICLs. However, Snm!B and Snm!C could 
also be involved in other cellular processes. The human SNMJ CIARTEMIS gene has been 
isolated as one of the genes responsible for severe combined immunodeficiency, which is 
probably due to a defect in NHEJ [361]. 
7.6 Fan coni anemia 
Fanconi anemia is a rare, autosomal recessive disorder, characterized and diagnosed 
by the sensitivity of patient cells to ICL agents. Clinical symptoms of Fanconi anemia 
include progressive bone marrow failnre, leading to pancytopenia, developmental 
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abnormalities, such as aplasia of the thumb and radius, growth retardation, 
hyperpigmentation of the skin, kidney and urinary tract malformations, and microcephaly. 
Patients are predisposed to the development of cancer, particularly acute myeloid 
leukemia and squamous cell carcinoma [13, 238]. Increased spontaneous and ICL-
induced chromosomal breakage is observed, which places Fanconi anemia among the 
chromosomal instability disorders, like ataxia telangiectasia, Bloom's syndrome, 
Nijmegen breakage syndrome and hereditary nonpolyposis colorectal carcinoma. Further 
characteristics of Fanconi anemia cells are sensitivity to oxidative DNA damage, cell 
cycle abnormalities, changes in certain cytokines and abnormal apoptosis [68, 83, 101, 
238, 444]. There is no clear defect in the formation and repair of ICLs in Fanconi anemia 
cell lines, although they do show prolonged G2 arrest and highly increased cell death on 
ICL agent treatment [68, 101, 444]. 
Thus far, eight Fanconi anemia complementation groups have been defined and six 
genes have been mapped and cloned, FANCA, FANCC, FANCD2, FANCE, FANCF, and 
FANCG [108, 127, 128, 130,205,236,237,314,493, 528]. A correlation has been found 
between the complementation group, the type of mutation, and the clinical severity [!57]. 
Both FANCA and FANCC knockout mice have been generated [91, 95, 565]. The mice 
and cell lines isolated from them are very sensitive to ICL agents and also show ICL-
induced chromosomal instability and cell cycle abnormalities. Otherwise, their phenotype 
is very mild under normal breeding conditions, except for reduced fertility [74, 91, 95, 
382, 565]. 
Although Fanconi anemia is a very intriguing human disease that will be of great 
value in understanding human ICL repair mechanisms, the function of the Fanconi anemia 
(FA) proteins is still unclear. The FA genes encode novel proteins, whose sequence 
provides no immediate clues for a biochemical function. Up to now, FANCD2 is the only 
FA gene that has homologs in lower eukaryotes, namely Caenorhabditis elegans, D. 
melanogaster, and Arabidopsis thaliana, but there is no homolog in S. cerevisiae [528]. 
The role of the other, probably upstream ofF ANCD2 functioning FA proteins may be 
fulfilled by sequence-unrelated proteins in lower eukaryotes. Because there are no 
homologous proteins in yeast, it is much more difficult to unravel the role of the FA 
proteins, than the role of most of the other proteins involved in !CL repair that have been 
discussed above. 
A substantial amount of work has been done to determine the cellular localization and 
interactions of the FA proteins. FANCA, FANCC, and FANCG are found both in the 
cytoplasm and in the nucleus, while F ANCD2, F ANCE, and FANCF are predominantly-
nuclear [129, 174-176, 213, 271]. Interactions have been observed among FANCA, 
FANCC, FANCE, FANCF, and FANCG, but only the interaction between FANCA and 
FANCG has been shown to be direct [129, 174, 175, 271, 273, 277, 341, 554]. These 
interactions suggest the presence of a large complex formed by the FA proteins in the 
nucleus. All the interactions found are diminished or absent in cells belonging to other 
Fanconi anemia complementation groups, except for group Dl and D2 cells [129, 174, 
175,554, 580]. 
An interaction model has been proposed in which the different FA proteins 
sequentially form a complex and translocate to the nucleus [129]. This complex may be 
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required for DNA damage-dependent activation of FANCD2 to a monoubiquitinated 
isoform, that forms nuclear foci after treatment with UV 254 nm• ionizing radiation, and ICL 
agents [176]. The ubiquitination of FANCD2 also depends on Brcal, and ubiquitinated 
FANCD2 can be coprecipitated with BrcaL After ionizing radiation, FANCD2 and Brcal 
colocalize in nuclear foci. Interactions with other cellular proteins have also been 
investigated. FANCC interacts with NADPH cytochrome P450 reductase, with 
glutathione S-transferase, with a transcriptional repressor protein, and with a nonerythroid 
a spectrin, which may function as a scaffold for interacting proteins [117, 214, 272, 339]. 
These interactions suggest that the FA proteins may have other functions apart from their 
role in the response to ICL agents [384]. 
The FA proteins may work together in a stable bolo-complex of all FA proteins, or in 
dynamically interacting complexes containing a subset ofF A proteins [23 8]. They might 
have some direct role in ICL repair, but could as well have a more indirect role, 
influencing ICL formation, damage recognition, or the cellular response to ICLs. The 
interaction with Brcal may provide a link between the FA proteins and the cellular 
damage response, cell cycle regulation, or homologous recombination. Whatever their 
role, the FA proteins are essential for chromosomal stability, especially when cells are 
exposed to ICL agents. 
7.7 Conclusions on mammalian DNA interstrand cross-link repair 
Generally, ICL repair in mammalian cells is comparable to ICL repair in bacteria and 
in yeast The pathways described in Figures I, 2, and 3 are also feasible for ICL repair in 
mammals. However, as with most other cellular processes, mammalian ICL repair is 
more complex than yeast ICL repair. Several mammalian homo logs of S. cerevisiae ICL 
repair genes have a number of paralogs. This expansion could be a sign of the 
specialization of proteins in the repair of ICLs, or they could be active in different cell 
types or cell cycle stages. Furthermore, proteins without a homolog in S. cerevisiae, such 
as the Brca and FA proteins play a role in mammalian ICL repair. 
A remarkable difference between mammals and yeast is that only Ercc 1 and Xpf play 
a major role in ICL repair in mammalian cells in contrast to the involvement of most other 
NER proteins in S. cerevisiae. Although the other NER proteins are important for making 
incisions in yeast cells, they may have only a limited or even no role in making incisions 
next to ICLs in mammalian cells, while the incisions are still dependent on Erccl-Xpf. 
Alternatively, the difference between mammals and yeast may be due to an additional role 
for Ercc!-Xpf later during ICL repair. For example, Erccl-Xpf could possibly be 
responsible for the removal of nonhomologous ssDNA tails during recombinational repair 
of an ICL (Fig. 2C). Break-induced replication is a frequently used pathway during 
homologous recombination in yeast, but in mammalian cells, there is no direct evidence 
for the existence of break-induced replication [386]. The reason may be the length and 
complexity of mammalian chromosomes, compared to yeast chromosomes. Instead of 
using the pathway that depends on break-induced replication (Fig. 2B), mammalian cells 
could be much more dependent on single-strand annealing to resolve recombination 
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intermediates (Fig. 2C). It is likely that Erccl-Xpf plays an essential role in this 
recombinational subpathway. 
Furthermore, the importance of the induction of DSBs during ICL repair in 
mammalian cell lines is unknown. Nevertheless, homologous recombination is very 
important in mammalian ICL repair. The Rad51 paralogs could play a special role in 
adapting homologous recombination to ICL repair, especially when no DSBs are induced, 
or when only one end of a DSB is available for homologous recombination (Fig. lA, 2B, 
2C, 3A, 3B). While in yeast, Rad52 is even more important than Rad51 for a number of 
homologous recombination subpathways, the role of Rad52 in mammalian homologous 
recombination is minor [386, 428]. Mammalian cells could more strongly depend on the 
Rad51 paralogs to stimulate Rad51-mediated DNA strand exchange than on Rad52 [353]. 
The idea of a redundant role for the Rad51 paralogs and Rad52 in stimulating Rad51-
mediated DNA strand exchange is supported by the fact that while chicken DT 40 cells 
deficient for either RAD52 or XRCC3 are viable, cells deficient for both genes are not 
viable (unpublished observations in [483]). 
The Snml, FA, and Brca proteins may function in the regulation of the cellular 
damage response to ICLs. The Brca proteins are involved in damage-induced cell cycle 
checkpoints via Atm and in homologous recombination, and Brcal has been associated 
with transcription. The pleiotropic phenotype of Fanconi anemia and the link between 
FANCD2 and Brcal are also consistent with a regulatory role for the FA proteins. The 
transport of some of the FA proteins from the cytoplasm to the nucleus, and their 
activation by phosphorylation and ubiquitination suggest a role in a signal transduction 
pathway. The specific roles for the large number of proteins involved directly or 
indirectly in the repair of!CLs will have to be elucidated by further research. 
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Disruption of mouse SNMJ causes increased sensitivity to the DNA 
interstrand cross-linking agent mitomycin C 
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DNA interstrand cross-links (ICLs) represent lethal DNA damages, because they block 
transcription, replication, and segregation of DNA Because of their genotoxicity, agents 
inducing ICLs are often used in antitumor therapy. The repair of ICLs is complex and 
involves proteins belonging to nucleotide excision, recombination, and 
postreplication/translesion DNA repair pathways, in Escherichia coli, Saccharomyces 
cerevisiae, and mammals. The molecular mechanisms of ICL repair in mammalian cells 
are still unknown. We cloned and analyzed mammalian homologs of the S. cerevisiae 
gene, SNMJ(PS02), which is specifically involved in ICL repair. Human Snml, a nuclear 
protein, was ubiquitously expressed at a very low level. We generated mouse SNMr1-
embryonic stem cells, and showed that these cells were sensitive to mitomycin C. In 
contrast to S. cerevisiae snml mutants, they were not significantly sensitive to other ICL 
agents, probably due to redundancy in mammalian ICL repair and the existence of other 
SNMJ paralogs. The sensitivity to mitomycin C was complemented by transfection of the 
hSNMJ eDNA and by targeting of a genomic-eDNA murine SNMJ fusion construct to the 
disrupted locus. We also generated mice deficient for murine SNMJ. They were viable 
and fertile and showed no major abnormalities. However, they were sensitive to 
mitomycin C. Snml is probably not involved in recombinational repair, because the 
response ofRad5 1 towards ICL agents and the induction of sister chromatid exchanges by 
DNA damaging agents are not affected by the absence of Snml. The ICL sensitivity of 
the mammalian SNMJ mutant suggests that SNMJ function and, by implication, ICL 
repair are at least partially conserved between S. cerevisiae and mammals. 
INTRODUCTION 
DNA interstrand cross-links (ICLs) prevent strand separation, thereby physically 
blocking transcription, replication, and segregation of DNA. In bacterial and yeast cells, 
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the presence of one unrepaired ICL can be lethal [287, 320], Humans are exposed to 
environmental ICL agents, such as furocoumarins, from plants and cosmetics [454], Due 
to their extreme genotoxicity, agents that induce cross-links in DNA are widely used in 
antitumor therapy. Examples include cisplatin, mitomycin C, and derivatives of nitrogen 
mustard such as melphalan and cyclophosphamide (See Chapter 4 ). Most of these agents 
cause a number of different lesions in DNA, including monoadducts, DNA-protein cross-
links, DNA intrastrand cross-links, and ICLs. The latter are the main cause of cell death, 
although they constitute only a few percent of the total number of adducts [63, 287]. 
Resistance of tumors to cross-linking agents can be caused by a variety of mechanisms, 
including increased repair of ICLs [6, 25, 59, 152, 244, 488, 582, 591], Therefore, an 
understanding of how ICLs are repaired is important. 
To elucidate the mechanism of ICL repair in yeast, genetic screens have been 
performed to find genes specifically involved in ICL repair. A number of snm and pso 
mutants have been isolated after screening for strains with increased sensitivity towards 
nitrogen mustard and 8-methoxypsoralen plus UV A light, respectively [208, 438]. Some 
of the mutants isolated are sensitive to several classes of DNA-damaging agents, while 
others are almost exclusively sensitive to ICL agents. The gene mutated in one of these 
strains is SNMJ, which is allelic with PS02 and encodes a nuclear 76-kDa protein [82, 
207, 427]. snml mutants are sensitive to a number of agents that cause ICLs, but they are 
only mildly sensitive to monofunctional a1kylating agents and 254-nm UV light (UV254 ,m) 
and are not hypersensitive to gamma rays [63, 208, 439]. In exponentially growing cells, 
the expression of SNMJ can be induced by ICL agents or UV254 "m [570]. Overexpression 
of SNMJ results in an increased resistance to nitrogen mustard and cisplatin [206]. 
Many genes involved in DNA damage repair are conserved between yeast and higher 
eukaryotes. One way to elucidate the mechanisms of ICL repair in mammalian cells is by 
studying mammalian homologs of S. cerevisiae genes specifically involved in ICL repair. 
A human homolog of SNMJ has been isolated and comparison of its predicted protein 
product (hSnml) to S. cerevisiae Snml (ScSnml) has shown that 39% of the ScSnml 
amino acids have a similar amino acid in hSnml [369]. The hSNMJ gene is located on 
chromosome 10q25, a region often found to be rearranged in tumors [48, 267, 396, 475, 
491,531]. 
Here, we report on the characterization of the mammalian SNMJ homologs. We 
generated mouse embryonic stem (ES) cells in which both alleles of mouse SNMJ 
(mSNMJ) are disrupted. These cells were sensitive to mitomycin C, but not to 8-
methoxypsoralen plus UV A light, cisplatin, melphalan, UV254 "m' methyl methane-
sulfonate or gamma rays. The sensitivity to mitomycin C was restored to wild-type 
sensitivity by transfecting either a plasmid expressing hSnm1 or by targeting a genomic-
eDNA mSNMJ fusion construct to the disrupted locus. We also generated mice deficient 
for mSNMJ. They were viable and fertile and showed no major abnormalities. However, 
the mice were sensitive to mitomycin C. Our results show that mammalian SNM I is a 
functional homolog of yeast SNMJ, even though only 22% of the ScSnm1 amino acids are 
identical to hSnml amino acids. This indicates that at least parts of the DNA repair 
mechanisms specific for the repair of ICLs are conserved between S. cerevisiae and 
mammals. 
108 Chapter 5 
MATERIALS AND METHODS 
hSNMI eDNA constructs. The eDNA of hSNMI (kindly provided by N. Nomura) was 
used to make several constructs containing tags at the 5'- and 3' -termini of hSNMI (Table 
1). For this purpose, the 5' terminus of hSNMI was modified to generate an Xhol 
restriction enzyme site just in front of the expected initiation codon, thereby deleting the 
900-bp 5' untranslated region that contains 15 additional ATG sequences. The constructs 
were generated in pBluescript II KS (Stratagene) and subsequently subcloned into 
appropriate expression vectors (Table 1). The sequence of all DNA fragments produced 
by PCR was determined by sequence analysis. The following tags were added to hSnml: 
an amino-terminal histidine tag (His 10: single letter amino acid code: 
MGHHHHHHHHHHGGSR), a carboxy-terminal hemagglutinin tag (HA: 
PGGYPYDVPDY AS) and a carboxy-terminal histidine-hemagglutinin tag (His6HA: 
PHHHHHHGGSAYPYDVPDYAS). The first 570 bp of hSNMI, the first 1515 bp of 
hSNMI and the last 1470 bp and the total hSNMI eDNA with a carboxy-tenninal 
His6HA tag were subcloned into pEGFPC vectors (Clontech) to obtain hSnml protein 
with an amino-terminal Green Fluorescent protein (GFP) tag (Table 1). 
Subcellular localisation of hSNMJ. The constructs GFP-hSNMI, GFP-570hSNMJ, 
GFP-1515hSNMJ, and GFP-ChSNMI were transfected with lipofectin into CH09 cells, 
grown in F!O-DMEM containing 10% fetal calf serum. To obtain stable transfectants, 
cells were split after one day and put on G4!8 selection (! mg/ml). Single colonies 
expressing GFP-hSnml proteins were expanded. The GFP-hSNMJ construct was also 
microinjected into multinucleated fibroblasts according to previously described 
procedures [215]. The cellular localization of the GFP was determined using an Olympus 
IX70 microscope. 
Generation of a-hSnml antibodies. A 354-bp Psti-Hindlll fragment from the hSNMJ 
eDNA was subcloned into pTrcHisC (Table I). The fusion protein derived from this 
plasmid contained amino acid 644 to 763 ofhSnml fused to a His6 tag and was produced 
in E. coli strain DH5a. The protein was present in the insoluble fraction and was 
dissolved in 6 M urea. It was purified on a Ni-nitrilotriacetic acid column, eluted with 
200 mM imidazole and used to immunize two rabbits. The detection limit of the 
polyclonal antibodies was determined by immunoblotting using a range of 1 to 1,000 ng 
of antigen and was shown to be below I ng. The antibodies were affinity purified using 
fusion protein immobilized on a nitrocellulose filter. 
Expression of recombinant hSnml. The eDNA encoding His10-hSnml-HA was 
subcloned into pFastBacl (BAC-TO-BAC Baculovirus Expression System, GibcoBRL) 
(Table l ). The resulting plasmid was transformed into DH! OBac E. coli cells to allow 
site-specific transposition into bacmid bMONI4272. High molecular weight recombinant 
bacmid DNA was isolated and transfected into Sf2! cells to produce virus stocks that 
were amplified as described by the manufacturer. Protein extracts of these cells were 
made as described [505]. 
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TABLE I. Characteristics of the mammalian SNMJ constructs. 
Construct Vector gene tag(s)a 
hSNMI-HA pPGK-p(A) hSNMJ eDNA HA 
hSNMI-HisHA pcDNA3 hSNMJ eDNA His6HA 
His-hSNMJ-HA pFastBacl hSNMJ eDNA His10, HA 
GFP-hSNMI pEGFPC2 hSNMJ eDNA GFP, His6HA 
GFP-570hSNMJ pEGFPC3 hSNMJ eDNA bp 1-570 GFP 
GFP-1515hSNMJ pEGFPC2 hSNMJ eDNA bp 1-1515 GFP 
GFP-ChSNMI pEGFPC3 hSNMJ eDNA bp 1652-3123 · GFP, His6HA 
TrcHis-hSNMI pTrcHisC hSNMJ eDNA bp 1930-2285 His6 
mSNMI'" pBluescript II KS mSNMI genomic disruption NA 
mSNMihyg pBluescript II KS mSNMI genomic disruption NA 
mSNMJC-GFP pBluescript II KS mSNMl genomic-eDNA fusion GFP 
'GFP, green fluorescent protein; His, histidine; HA, hemagglutinin; NA, not applicable 
Construction of mSNMJ targeting vectors. A mouse testis eDNA library was 
hybridized with a 2.7-kb EcoRI hSNMI eDNA fragment. The resulting murine SNMJ 
(mSNMJ) eDNA clone was sequenced and used to screen a lambda phage genomic library 
made from mouse strain 129/Sv. Genomic fragments hybridizing to the mSNMJ eDNA 
were subcloned in pBluescript II KS. The locations and intron and exon borders of the 
first five exons were detennined by restriction analysis and DNA sequencing. Targeting 
constructs were made by cloning a 4-kb Sal! fragment encompassing exons 2 and 3 and a 
5-kb Hindiii fragment encompassing part of exon 4 and exons 5 to 7 in pBluescript II KS. 
Between these fragments, a cassette containing either a neomycin (neo) resistance gene 
driven by a thymidine kinase promoter or a hygromycin (hyg) resistance gene driven by a 
phosphoglycerate kinase (PGK) promoter was inserted. This step resulted in the partial 
deletion of ex on 4. These targeting constructs are referred to as mSNMreo and mSNMlhyg' 
respectively (Table!) (see Figure 3A). 
ES cell culture and electroporation. E 14 ES cells (kindly provided by A. Berns, The 
Netherlands Cancer Institute, Amsterdam) were electroporated with the mSNMJ"Yg 
targeting construct and cultured on gelatinized dishes as described previously [154]. The 
cells were split 24 h after electroporation and hygromycin B was added to a final 
concentration of 200 ~glml. After 7 to 10 days, colonies were isolated and expanded. 
Genomic DNA from individual clones was digested with Spel or Hindiii and analyzed by 
DNA blotting using the flanking exon 1 probe (see Figure 3A). DNA from targeted 
clones with the expected hybridization pattern was subsequently digested with Ssp! and 
hybridized with the internal intron 5 probe to confirm proper homologous integration. To 
obtain ES cell lines carrying a disruption in both mSNMI alleles, an mSNMlhyg_targeted 
ES cell line was electroporated with the mSNMreo targeting construct. After selection 
with G4!8 (200 ~g/ml) for 7 to II days, colonies were isolated and expanded. The 
isolated DNA was digested with Hindiii and hybridized with exon I DNA, to identifY cell 
lines containing two targeted mSNMJ alleles. 
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Rescue of mSNMl-1- cells by hSNMJ eDNA constructs. The hSNMI-HA eDNA was 
subcloned into pPGK-p(A) to express the gene under the control of the PGK promoter 
with a carboxy-terminal HA tag (Table 1 ). This eDNA expression construct was co-
electroporated with a puromycin-expressing plasmid into mSNMreo!hyg cells. Clones were 
selected with puromycin (1 ~g/ml) for 10 days. Integration of the eDNA construct was 
confirmed by DNA blotting. 
Rescue of mSNMl-1- cells by mSNMI genomic constructs. An mSNMJ-GFP targeting 
fusion construct was made under the control of the mSNMJ promoter (Fig. 3B). To obtain 
expression of mSNMJ with 3'-terminal GFP, the 3' terminus of mSNMJ eDNA was 
modified by PCR to create an EcoRV site in front of the stop codon. In this site, the GFP 
eDNA was cloned, and the borders were sequenced. Then, the 5.6-kb genomic mSNMJ 
Hindiil fragment encompassing exons I to 4 was cloned into the eDNA, thereby fusing 
exon 4 from the genomic fragment with eDNA exons 4 to 9. Behind the endogenous 
polyadenylation signal, a neomycin cassette and the 5-kb mSNMJ Hindiil fragment were 
cloned (see Figure 3B). The construct, named mSNMJC-GFP, was transfected into 
mSNMlhyg_targeted ES cells, and clones were selected with G4!8 (200 ~g/ml) and 
expanded. The isolated DNA was digested with Ssp! and hybridized with the intron 5 
probe to screen for cell lines containing the homologously integrated target DNA. 
RT-PCR reactions. mRNA was isolated from 106 to 107 ES cells as described 
(Pharmacia Quick Prep Micro mRNA purification). eDNA was made using Pharmacia 
'Ready to go you prime first strand' beads and either a specific primer or a random 
hexamer primer. Then, PCR was performed on I to 10 ~1 eDNA preparation. The PCR 
reaction to detect mRNA from mSNMr1- cells was performed with 5'-
GAGACGGACTCGTGGCAGGAC and 5'-AGTCGCACATGTCTGTGGTTATGA as a 
forward and reverse primer, respectively, and gave a product of 740 bp. To detect mRNA 
from mSNMJC-GFP' the forward and reverse primers were 51-
GAGACGGACTCGTGGCAGGAC and 5'-TTGTGGCCGTTTACGTCGCCG, 
respectively. These primers yielded a PCR product of 1.2 kb. 
Cell survival assays. The sensitivity of ES cells to increasing doses of DNA-damaging 
agents was determined by measuring their colony-forming ability as described before 
[!54]. The cloning efficiency of untreated cells varied between 10 and 30%. Cells were 
incubated in drug-containing media for I h. To detect sensitivity to 8-methoxypsoralen 
plus UV A light, cells were incubated for 30 min in medium with 8-methoxypsoralen in 
the dark. Then, the cells were irradiated with 12 kJ of 320- to 380-mn UV A light at 2 
mW/cm2 in phosphate-buffered saline (PBS) containing 8-methoxypsoralen. Ionizing 
radiation sensitivity was determined by comparing the colony-forming ability of targeted 
ES cells after irradiation 'With a 137Cs source. For U\1254 run irradiation, the medium was 
replaced with PBS prior to exposure. Cells were grown for 7 to 10 days, fixed, stained, 
and counted. All measurements were performed in triplicate. 
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Immunofluorescence. ES cells were grown on gelatinized glass slides and treated with 
12 Gy gamma rays, 2.4 ~g mitomycin C/ml, or left untreated. Two hours after treatment, 
the slides were fixed with methanol/acetone and processed as described [328]. Slides 
were incubated for 1.5 hat 20'C with a-HA, a-hSnml or a-hRad51 antibody, followed 
by a 1.5 h incubation with Alexa 594-conjugated goat a-rat or goat a-rabbit secondary 
antibody obtained from Molecular Probes. Nuclei were counterstained with 4' ,6-
diarnidino-2-phenylindole. Cells with two or more nuclear foci were considered positive. 
The data were obtained in tbree independent experiments and based on the analysis of at 
least 100 nuclei in every experiment. 
Sister chromatid exchanges. Sister cbromatid exchanges (SCEs) in ES cell lines of the 
genotype mSNMJ+1+, mSNMJ+1-, mSNMr1·, and mSNMJC·GFPt- were analyzed. The cell 
lines were coded to prevent bias in the analysis. The code was revealed only after the 
SCE analysis of all cell lines was completed. Cells were seeded in 60-mm dishes and 
after 24 h, the medium was removed and replaced with medium containing I 0 ~M 
bromodeoxyuridine (BrdU) with or without 0.2 ~g mitomycin C/ml. After I to 2 h, cells 
were washed with PBS and fresh medium supplemented with I 0 ~M BrdU was added. 
Cells were cultured for two rounds of DNA replication (23 to 26 h), collected by mitotic 
shake off 2 h after the addition of colcemid to a final concentration of 0.1 ~g/ml, and 
treated with trypsin/EDT A for 5 min. Cells were treated with cold hypotonic solution 
(0.075 M KCI) immediately followed by centrifugation. Subsequently, cells were fixed 
with tbree changes of methanol/acetic acid (3: I) and metaphase preparations were made. 
To visualize the SCEs, slides were stained in diluted acridine orange for 5 min, mounted 
in 0.07 M Na2HP04/KH2P04 (pH 6.5) with a coverslip, and exposed to UV light of 265 
mn for 10-15 min. SCEs were observed tbrough a fluorescence microscope (Leitz 
Orthoplan) using an IOOx objective. At least 47 metaphases per cell line were analyzed 
for both the number of chromosomes and SCEs. Metaphase spreads were also analyzed 
for the presence of gross chromosomal abnormalities. 
Generation of mSNMJ mutant mice. Cells of mSNMJ"yg_targeted clones were 
karyotyped, and ES cells from four independent clones with 40 chromosomes were used 
for injection into C57BL/6 blastocysts [595]. Male chimeric mice were mated with 
C57BL/6 females and found to transmit the disrupted mSNMJ allele to their offspring. 
mSNMr1- mice were obtained by intercrossing Fl heterozygous mice. Genotyping was 
performed by DNA blot analysis with a flanking probe, PCR analysis, or both. 
In vivo mitomycin C survival. For in vivo mitomycin C survival, 6- to 8-weeks old 
mSNMJ+I- and mSNMJ-1- animals were intraperitoneally injected with 7.5, 10, or 15 
mglkg bodyweight mitomycin C. After injection, mice were kept in sterile isolators and 
observed for 14 days. After this period, surviving animals were euthanized. 
112 Chapter 5 
RESULTS 
Comparison of Snml from different species. A computer database search using either 
ScSnm1 or hSnm1 as a query sequence revealed the existence of homologs of Snm1 in 
many different species, including Schizosaccharomyces pombe, Aspergillus niger, 
Arabidopsis thaliana, Caenorhabditis elegans, and Drosophila melanogaster (Fig. 1 and 
appendix). We isolated and sequenced the mouse homolog (mSnml) as described below. 
In addition, we identified two additional human and mouse Snml paralogs that we refer to 
as Snm1B and Snm1C, respectively. hSNMJC has been isolated recently as one of the 
genes responsible for severe combined immunodeficiency, which is probably due to a 
defect in the end-joining of DNA double-strand breaks (DSBs) and was called ARTEMIS 
[361]. Comparison of these different mammalian paralogs showed that hSnm1 and 
mSnm1 displayed the highest degree of similarity to each other and to ScSnml. hSnmlB 
and mSnmlB showed a high degree of similarity to each other but less similarity to 
ScSnml. The same is true for hSnm1C and mSnm1C. The carboxy-terminal region of 
mammalian Snml appeared to be similar to the amino-terminal region of Snm1B and 
SnmlC. In A. thaliana, three Snml paralogs were also found, but these were not clear 
homologs of either hSnm1, hSnmlB, or hSnmlC. The length of the protein varied 
between different homologs/paralogs and species. Some homologs/paralogs showed 
similarity in the amino-terminal region of Snml, including the putative Zn finger domain 
present in ScSrnnl. Others did not contain this Zn finger domain and showed no 
significant similarity in the amino-terminal region. Deletion of the Zn finger in S. 
cerevisiae did not render cells more sensitive to nitrogen mustard [207]. The middle part 
of the protein was least conserved among all species, while conservation was highest in 
the carboxy-terminal region. Eight regions stood out in particular, and we will refer to 
these as motifs (Fig. 1). However, no clues regarding the function of these motifs could 
be obtained through database searches. 
Subcellular localization of hSnml. The subcellular localization of hSnm1 was 
determined by microinjecting human fibroblasts and by transfecting CH09 cells with a 
GFP-hSNMJ fusion construct (Table 1 and Fig. 2). As a control, the pEGFPC2 vector 
was transfected. In this case, the GFP protein was diffusely present throughout the cell. 
In contrast, the location of GFP-hSnml was clearly restricted to the nucleus after both 
microinjection and transfection, as revealed by inspection of the cells under a fluorescence 
microscope after one to several days (Fig. 2B). GFP-hSnml was excluded from the 
nucleolus. In cells expressing large amounts of protein, there was also weak staining of 
the cytoplasm. We conclude that hSnml is a nuclear protein. A few days after 
transfection or microinjection, many of the cells expressing high amounts of GFP-hSnm1 
underwent morphological changes that were consistent with apoptosis. This finding 
indicates that Snml could be toxic when overexpressed in cells. This notion would also 
explain why extensive attempts to generate stable protein-expressing clones after G418 
selection failed. 
We made GFP-hSNMJ fusion constructs expressing parts ofhSnm1 to determine the 
position of the nuclear localization signal (Fig. 2A). Constructs expressing the amino-
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tenninal 190 amino acids or the amino-terminal 505 amino acids gave a fluorescent signal 
in the nucleus. The construct expressing the carboxy-terminal 490 amino acids, which are 
most highly conserved between different species, showed a fluorescent signal both in the 
nucleus and the cytoplasm (Fig. 2B). Thus, the nuclear localization signal is located 
within the amino-tenninal 190 amino acids, which corresponds to the potential sequence 
for the nuclear localization signal at around amino acid 20 (Fig. 2A). 
Generation of mSNMJ-disrupted mouse cells. Screening of a mouse testis eDNA 
library with the hSNMJ eDNA yielded a mouse eDNA clone spanning the 3'-terminal 2 
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FIG. 1. Comparison of the deduced amino acid sequences of SNM1 homologs/paralogs. 
The amino acid sequences of the carboxy termini of S. cerevisiae (Sc), A. thaliana (At), 
mouse (m) and human (h) Snm1 are aligned and shown in the single-letter code. From the 
second and third human and mouse Snm1 paralogs, called Snm1 B, and Snm1C/Artemis, 
the amino termini are shown. A more extensive version of this Figure, including Snm1 
homologs from additional species, can be found in the appendix. Identical and similar 
amino acids are shown in black and gray boxes, respectively. Dots denote gaps; question 
marks denote unknown sequences. Amino acid positions are shown on the left. The eight 
motifs with high conservation are underlined. GenBank accession numbers are X64004 
(ScSnm1), X98130 (AtSnm1), 042045 (hSnm1), AK024060 (hSnm1B), AJ296101 
(hSnm1C), AF241240 (mSnm1), Al530740 and mCP20194 (Celera database [548]) 
(mSnm1B), mCP15877 and mCP36740 (Celera database [548]) (mSnm1C). 
kb of mSNMJ. This clone was sequenced and used as a probe to obtain genomic mouse 
DNA. Two clones spanning the first seven exons of the mSNMJ genomic locus were 
obtained. The locus was characterized by restriction site mapping, PCR, and sequencing 
of the first two exons (Fig. 3A). A targeting construct was made by subcloning into 
pBluescript II KS a 4-kb Sal! fragment encompassing exons 2 and 3 and a 5-kb Hindiii 
fragment encompassing part of exon 4 and exons 5 to 7 with a selectable marker gene in 
between. In this way, part of intron 3 and 25 bp of ex on 4 were deleted. This procedure 
resulted in e1imination of the carboxy-terminal 287 amino acids of mSnm 1, which contain 
most conserved motifs (Fig. I). Moreover, aberrant RNA splicing that skips the targeted 
exon would result in a frameshift mutation. Disruption constructs were made containing 
the neomycin or the hygromycin selectable marker gene. They are referred to as 
mSNMlneo and mSNMlhyg' respectively. 
The mSNMlhyg construct was electroporated into ES cells. After selection, targeted 
clones were identified by DNA blotting using a unique probe outside the targeting 
construct (Fig. 3A, C). Four independent cell lines containing one disrupted mSNMJ 
allele were obtained. The frequency of homologous versus random integration of the 
targeting construct was 2.5%. The second wild-type allele was disrupted by targeting 
with the mSNMI"" construct. Three double-knockout cell lines in which the remaining 
wild-type allele was replaced by mSNMI"'" were obtained (Fig. 3C). 
RT -PCRs with RNAs isolated from mSNMI +!- and mSNMr1- cells were performed 
using primers for exons 2 and 7. RNA from mSNMI+I- cells showed a clear signal from 
the wild-type mSNMJ allele, and both cell lines showed three weak signals from the 
knockout allele (data not shown and Fig. 3D). These three bands were cloned and 
sequenced. One product would result in a frameshift and a premature stop codon. The 
other two products, one containing an insert from the neomycin cassette and the other 
splicing around exon 4, used an alternative splice site in exon 5 which restored the reading 
frame. Both would result in disruption of conserved motifs 2 and 3 of mSnml (Fig. 1). 
No significant difference in growth rate between mSNMJ+I+ ES cells and all mSNMI+I-
and mSNM r 1- cell lines was detected. We conclude that, similar to the situation in S. 
cerevisiae, disruption of the mSNMJ in mouse cells results in viable cells [427]. 
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FIG. 2. Subcellular localization of hSnm1. 
(A) Schematic representation of the different GFP-h$NM1 fusion constructs transfected 
into CH09 cells. The upper line shows the hSNM1 eDNA with the putative nuclear 
localization signal (NLS), the Zn finger, and the conserved motifs. Below are the different 
hSNM1 constructs tagged with 5'-terminal GFP and the localization of their fluorescence 
signal in the cells(-, absent;+ through+++, present in increasing amounts). 
(B) Examples of representative cells containing the indicated GFP-hSNM1 fusion 
constructs. 
mSNMl-1- ES cells are sensitive to mitomycin C. S. cerevisiae snml mutants are 
sensitive to DNA ICL agents, but not to gamma rays and only slightly to UV254 nm light 
[208, 439]. We therefore investigated the effects of these DNA-damaging agents on the 
survival of mSNMr1- ES cells. These cells were found to be approximately two-fold 
more sensitive to mitomycin C than mSNM ]-proficient cells, which were otherwise 
isogenic (Fig. 4A). There was no difference between mSNlvfl+l+ and mSNMI+I- cells. In 
contrast, we did not find any significant sensitivity to 8-methoxypsoralen plus UV A light, 
cisplatin, melphalan, UV254 nm• methyl methanesulfonate, and gamma rays (Table 2). As a 
control, ERCCr1- ES cells were also treated with these agents and found to be sensitive to 
UV,,4 nm and all ICL agents tested (Table 2), as expected from the behavior of ERCCJ·I-
mouse embryonic fibroblasts and ERCCJ mutant CHO cells [124]. ERCCr1- cells were 
not sensitive to methyl methanesulfonate and gamma rays (Table 2). 
To prove that the phenotype of the mSNMr1- ES cells was caused exclusively by the 
disruption of mSNMJ, eDNA rescue experiments were performed. mSNMreolhyg cells 
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TABLE 2. Sensitivity of mSNMr1- and ERCCI_1_ ES cells to various genotoxic agents 
Sensitivity' of the following 
cells: 
Genotoxic agent Dose range mSNMI cells ERCCJ ;. cells 
Mitomycin C 0.1-1.6 flg/ml Sens Sens 
Melphalan 0.5-12 f.LM Wt ND 
8-Methoxypsoralen plus UV A light 0.1-100 ng/ml Wt Sens 
Cisplatin 0.25-4 flg/ml Wt Sens 
Gamma rays 1-8 Gy Wt Wt 
Methyl methanesulfonate 1-2.5 mM Wt Wt 
UV254 ,m 2-12J/m2 Wt Sens 
"Wt, sensitivity equal to that of wild-type cells; Sens, sensitivity higher than that of wild-
type cells; ND, sensitivity not determined. 
were electroporated with a eDNA construct expressing HA-tagged hSnml together with a 
plasmid expressing the dominant selectable marker for puromycin. Puromycin-resistant 
cell lines that had integrated hSNMJ-HA were fully corrected for the mitomycin C 
sensitivity ofmSNMr1- ES cells (Fig. 4B). 
mSNMI is expressed at low levels in ES cells. To investigate the expression of mSNMI 
in ES cells, we generated a GFP-tagged version of mSNMI under the control of the 
endogenous mSNMI promoter (Fig. 3B and Table 1). For this purpose, a knockin 
targeting construct, mSNMJC-GFP' was made by cloning mSNMJ eDNA exons 4 to 9 with 
3 '-terminal GFP behind genomic exon 4. As a consequence, the mRNA consisted of a 
fusion of four genomic exons and the eDNA with 3 '-terminal GFP and was transcribed 
under the control of the endogenous mSNMl promoter. The remaining genomic exons 
were not transcribed, because of the poly-adenylation signal and the neomycin selectable 
marker behind the GFP. mSNMIC-GFP was transfected into mSNMJ+I- ES cells and clones 
containing tagged and knockout mSNMI alleles were obtained. 
mSNMJC-GFP was expressed and functional, because the mitomycin C sensitivity of 
mSNMr1- ES cells was complemented by the presence of mSNMIC-GFP (Fig. 4C). 
Amplification by RT -PCR using an mSNMI primer and a GFP primer spanning at least 
one intron revealed the expression of mSNMIC-GFP at the RNA level (Fig. 3D). However, 
fluorescence microscopy failed to detect the GFP signal. Given the detection limit, these 
results imply that there are less than 10,000 molecules of mSnml per cell [392]. We also 
analyzed mSnml expression in wild-type, knockout, and mSNMJC-GFP containing cell 
lines by immunoblot analysis with affinity-purified o:-hSnm I antibodies and polyclonal o:-
GFP antibodies (Clontech). We were unable to detect either the endogenous or the 
transfected mSnml, even though o:-hSnml antibodies were highly sensitive with a 
detection limit of approximately 5,000 Snml molecules per cell (data not shown). 
Furthermore, they could immunoprecipitate in vitro translated pcDNA -hSNM 1-HisHA. 
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FIG. 3. Characterization of the mSNM1 genomic locus and generation and transfection of 
mSNMJ-knockout and -knockin constructs. 
(A) Schematic representation of part of the genomic mSNM1 locus and the gene targeting 
constructs. The top line represents part of the mSNM1 locus. The first seven exons are 
indicated by boxes. The lines below exon 1 and intron 5 indicate the position of the probes 
used to screen for the disrupted alleles and the presence of the knockin allele. The 
locations of selected restriction sites are shown. The middle lines represent the targeting 
constructs and show the positions of the selectable marker genes for neomycin (neo) and 
hygromycin (hyg) in exon 4, indicated by the arrows. The bottom line represents the 
disrupted genomic locus. 
(B) Genomic construct for the rescue of mSNM1-'- cells. The genomic-eDNA mSNM1 
fusion construct containing a GFP tag (hatched box) is shown. mSNM1 eDNA is 
represented by a white box, and the neo selectable marker gene is represented by an 
arrow. 
(C) DNA blot of mSNM1 wild-type (wt) and mutant ES cells. ES cells were electroporated 
with the different targeting constructs. Genomic DNA was isolated from individual clones 
and digested with Hindlll. Clones containing the homologously integrated targeting 
constructs were identified by DNA blotting using the exon 1 probe. Heterozygous mutant 
cell lines containing the mSNM1hyg allele were subsequently targeted with the mSNM1"" 
targeting construct to generate mSNM1-t- cell lines. On the right the lc-Pstl size marker is 
shown. 
(D) Expression of mSNM1c-GFP under the mSNM1 promoter in ES cells. mRNA was 
isolated from mSNM1c-GFPI~ ES cells. eDNA was made using random hexamers and a 
PCR reaction performed with a GFP primer and an mSNM1 primer. As a control, two 
mSNM1 primers detecting RNA from the knockout allele were used. 
We cannot exclude the possibility, however, that our a-hSrnnl antibodies were unable to 
recognize mSnml. 
Similarly, we tried to detect the presence of hSrnnl-HA expressed under the control 
of the PGK promoter in mSNMr1- ES cells; the presence ofhSrnni-HA could be deduced 
from its ability to complement the phenotype of mSNMr1- ES cells (Fig. 4B). Although 
both a-hSrnnl and a-HA antibodies recognize the protein, when overproduced in Sf21 
cells, we could not detect the protein by either immunoblot or immunofluorescence 
microscopy before or after treatment of the cells with mitomycin C (data not shown). 
Taken together, these results indicate that Snml protein levels in ES cells are very low, 
even when the protein is expressed under the control of the relatively strong PGK 
promoter. 
Induction of mRad51 foci is normal in mSNMJ-1- cells. Homologous recombination is 
an important pathway for DSB repair, in which the the RAD52 group genes, including 
RAD51 and RAD54 are involved (Chapter I) [253, 386]. This pathway is also involved in 
ICL repair in vertebrate cells, because mouse and chicken cells mutated in RAD54 are 
sensitive to ICL agents such as mitomycin C (Chapter 4) [40, !54]. After treatment of 
wild-type ES cells with ionizing radiation or mitomycin C, mRad51 foci are induced as 
detected by immunofluorescence [194]. In mRAD54 knockout ES cells, these foci are not 
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FIG. 4. Effect of mitomycin C on wild-type and mutant mSNM1 ES cells. ES cells were 
treated with mitomycin C for 1 h, washed with PBS and then grown for 7 to 1 0 days in fresh 
medium. Subsequently, they were fixed, stained, and counted. Cloning efficiencies of 
untreated cells varied between 10% and 30%. All measurements were performed in 
triplicate. Error bars represent standard errors of the mean. Numbers following symbol 
definitions (figure insets) indicate the cell line isolation numbers. 
(A) Clonogenic survival of mSNM1•t- and mSNMr'· ES cells after treatment with 
increasing concentrations of mitomycin C. 
(B) Rescue of the mitomycin C sensitivity of mSNM1-t- cells by hSNM1-HA. An mSNMJ+ 
cell line containing randomly integrated hSNM1-HA eDNA expression constructs was 
obtained as described in Materials and Methods. The survival of this cell line was 
compared to the survival of mSNM1•t• and mSNMr'· ES cells. 
(C) Rescue of the mitomycin C sensitivity of mSNM1-t- cells by mSNM1°·GFP Two 
mSNM1c-GFPt- cell lines were obtained as described in Materials and Methods. The 
survival of these cells was compared to the survival of mSNM1•t- and mSNMr'· ES cells. 
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seen using methanol/acetone fixation, suggesting that mRad54 functions at an earlier or 
the same step as mRad51 [513]. In contrast, mSNMJ knockout ES cells showed wild-type 
induction of mRad51 foci both after gamma ray and mitomycin C treatment (data not 
shown). 
Induction of sister chromatid exchanges is normal in mSNMr1- cells. Homologous 
recombination events can result in SCEs. Treatment with mitomycin C increases the 
number of SCEs detected in cells, due to recombinational repair of the DNA damage 
induced. In RAD51- and RAD54-deficient chicken B lymphocytes and in RAD54-
deficient mouse ES cells, a reduced frequency of SCEs is observed after treatment with 
mitomycin C (Chapter 2) [144, 482]. Normal mRad51 foci formation in mSNMI 
knockout cells does not exclude a role for mSnml later in the homologous recombination 
repair ofiCLs. Therefore, we measured the spontaneous and mitomycin C-induced levels 
of SCEs in mSNMJ-proficient and -deficient ES cells. ES cells of the genotype 
mSNMJ+I+, mSNM1+1-, mSNMr1-, and mSNMlc.GFPI- were analyzed. Mitomycin C 
treatment induced a dose-dependent increase in SCEs. No differences in the level of 
SCEs were observed between the different cell lines (data not shown). In all cell lines 
treated with mitomycin C, no apparent chromosomal changes were observed. These 
results suggest that Snml is not involved in repair ofiCLs by homologous recombination. 
Alternatively, there could be redundancy between Snml and another protein for its 
function in homologous recombination during ICL repair. 
Generation of mSNMI--1- mice. The experiments described above show that disruption 
of mSNM I is compatible with normal ES cell proliferation. Subsequently, we investigated 
whether mSnrn 1 is required for normal mouse development. Cells from four targeted ES 
clones, carrying the mSNMlhyg allele, were injected into C57BL/6 blastocysts and 11 
chimeric mice were obtained. The disrupted mSNMJ allele was transmitted to the mouse 
germline. F 1 heterozygous offspring were intercrossed, and F2 offspring were genotyped 
by DNA blotting, PCR analysis, or both (data not shown). Among 78 genotyped animals, 
20 mSNMJ+I+, 30 mSNMJ+1-, and 28 mSNMr1- animals were identified. This outcome is 
compatible with normal Mendelian segregation of the disrupted mSNMI allele. Thus, 
disruption of mSNMJ does not result in embryonic or neonatal lethality. No statistically 
significant difference in weight was observed among mSNM1+1+, mSNM1+1-, and mSNMr 
/-littermates (data not shown). Importantly, the mSNMr1- mice exhibited no macroscopic 
abnormalities up to at least 12 months of age. Both mSNMr1- males and females were 
fertile. 
mSNMI--1- mice are sensitive to mitomycin C. We tested whether the sensitivity of 
mSNMr1- ES cells to the ICL agent mitomycin C was also found in mSNMJ-1- mice. 
mSNMl+l- and mSNMr1- mice were treated with various doses of mitomycin C, ranging 
from 7.5 to 15 mg/kg of body weight. ll)iection of 10 and 15 mg/kg in female mice 
resulted in enhanced sensitivity in mSNMr- mice (Fig. 5). In addition, with 15 mg/kg, a 
shorter latency period in mSNMr1- mice was observed. In male mice, 7.5 mg/kg was 
lethal for 30% of the knockout mice, while all heterozygous mice survived. At 10 mg/kg, 
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FIG. 5. Mitomycin C sensitivity of mSNMr'- mice. Shown are survival curves for 
mSNM1+J- and mSNMr1- mice after a single intraperitoneal injection of the indicated 
amounts of mitomycin C. 
(A) Survival of 12 mSNM1•t- and 8 mSNM1--t- female mice after injection with a dose of 10 
mg of mitomycin C per kg bodyweight 
(B) Survival of 11 mSNM1•t- and 5 mSNMr1- female mice after injection with 15 mg of 
mitomycin C per kg. 
(C) Survival of 6 mSNM1H- and 7 mSNMr1- male mice after injection with 7.5 mg of 
mitomycin C per kg. 
(D) Survival of 16 mSNM1•t- and 9 mSNMr1- male mice after injection with 10 mg of 
mitomycin C per kg. 
only 10% of the mSNMr1- mice survived treatment, while 70% of the mSNMJ+!- mice 
survived (Fig. 5). These results show that the hypersensitivity to mitomycin C found in 
mSNMr1- ES cells is also present in mSNMr1- mice. 
DISCUSSION 
Characterization of mammalian SNMJ. In elucidating ICL repair in mammalian cells, 
most attention has been given to the role of genes that are involved in several different 
DNA damage repair pathways, such as nucleotide excision repair (NER) and 
recombination repair (See Chapter 4). In contrast, we have analyzed mammalian 
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homo logs of the S. cerevisiae SNMJ gene, which specifically provides resistance to ICL 
agents, Like yeast snml knockout cells, mSNMr1- ES cells and mice are viable, showing 
that SNMJ is not essential for viability under normal culture and breeding conditions 
[195], The mice do not show any major abnormalities and are fertile. mSNMr1- ES cells 
and mice are hypersensitive to mitomycin C, but the cells are not sensitive to UV254 nm• 
methyl methanesulfonate or gamma rays, in agreement with the results obtained with S. 
cerevisiae snml cells [208, 439], These results argue for a specific role of mammalian 
SNMJ in the cellular response to ICL agents, similar to yeast SNMJ. 
hSnml resides in the nucleus (Fig. 2), similar to its yeast homolog, a location 
expected for a DNA repair protein [207], It has a putative nuclear localization signal at 
the amino terminus, and there may be another signal in the carboxy terminus of the 
protein. The gene is expressed in all tissues tested [369], The promoter region contains a 
consensus sequence for AP 1 and NFtcB, that can induce the expression of genes after 
being induced themselves by stress factors including DNA damage [132], hSNMJ 
contains an exceptionally long, 911-bp 5'-terminal untranslated region, containing several 
ATGs in all reading frames, which might cause inefficient translation. We could not 
detect any hSnml-HA or mSnml-GFP after transfection into mSNMJ+ cells, although the 
detection limit of our antibodies was below 1 ng, and the fluorescence microscopy 
detection limit of GFP is about 10,000 molecules per cell [392]. This suggests that the 
level of expression of Snml is very low, in agreement with the codon usage and the lack 
of a TATA box. Nevertheless, we could complement the mitomycin C sensitivity of 
mSNMr1- cells with hSnml-HA and mSnm!-GFP. Thus, the protein levels must have 
been sufficient, and the HA and GFP tags at the carboxy terminus of Snml must not have 
interfered with its function. ScSNMJ is also expressed at a very low level [427], 
Cross-link repair pathways, The formation and repair of ICLs in cells are complex 
processes, with major differences between ICL agents. The sensitivity of a cell to a 
certain ICL agent is dependent on all steps in the processing of ICLs, ranging from uptake 
and metabolization to damage recognition and repair (Chapter 4) [63]. A number of major 
DNA damage repair pathways are involved in the repair of ICLs. In E. coli, the major 
pathway involves NER and recombination repair (Fig. I in Chapter 4). First, UvrABC 
incises the DNA in one strand on both sides ofthe ICL. After a single-stranded DNA gap 
has been made by the exonuclease activity of DNA polymerase I, RecA performs strand 
exchange past the cross-link. Once recombination is complete, UvrABC makes incisions 
in the other strand around the cross-link, resulting in removal of the cross-linked 
oligonucleotide. Repair is completed by repair synthesis and ligation. Other, RecA 
independent, pathways depend on translesion synthesis by DNA polymerase II after 
incision by UvrABC [35]. This RecA-independent ICL repair is more efficient in the 
repair of nitrogen mustard ICLs, than psoralen ICLs [36]. In the absence of UvrABC, 
some error-prone ICL repair still takes place [544]. 
In S. cerevisiae, mutants m the NER, recombination repair, and 
postreplication!translesion repair pathways are sensitive to ICL agents [209]. Moreover, a 
number of ICL-sensitive mutants have been found that do not quite fit into one of these 
pathways, such as pso2 to pso4 [207]. The major repair pathway of ICLs inS cerevisiae 
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is supposed to start with incision by the NER system, resulting in a DSB, in contrast to the 
incisions in E. coli, which do not result in a DSB [119, 229, 320, 348, 544]. The DSB can 
be repaired by the recombination repair pathway (Fig. 2 in Chapter 4) [14, 229]. Repair 
may also occur via the postreplication/translesion repair pathway, involving RAD6 and 
RAD18, which is more error-prone [467]. Yeast postreplication/translesion repair mutants 
are not defective in the repair of an ICL on a plasmid, in contrast to recombination repair 
mutants, suggesting that chromatin structure may have an important influence [319]. 
In mammals, a large number of mutant cell lines are known to be sensitive to ICL 
agents (Table 3 in Chapter 4) [107]. Many of the known mutated genes in those eel! lines 
belong to the NER pathway, the recombination repair pathway, and/or the error-prone 
postreplication!translesion repair pathway [107, 154, 251]. A number of genes cannot be 
attributed to one of the known repair pathways [68, 107]. The molecular mechanisms of 
mammalian ICL repair are still unknown, but they are probably similar to S. cerevisiae 
and E. coli ICL repair (See Chapter 4). For some ICL agents, there seems to be a 
transcription-dependent repair pathway [171, 221, 222, 284]. Incision of the ICLs is 
supposed to be performed by some of the NER proteins, as mutations in ERCCJ result in 
a decrease in the incision of ICLs and reduced repair-associated replication [282]. In 
contrast to the situation in S. cerevisiae, where no significant differences among NER 
mutants are found, most mammalian NER-deficient cells are only moderately sensitive to 
ICL agents [107]. However, ERCCJ and XPF mutants are among the cell lines that are 
most sensitive to mitomycin C. Therefore, in addition to their role inNER, ERCCJ and 
XPF are likely to be involved in the incision of ICLs or subsequent recombination, 
independent of the other NER genes. The sensitivity of the other NER mutants might be 
caused solely by a defect in the repair of monoadducts. Hamster cell lines with a 
mitomycin C sensitivity similar to that of ERCCJ mutants are irs! and irslSF [107]. The 
genes mutated in these cell lines are XRCC2 and XRCC3, which are paralogs of the 
recombination repair gene RAD51 and are important for chromosomal stability and DSB 
repair [77, 116,240,310,405,519, 524]. The mechanism by which these genes work is 
still unknown, but they could have an important role in recombination repair ofiCLs. 
Another group of genes involved in the response to ICL agents, consists of the 
Fanconi anemia (FA) genes. Fanconi anemia is a rare, autosomal recessive disorder, 
characterized clinically by developmental abnormalities, pancytopenia of blood cells and a 
predisposition to the development of leukemia and other tumors [13, 137]. Fanconi 
anemia patient cells are sensitive to ICL agents and to oxidative DNA damage and they 
show cell cycle abnormalities [68, 101]. To date, eight complementation groups have 
been defined, six genes have been cloned, FANCA, FANCC, FANCD2, FANCE, FANCF, 
and FANCG [108, 127, 128, 130, 205, 236, 237, 314, 493, 528]. Interactions have been 
observed between FANCA, FANCC, FANCE, FANCF, and FANCG [108, 129, 130, 174, 
175, 237, 271, 314, 341, 493, 554]. FANCC knockout mice are very sensitive to 
mitomycin C, although otherwise, their phenotype is very mild [74, 91, 565]. The FA 
proteins do not show any homology to other known proteins and Fanconi anemia patient 
cells do not show a consistent picture of a deficiency in ICL repair [68, 101]. For this 
reason and because of their pleiotropic phenotype, they may not be involved in ICL repair 
directly, but rather have some regulatory role in response to DNA damage. 
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Role of Snml in ICL repair. The results for S. cerevisiae SNMJ show that Snml is not 
required for all ICL repair. S. cerevisiae snml cells show synergism with mutants from 
both the postreplicationltranslesion and the recombination repair pathways with regard to 
sensitivity to ICL agents. suggesting that Srnnl functions in an alternative pathway [209. 
467]. Moreover, snml cells are capable of repairing an ICL on a plasmid, suggesting that 
the activity of Srnnl may be related to the modulation of chromosomal structure [319]. 
The sensitivity of snml mutants to ali!CL agents tested suggests that Snml is involved in 
an ICL agent-independent step and therefore probably after the formation of ICLs [63, 
208, 439]. This notion is consistent with the fact that snml mutants are capable of 
creating DSBs after treatment with 8-methoxypsoralen plus UV A light, iri contrast to 
NER mutants, which are not able to incise the DNA near the ICL [320, 344]. snml 
mutants are, however, epistatic to NER mutants, suggesting that they play a role in this 
repair pathway [209, 467]. Snml may be involved in restoring the continuity ofthe DNA, 
because snml cells are not able to repair the DSBs formed [320]. Alternatively, Srnnl 
could also play a more indirect role, in the regulation of!CL repair. 
mSNMJ knockout ES cells are specifically sensitive to mitomycin C, but not to 
cisplatin, melphalan, or 8-methoxypsoralen plus UV A light, in contrast to S. cerevisiae 
snml cells. Therefore, mammalian SNMJ is probably not essential for a general ICL 
repair pathway. Mammalian cells could have different proteins for the recognition and 
repair of different ICLs, while yeast cells could depend on a single protein. Alternatively, 
some postreplication/translesion repair pathways in mammals could be more efficient than 
those in yeast, taking over most ICL repair in mSNMJ knockout ES cells, but being 
insufficient to repair mitomycin C-induced ICLs. We cannot exclude the possibility of the 
presence in our knockout ES cells of some mutated mSnml that could fulfill some of the 
functions of the protein and thereby mitigate the phenotype. However, this notion is not a 
likely explanation of the mild phenotype, because two highly conserved motifs were 
deleted. Some of the conserved motifs of Snml constitute a metallo-lyase domain, which 
is found in a wide variety of proteins with different functions, like bacterial ~-lactamase 
II, cyclic phosphodiesterases, glyoxylases, and proteins involved in the uptake of DNA 
(I.S. Mian, personal communication). Despite this clue about a possible function for 
Snml, we can only speculate about its role. mSnml could be involved in the activation of 
mitomycin C, decreasing the number of ICLs or other damage caused by tbis agent. 
Alternatively, it could be responsible for the recognition of mitomycin C-induced ICLs 
and other structurally related ICLs. These explanations would be inconsistent with the 
yeast snml phenotype, although a direct comparison is not possible because of the 
existence of multiple mammalian SNMI paralogs and because mitomycin C has not been 
tested inS. cerevisiae. It is also possible that Snml is involved in a regulatory pathway, 
influencing the response of the cell to the damage caused by mitomycin C. The most 
attractive assumption for the function of rnSnml is a direct role in the repair of ICLs, as 
suggested by the results for its homolog in S. cerevisiae. 
Induction of mRad51 foci and sister chromatid exchanges is normal in mSNMJ-1-
cells. One of the pathways for ICL repair is constituted by the homologous recombination 
repair pathway, in which Rad54, Rad51, and its paralogs play an important role [154, 253, 
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386, 523]. Upon treatment with mitomycin C, mRad51 forms nuclear foci [194]. 
Immunofluorescence on mSNMl knockout ES cells after mitomycin C treatment showed 
normal foci formation by Rad51 (data not shown). This is in contrast to RAD51 paralog 
mutant chicken cells, XRCC3 mutant CHO cells, and mRAD54 mutant ES cells that do not 
show Rad51 foci after treatment with cisplatin and mitomycin C, respectively [45, 509, 
511, 513]. Using a different fixation technique than was used for mRAD54 mutant ES 
cells, Rad51 foci formation was increased in chicken RAD54 mutant cells, suggesting 
arrest of homologous recombinational repair of!CLs after Rad51 has accumulated [509]. 
SCE induction by mitomycin C is reduced in cells deficient for RAD51, its paralogs, or 
RAD54 (Chapter 2) [144, 482]. mSNMr1- cells, however, show normal induction of 
SCEs. These results on Rad51 foci formation and SCE induction suggest that Snml plays 
a role independent of the recombination repair pathway. This explanation is supported by 
the results inS. cerevisiae, which place Snml and Rad52 in different pathways [209, 467]. 
Redundancy of mammalian Snml function. The relatively mild phenotype of mSNMr 
; .. ES cells and mice is reminiscent of the phenotype found for mRAD54_1_ cells and mice, 
which are also about two-fold more sensitive to mitomycin C than wild-type cells and 
mice [154, 155]. This mild phenotype can probably be attributed in part to the existence 
of parallel pathways for the repair of ICLs. In addition, known paralogs for both mSNMl 
and mRAD54 could take over part of the function (Fig. 1) [212]. In fact, redundancy is a 
phenomenon that is quite common in mammalian DNA damage repair pathways. The 
NER gene RAD23, the postreplicationltranslesion repair gene RAD6, and the 
recombination repair gene RAD51 have several paralogs [252, 266, 330, 524]. These 
duplications provide cells with the possibility of functional differentiation in the repair of 
different types of damage, in different phases of the cell cycle, or in different cell types. 
Moreover, the cell can fall back on the alternative repair pathway in case of dysfunction of 
one of the proteins involved, a strategy which may prevent inappropriate repair and cell 
transformation. It will be important to analyze the other SNMJ paralogs and to look at the 
effects of ICL agents on double knockout cells. Furthermore, study of cells with 
mutations in SNMJ and other genes functioning in ICL repair, such as RAD54, will yield 
information on the relative importance of the different ICL repair pathways and the level 
of redundancy between different pathways. Nevertheless, the sensitivity of mSNMl 
knockout cells to mitomycin C shows that there is no complete redundancy in mammalian 
cells. Both the sequence conservation and the functional conservation with yeast Snml 
underline the significance of SNMJ in ICL repair. 
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APPENDIX 
FIGURE. Comparison of the deduced amino acid sequences of SNMI homologs/ 
paralogs. The amino acid sequences of Saccharomyces cerevisiae (Sc ), Schizosaccha-
romyces pombe (Sp). Arabidopsis thaliana (At), Drosophila melanogaster (Dm), 
Caenorhabditis elegans (Ce), mouse (m), and human (h) Snml are aligned and shown in 
the single-letter code. The second and third human and mouse Snm 1 paralogs are called 
SnmlB and SnmlC, and the A. thaliana homologs/paralogs AtSnmlB, C, and D. 
Identical and similar amino acids are shown in black and gray boxes, respectively. Dots 
denote gaps, question marks denote unknown sequences. Amino acid positions are shown 
on the left. The putative nuclear localization signal lies around amino acid 20. The Zn-
finger domain at the N-terminus and the eight motifs with high conservation are 
underlined. Gene bank accession numbers are X64004 (ScSnml), Z69728 (SpSnrnl), 
X98130 (AtSnml), AC004665 (AtSnrnlB), AC004557 (AtSnmlC), AC013288 
(AtSnmlD), AE003602 (DmSnml), Z81080 (CeSnml), D42045 (hSnrnl), AK024060 
(hSnmlB), AJ296101 (hSnmlC), AF241240 (mSnml), Al530740 and mCP20194 (Celera 
database, www.celera.com, [548]) (mSnmlB), mCP15877 and mCP36740 (Celera 
database) (mSnm 1 C). 
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mSNMJ. n5 
hSNMl 802 
mSNMlB 98 
hSNMlB 108 
mSNMlC 21 
hSNMlC 12< 
ScSNMl 395 
SpSNMl 312 
AtSNMl 303 
AtSNMlB 5<7 
AtSNMlC 165 
AtSNMlD 217 
OmSNMl 
'" CeSNMl 429 
mSNMJ. 
'" hSNMl 857 
mSNMlB 15< 
hSNMJ.B 154 
mSNMlC 79 
hSNMlC 180 
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VSSSVKKMKQSNLFQIWGL.QENSP.DTTKRMKQTDLFQSWGLQRPSPFTSPASNSAKKTTSALGKRRRD 
QSBCTSGHVTERQRDKSTTRKASEPKKPTANKLITEFFPGQATEGTKIRTAPKPVAEKSPSDSSSRRAVR 
.. MASDSAGATISGNFSNSDNSETLNLNTTKLYSSAISSISPQFPSPKPT 
IASPCEKSSDVQATKFRTPETSMPEAKLSNSSLDLVEISPGPNKSPTNNFYRSSPAAITKESPLGKNSKK 
SVGLTEMQVLHGGGQAYNRGISKVPVDFRNEAFQIFKKRVESVLEAVTDCONFIEFQQKENVVQSETSTQ 
VGLSGEKRQHR ... RKRHK.TSNSPREGPCQRRSGHLMNNP.ELGPVSLSKAFVRRTRGRTQRGNMNISE 
VELSSERSQRQ ... KKRCR.KSNSLQEGACQKRSDBLINTESEAVNLSKVKVFTKSAHGGLQRGNKKIPE 
.KFNNG.HEI NYKASETISQY 
... KQINVRSVVPFYKLMPYNIPF YGAIDGVJ::AY 
SSFSNDSPR.PCPFYKKLPG.TPFT RYGCVQGCSAY 
RNGNNGKSK.VIPHWNCIPG.TPF KYLTRDCC.HW 
.... MESGLIS •RWRN .... GSQAY 
sse .. .PSIPNSKRIPNTNFI L RLP.IIQSSSVA 
GTVRKQRKPKPCPPYKVVEG.TSFC •G QFGEIEGVTHY 
TSSSNTSGDADLKHCQQIKIGEDIS •Y LK .. KSGSRYN 
SSGAGEVRR.TCPFYKRIPG.TGFT QYGEIEGCTAY 
SSNVGGSRKKTCPFYKKIPG.TGFT QYGVVEGCTAY 
... MNGVVIPQ.TPI WSLRRAGSARLF 
. . . MNGVLIPH.TPIA •FWSLRRAGTARLF 
~PVDKE~LLTSPKYRFW:: .... KKRr 
QEFLANSYDKPI 
ETLQSN. QTR~.~~~~S 
RLLD~ .... 
EPAN .. 
RGDF . 
VKLESSGF. 
KLSS~. 
EGSKIEEIAG. 
~~:~ :::: EGYF .... . 
EGYF ... . 
.. GSN .. 
!QGN . 
s' F"S• ·YI KKSWNNPDEN .PIKKTL 
S• "YG TPKWKHG. . .... PI 
T F • · YI TKAWSHG. . .... PI 
T. F.L• YQ TKSFSHG. . .... KI 
" 
I :S • TR SGGWSQG. ..... PL 
'' 
F·s• -ys SSSWSKG. ..... II 
T F • ·YI TKKFCH. ..... PL 
T. S• "YR DKKWTR. . .... sv 
T F-S• :YA SKDFTR. ..... f?V 
·p S• "YA SKHFTF_ ... PV 
T c•:TVSKHWIRAL. ..... PL 
s S•"TVWSSTWAR . ..... PL 
TVADFTLRL I KH :G~~RT> G~>SilR;"~~RFOi~~OKOOL~:g~~;~:.~~:;~~; i ACADKAISIKKS. 
YVVRITKDFLR. 
FVVEAIQAEAF. 
LVADIIASHP. 
YVVSVIDK .. 
RAVDLVRAFLEK. 
ILL ... KAIEA. 
FAINTAFEAVT. 
FAINTAFEAVT. 
lRQFP. 
IRKBP. 
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ScSNMl 
SpSNMl. 
AtSNMl 
AtSNMlB 
AtSNMlC 
AtSNMlD 
DmSNMl 
CeSNMl 
mSNMl 
hSNMl. 
mSNMlB 
hSNMl.B 
mSNMl.C 
hSNMlC 
ScSNMl. 
SpSNMl 
AtSNMl. 
AtSNMlB 
AtSNMl.C 
AtSNMl.D 
DmSNMl. 
CeSNMl 
mSNMl 
hSNMl 
mSNMl.B 
hSNMlB 
m.SNMlC 
hSNMlc 
ScSNMl 
.SpSNMl 
AtSNMl 
AtSNMl.B 
AtSNMlC 
AtSNMl.D 
DmSNMl 
CeSNMl 
mSNMl 
hSNMl 
mSNMlB 
hSNMlB 
mSNMlC 
hSNMlC 
ScSNMl 
SpSNMl 
AtSNMl 
AtSNMlB 
AtSNMlC 
AtSNMlD 
OmSNMl 
CeSNMl 
mSNMl 
hSNMl 
mSNMlB 
hSNMlB 
mSNMlC 
hSNMlC 
ScSNMl 
SpSNMl 
AtSNMl 
AtSNMlB 
AtSNMlC 
AtSNMlD 
OmSNMl 
CeSNMl 
mSNMl. 
hSNMl 
mSNMlB 
hSNMlB 
mSNMl.C 
hSNMlC 
464 MPNSVKFSMMLTVLQNNENQNDMWDESLL~SNLHESS~LVPIRVLK SQETIEAYLKSL 
357 VP RKMHIIKQ~ENQD LIDLL~DDPTQASV: VTMMGIH PNSL 
347 NA SRRRILQSFGWDD ISKNLSTDGKATCL: LPMSSLK VERL 
590 NP AKLKLLECIFSK DDIQWFTVKEEESHIHVVPLWTL ASFKRL 
205 WP ERLRTMHL GFQD IFTTDTSLTRVRAVPRYSF 
259 DA RKMSMLSV GCGE EGMF~EDENESDVIDvVGWNVLG ETWPYFRPNFVKM 
468 ES NRSTAVRC WPD LDSVL~EDRSGANLWVIAMGKISYPVSVFLKYINFLVSDIILFQSL 
469 YO ERKVISD LDFS SNCGVLKQYRDIKVIK KGS 
884 SQ EKYKTLQC IPE VSSLI~DMCDSLI.LLPMMQIN FKGL 
901 SQ EKYKTLQC IPE INSLI TDMCSSL LLPMMQIN FKGL 
194 SP QRLELVQL GLAD VF EEEAGRI VOHTEI C 
204 Sp RRLELVQL GLAD VF EEKAGRI VDHMEI C 
149 D ......... KLDMFKNMPO ... ILHHL TDRNTQ.I CRHPK?? .. 
230 N .......... KLOMFRNMPE ... ILHHL TDRNTQ. I CRHPKA. . . .. EEYFQWSKL 
523 KELETDYVKDIEDVVGFIPTGWSHNFGLKYQKKNDDDENEMSGNTEYCLELMKNORDNDDENGFEISSIL 
399 LDYLEQYNSSFDKIIGYKVTGWTFQPLENR ....... AQLSSSLDSIISRPP ...... KFVEYDLRAIR 
389 DEHLKIYREQYGAVLAFRPTGWTYS. . ........ EKIGEHLDLIKPTS. 
634 KHVANRYTNRYSLIVAFSPTGWTSG. . ...... KTKKKSPGRRLQQG. 
239 SIQTLEGLNTMCPTIGIMPSGLPWVKRPFKGDDKLSGSFLTASMKNETVSA. . .KKELE 
309 NEIMVEKG .. YDKVVGFVPTGWTYE. . ...... VKRNKFAVRF .. 
529 VOYFTEFEDQYDMLLGIRPSGWEKN. .SKPSY. 
502 YCEISQNSVIIDISMLY .... YTFGNGVN .. 
926 QSHLKKCGGKYDQILAFRPTGWTHS. .NNITSTADIIPQT. 
943 QSHLKKCGGKYNQILAFRPTGWTHS.. . .NKFTRIADVIPQT. 
229 HSAMLQWNQSHPTIAIFPTSRKVRS .. 
239 HSNMLRWNQTHPTIAILPTSRKIRS .. 
~80 ... ??MWFG .. 
271 PCGITSRNRIPLHIISIKPSTMWFG .. 
593 
455 
428 
'" 295 
342 
559 
527 
964 
981 
254 
264 
196 
308 
522 LENVDW. 
. ..... ERTRKTNVIVRT. 
. .. ERSRKTNVIVRT. 
365 PDIAEEFRAVRIKSYSASDKTRMLAKEKRWKRDSHSSLKRNKKRARIQVKCAKILEVD .. 
407 KDFLLGFYRQSYQKNEKSDVDVVSHSAEVYEEEEKNACEDGGENVPSSRGPILHDTTPSSDSRLLIKLRD 
623 GFQPSISTFLATPKRAFAKFSADTEMFLSPVDENASKGSEDKKDDDRESVVPTNHVTIISDTPEECFQTD 
318 MSSSSRKTNVLWQLERRLKRPRTQGVVFESPEEKANQVKVDROSKKRKKENLSPWAGHLERL.CPHPLQA 
327 MSSSSRKPSLLWLLERRLKRPRTQGVVFESPEESADQSQADRDSKKAKKEKLSPWPADLEKQPSHHPLRI 
255 PKYKPLGKLKRARTIHLDSEEDDD.LFDDPLPTPLRHKVPYQLTLQPELFSMKALPLDQPE.LRQSPGGC 
367 PKYKPLGKLKRARTVHRDSEEEDOYLFDDPLPIPLRRKVPYPETFHPEVFSMTAVSEKQPEKLRQTPGCC 
477 S~PAWVTEEQMLDLIKK~AGNPVDIVSNFYEYEAEiYKQASiPTPSLNNQAVLFDDDVTDLQPNPVRGIC 
693 SKIPVKNEPLAPOTSPNSEIV. 
387 RKQLFPOFCRKEROELVLFCOSNKMATVLTAPLEFSVQLQPIDE.FLFPETREKIGLESPLLSRGDS.GS 
397 KKQLFPDLYSKEWNKAVPFCESQKRVTMLTAPLGFSVHLRSTDEEFISQKTREEIGLGSPLVPMGDODGG 
323 KAESVWSPSLANFIDCEESNSDSGR?? .. 
437 RAECMQSSRFTNFVDCEESNSESEEEVGIPASLQGOLGSVLHLQKADGDVPQWEVFFKRNDEITDESLEN 
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ScSNM1 
SpSNM1 
AtSNM1 
AtSNM1B 
AtSNM1C 
AtSNM1D 547 PDVQAIQKGFDLPRKMNLTKGTISPGKRGKSSGSKSNKKAKKDPKSKPVGPGQPTLFKFFNKVLDGGSNS 
OmSNM1 
CeSNM1 
mSNM1 
hSNM1 
mSNM1B 
hSNM1B 
mSNM1C 
hSNM1C 
ScSNM1 
SpSNM1 
AtSNM1 
AtSNM1B 
AtSNM1C 
AtSNM1D 
OmSNM1 
CeSNM1 
mSNM1 
hSNM1 
455 P.ARGNQSDCVGCGSPPAHISRAVPL.TPESRGLALKYLLTPVHFLQAGFSSRNFDKQVEKHQRVQRSSP 
467 PEATGNQSAWMGHGSPLSHSSKGTPLLATEFRGLALKYLLTPVNFFQAGYSSRRFDQQVEKYHKPC. 
348 ??STFLCLPARYYSHNANILSRSGKHKCLNSSQSTHITDQGSQGWDSQCDTVLLSSQEKSGGDSTSLNKG 
507 FPSSTVAGGSQSPKLFSDSDGESTHISSQNSSQSTHITEQGSQGWDSQSDTVLVSSQERNSGDITSLDKA 
617 VSVGSETEECNTDKKMVHIDASEAYKEVTDQFIDIVNGSESLRDYAASIIDEAKGDISRALNIYYSKPRE 
mSNM1B 523 AVLSPVDVG. 
hSNM1B 
mSNM1C 416 AYKPKLKESISASQIEQDALCPQDTHCDLKSR.AEVNGAPCLVELDTLSGRKS.PPEKTLLS.STRADSQ 
hSNM1C 577 DYRPTIKENIPASLMEQNVICPKDTYSDLKSRDKDVTIVPSTGEPTTLSSETHIPEEKSLLNLSTNADSQ 
ScSNMl 
SpSNMl 
AtSNM1 
AtSNM1B 
AtSNM1C 
AtSNM1D 687 IPGDHAGERGLSSKTIQYPKCSEACSSQEDKKASENSGHAVNICVQTSAEESVDKNYVSLPPEKYQPKEH 
OmSNM1 
CeSNM1 
mSNM1 
hSNM1 
mSNM1B 
hSNM1B 
mSNM1C 483 SSSDFEIPSTPEAELPTPEHLQCLYRKLATGQSIVVEKRKCSLLDS. 
hSNM1C 647 SSSDFEVPSTPEAELPKREHLQYLYEKLATGESIAVKKRKCSLLDT. 
AtSNM1D 757 ACWREGQPAPYIHLVRTFASVESEKGKIKAMSMLCNMFRSLFALSPEDVLPAVYLCTNKIAADHEN!ELN 
AtSNM1D 827 IGGSLISSALEEACGISRSTVRDMYNSLGDLGDVAQLCRQTQKLLVPPPPLLVRDVFSTLRKISVQTGTG 
AtSNM1D 897 STRLKKNLIVKLMRSCREKEIKFLVRTLARNLRIGAMLRTVLPALGRAIVMNSFWNDHNKELSESCFREK 
AtSNM1D 967 LEGVSAAVVEAYNILPSLDVVVPSLMDKDIEFSTSTLSMVPGIPIKPMLAKIAKGVQEFFNLSQEKAFTC 
AtSNMlD 1037 EYKYDGQRAQIHKLLDGTVCIFSRNGDETTSRFPDLVDVIKQFSCPAAETFMLDAEVVATDRINGNKLMS 
AtSNM1D 1107 FQELSTRERGSKDALITTESIKVEVCVFVFDIMFVNGEQLLALPLRERRRRLKEVFPETRPGYLEYAKEI 
AtSNM1D 1177 TVSATVGAEEASLNNHDTLSRINAFLEEAFQSSCEGIMVKSLDVNAGYCPTKRSOSWLKVKRDYVDGLGD 
AtSNM1D 1247 TLDLVPIGAWYGNGRKAGWYSPFLMACFNPETEEFQSVCRVMSGFSDAFYIEVMKSSTLTLLFNDETDGM 
AtSNM1D 1317 KEFYSEDKILAKKPPYYRTGETPDMWFSAEVVWEIRGADFTVSPVHSASLGLVHPSRGISVRFPRFISKV 
AtSNM1D 1387 TDRNPEECSTATDIAEMFHAQTRKMNITSQH 
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SUMMARY 
The aim of my thesis was to investigate repair pathways for DNA interstrand cross-
link (ICL) repair. ICLs are formed by a number of anti-tnmor agents like mitomycin C 
and are one of the most toxic lesions to DNA. A number of different repair pathways are 
involved in ICL repair. One of these pathways is homologous recombination. First, I 
discuss homologous recombination and my work on mouse RAD54 and RAD54B, genes 
involved in this pathway. Then, I give an overview of ICL repair and my work on 
mammalian SNMJ, a gene involved in ICL repair. 
Homologous recombination 
Homologous recombination is one of the main pathways for the repair of DNA 
double-strand breaks (DSBs). DSBs occur in the cell endogenously during ICL repair and 
due to for example oxidative damage and stalled replication forks. External agents that 
induce DSBs are ionizing radiation and certain chemicals. Deficiencies in DSB repair 
pathways result in chromosomal instability and cell death. Two main pathways for DSB 
repair are homologous recombination and nonhomologous end-joining. Nonhomologous 
end-joining repairs a DSB by ligating the ends, either directly or after some processing. It 
may result in insertions, deletions, or translocations. 
Homologous recombination on the other hand uses homologous sequences, usually 
from the sister chromatid or the homologous chromosome to repair a DSB accurately. 
Key proteins involved in homologous recombination are the Rad52 group proteins, 
consisting of Rad51, Rad52, Rad54, and their paralogs. Furthermore, Mrell, Rad50, 
Xrs2/Nbsl, Radl/Xpf, RadlO/Erccl, and the mismatch repair proteins play a role in 
homologous recombination. The main subpathway of homologous recombination is gene 
conversion. In this pathway, the DSB ends are first nucleolytically processed to yield 
long 3' single-stranded DNA tails. The tails are coated with Rad51, forming a 
nucleoprotein filament. This process is stimulated by Rad52 and the yeast Rad51 
paralogs. The nucleoprotein filament searches the genome for homologous duplex DNA, 
it invades the homologous DNA and forms a joint molecule. Rad54 interacts with Rad51 
and can introduce unconstrained supercoils into the DNA. This supercoiling activity may 
facilitate the partial unwinding of the template double-stranded DNA, thereby stimulating 
strand invasion by the Rad51 nucleoprotein filament. After strand invasion, DNA 
synthesis elongates the DSB ends. Several models exist for the further steps of gene 
conversion. Either model or a combination of features from both models can explain the 
outcome of DSB repair in different assays. In the DSB gap repair model, a four-stranded 
structure is formed with so-called Holliday junctions. These are resolved and result in 
either gene conversion or gene conversion with crossover, in which flanking markers have 
been exchanged. Both the template and the broken DNA molecule contain newly-
synthesized DNA. In the alternative model, synthesis-dependent strand annealing, the 
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newly-synthesized DNA unwinds from the template DNA and anneals with the other end 
of the DSB. In this model, the template remains unchanged and no crossovers occur. 
There are several other subpathways of homologous recombination. One of these is 
break-induced replication, which has only been found in yeast. In break-induced 
replication, only the centromere-proximal end of the DSB invades homologous double-
stranded DNA, while the centromere-distal end is degraded. DNA synthesis from the 
invading end proceeds until the end of the chromosome, which results in a nonreciprocal 
translocation. Another, nonconservative homologous recombination pathway is single-
strand annealing (SSA). SSA can occur when two directly repeated sequences are present 
on either side of the DSB. During SSA, the two single-stranded DNA tails of the 
processed DSB anneal when the complementary sequences of the direct repeat are 
exposed. This results in deletion of one of the repeats and the intervening sequence. 
DSB repair assays have been set up in which repeated sequences are placed either on 
the same chromosome, measuring intrachromatid and sister chromatid recombination, or 
on homologous or heterologous chromosomes, measuring allelic and ectopic 
recombination, respectively. In one of the repeats, a site is created for a rare-cutting 
restriction enzyme. Expression of the enzyme induces a single, site-specific DSB. The 
contribution of the different subpathways of homologous recombination to the repair of 
this DSB can be assessed by the use of selection markers, PCR, and DNA blotting. These 
assays show that the different homologous recombination subpathways compete with each 
other. Similarly, homologous recombination competes with nonhomologous end-joining 
for the repair of DSBs. 
The role of mouse RAD54 in homologous recombination 
To investigate the contribution of different intrachromosomal homologous 
recombination repair pathways in both wild-type and RAD54-deficient mouse embryonic 
stem cells, we made use of a number of recombination-test substrates. These substrates 
consist of a hygromycin (hyg) gene surrounded by two nonfunctional neomycin (neo) 
genes. A site-specific DSB induced in one of the neo genes can be repaired by 
recombination with the other neo gene resulting in a functional neo gene. The substrates 
were all integrated at the same position in the mouse genome and only differ in the 
orientation of the neo genes. 
In the first substrate, SSA and gene conversion with crossover result in the same 
molecular outcome consisting of an intact neo gene with deletion of the hyg gene. Gene 
conversion without crossover results in intact neo and hyg genes. By selection for intact 
neo and/or hyg and DNA blotting, we showed that repair occurs mostly by SSA/crossover, 
and only in 15% of the cells by gene conversion. In RAD54-deficient cells, the 
contribution of gene conversion is two times lower, due to an increase in SSA/crossover 
events. In the second substrate, containing inversely oriented neo genes, the DSB cannot 
be repaired by SSA. Gene conversion is possible by intrachromatid and sister chromatid 
recombination, but crossover can only occur after intrachromatid recombination. With 
this substrate, crossovers are hardly recovered, and deletion of RAD54 has no effect. The 
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third substrate measures DSB repair by either gene conversion using the same chromatid 
or the sister chromatid, or by crossover using the sister chromatid. Tbe DSB can be 
repaired by SSA, but those events yield no intact neo gene and are not recovered. In this 
substrate, gene conversion with and without crossover are equally frequent. Disruption of 
RAD54 results in a 30% decrease of both gene conversion and crossover. Independent 
experiments, measuring mitomycin C-induced sister chromatid exchanges, the cytological 
equivalent of crossover events, showed a reduction in crossovers in R.AD54-deficient cells, 
consistent with the results using the third substrate. 
These results indicate that both SSA and gene conversion play a major role in the 
recombinational repair of the recombination-test substrates. The preferential template for 
gene conversion and crossover events appears to be the sister chromatid and not the neo 
gene on the same chromatid. The results suggest that Rad54 promotes error-free gene 
conversion using the sister chromatid at the expense of error-prone SSA. 
Mouse Rad54B 
Mouse Rad54 has a sequence homolog called Rad54B. Rad54B probably also 
functions in homologous recombination, as embryonic stem cells deficient for Rad54 and 
Rad54B are more sensitive to ionizing radiation than Rad54-deficient cells. Our 
preliminary experiments on Rad54B showed that mouse Rad54B is located in the nucleus. 
It interacts with Rad51 both after immunoprecipitation from cellular extracts containing 
overexpressed Rad54B and after immunoprecipitation from in vitro translated proteins. 
Homomeric interaction ofRad54B, mediated by its carboxy terminus, was also observed. 
DNA interstrand cross-link repair 
Anti-tumor agents like mitomycin C, nitrogen mustards, and nitrosoureas mainly 
derive their toxicity from the formation of ICLs, even though ICLs constitute only a few 
percent of the lesions they induce. ICLs are very toxic to cells because they establish a 
stable link between the two strands of the DNA double helix, thereby preventing 
separation of the two strands. This separation is necessary for DNA replication and 
transcription. The repair of ICLs is complex and requires the co-operation of different 
DNA repair pathways, like nucleotide excision repair (NER), homologous recombination, 
and postreplicationltranslesion repair. ICL repair in bacteria has been characterized both 
genetically and biochemically. NER enzymes are supposed to make incisions in one 
strand surrounding the ICL. Then, homologous recombination can take over and perform 
strand exchange with intact homologous DNA past the lesion. Alternatively, translesion 
DNA polymerases synthesize DNA across the lesion in an error-prone fashion. Finally, 
NER enzymes excise the ICL from the other DNA strand. 
In yeast, these repair pathways may also function, but besides, DSBs are often formed 
during ICL repair. They may be produced by NER euzymes making incisions in opposite 
strands close to each other, by other nucleases, or by the stalling of replication forks at the 
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ICL. Putative models for ICL repair can be depicted which include the occurrence of a 
DSB during ICL repair and its repair by homologous recombination. Homologous 
recombination in the repair of one DSB next to an ICL includes elements from either 
break-induced replication or gene converswn and SSA. Together with 
postreplication/translesion repair, homologous recombination could also bypass an ICL 
during replication. Apart from genes belonging to these major repair pathways, a few 
genes have been isolated in yeast that are involved only in ICL repair, like SNM1/PS02. 
Compared to ICL repair in yeast, even less is known about mammalian ICL repair, 
although many mammalian cell mutants have been found that confer sensitivity to ICL 
agents. The same major DNA repair pathways are involved in ICL repair in yeast and 
mammalian cells, suggesting that repair follows similar schemes. An important difference 
between yeast and mammalian cells is the extreme ICL agent sensitivity of ERCCJ and 
XPF mutant mammalian cells, compared to other NER mutants, while in yeast all NER 
mutants are equally sensitive. Erccl-Xpfmay be the only enzyme from the NER system 
involved in making incisions in mammalian cells, but it may also have additional roles, 
like the removal of nonhomologous tails during SSA. Furthermore, mammalian ICL 
repair is more complex than yeast repair, with more proteins involved in the (regulation 
of) ICL repair. Examples are the Rad51 paralogs, the breast-cancer associated proteins, 
and the Fanconi anemia proteins. 
Mouse SNMJ and ICL repair 
To investigate ICL repair in mammalian cells, we have analyzed the human and 
mouse homologs of the yeast SNMJ gene. Yeast snml mutants are sensitive to ICL 
agents, but they are hardly or not sensitive to UV 254 nm and ionizing radiation, and the gene 
does not belong to one of the main DNA repair pathways. Database searches revealed the 
existence of three mammalian Snrnl paralogs. Human Snml is a nuclear protein with the 
nuclear localization signal at the amino terminus. We isolated mouse SNMJ, and made 
embryonic stem cells deficient for SNMJ. These cells are sensitive to mitomycin C, but 
they are not sensitive to other ICL agents, UV254 nm, or ionizing radiation. The lack of 
sensitivity to other ICL agents could be explained by redundancy with the other SNMJ 
genes, or with other repair pathways. Mitomycin C-induced sister chromatid exchanges 
and Rad51 foci formation, two parameters indicative for homologous recombination, are 
not affected in SNMJ-deficient cells, suggesting that SNMJ is not involved in the 
homologous recombination pathway of ICL repair. SNMJ-deficient mice were also 
generated. They are viable, show no major abnormalities, and are also sensitive to 
mitomycin C. The ICL sensitivity of mammalian SNMJ mutants suggests that SNMJ 
function, and, by implication, ICL repair are at least partially conserved between yeast and 
mammals. 
170 
EENVOUDIGE SAMENVATTING 
Dit proefschrift beschrijft een stndie naar het herstel van schade aan het DNA in 
zoogdiercellen. Zoogdieren bestaan uit miljarden cellen, die vrijwel allemaal een kern 
bezitten waarin DNA zit opgeborgen. Bij de mens is het DNA aanwezig als 46 lange 
strengen, die samen uitgerekt wei twee meter lang zijn en in de kern opgerold liggen. 
DNA is de stof die de erfelijke informatie bevat die wordt doorgegeven aan het 
nageslacht. Het DNA van bijna iedere eel is gelijk en bevat alle benodigde informatie om 
eiwitten te maken. De eiwitten zijn nodig als bouwstenen voor de eel, als machines om de 
eel draaiende te houden en als boodschappers. DNA is vergelijkbaar met een groot 
kookboek vol recepten, waarvan elke eel die voorschriften gebruikt die hij nodig heeft. In 
het DNA staan deze recepten, de genen, allemaal achter elkaar op de 46 lange regels. 
Elke eel heeft twee versies van dit kookboek: 66n afkomstig van de vader en een van de 
moeder. Deze twee versies lijken sterk op elkaar, ze bevatten het voorschrift voor 
dezelfde gerechten (zoals oogkleur) maar kunnen verschillen in de precieze beschrijving 
van de recepten (wat bijvoorbeeld resulteert in blauwe of bruine ogen). Als een eel zich 
gaat delen, wordt al het DNA exact gekopieerd en krijgen beide dochtercellen vervolgens 
een eigen kopie. 
Door verschillende oorzaken kan het DNA beschadigd worden. De typen schade die 
hier behandeld worden zijn dubbelstrengs breuken en kruisverbindingen. Dubbelstrengs 
breuken zijn vergelijkbaar met het uit elkaar scheuren van het kookboek, waardoor 
verschillende delen van een recept uit elkaar raken en het recept onbruikbaar wordt. 
Zulke breuken kunnen bijvoorbeeld ontstaan door rontgenstraling. Kruisverbindingen zijn 
vergelijkbaar met grote vlekken die het recept onleesbaar maken en worden onder andere 
gevormd door bepaalde anti-kanker geneesmiddelen. Kennis van DNA schade en herstel 
is daarom ook van belang voor de behandeling van kanker. De eel lieeft verscliillende 
mechanismen om schade aan het DNA te herstellen en gebruikt daarvoor bepaalde 
groepen eiwitten. Een van de mechanismen om dubbelstrengs breuken te herstellen wordt 
ook gebruikt tijdens het herstel van kruisverbindingen, omdat daarbij ook breuken kunnen 
ontstaan. 
Zoals beschreven in hoofdstnk 1, kunnen dubbelstrengs breuken worden hersteld door 
de DNA fragmenten weer aan elkaar vast te plakken,. Bij een van de breukberstel 
mechanismen van de eel worden de gescheurde stukken gewoon aan elkaar geplakt. Als 
de stnkken niet op de goede plaats geplakt worden, of er stukjes verloren raken, kunnen de 
recepten onleesbaar worden. Het breukherstel mechanisme waar ik onderzoek naar heb 
gedaan, werkt op een andere manier en gebruikt ook andere herste1 eiwitten. Deze 
zogenaamde homologe recombinatie maakt gebruik van het feit dat de eel altijd een 
tweede, vergelijkbare versie van het DNA heeft en dat er vlak voor het delen van een eel 
ook nog een exacte kopie aanwezig is. Een van deze intacte kopieen wordt opgezocht en 
naast het gebroken DNA gelegd. Ontbrekende informatie wordt overgeschreven en de 
losse stukken worden weer op hun goede plaats vastgeplakt. In onderzoek naar homologe 
recombinatie worden vaak twee vrijwel gelijke varianten van zo'n recept dicht achter 
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elkaar in het DNA gezet. Vervolgens wordt gecontroleerd een breuk gernaakt in een van 
deze twee varianten en wordt gekeken naar het herstel. De eel kan in plaats van een van 
de intacte kopieen nu ook de tweede variant in dezelfde DNA regel gebruiken om de 
breuk te repareren. Naast het hiervoor beschreven 'nette' homologe recombinatie herstel 
is in dat geval ook 'slordig' hornoloog recombinatie herstel rnogelijk. Daarbij voegt de 
eel de twee varianten sarnen tot een recept, en verwijdert het tussenliggende stuk, 
waardoor de regel korter word!. 
In rnijn onderzoek heb ik twee zulke vrijwel gelijke varianten van een recept gebruikt 
die ik naast elkaar in verschillende volgorde in het DNA bracht van ernbryonale 
rnuizencellen (hoofdstuk 2). Daama rnaakte ik een dubbelstrengs breuk in een van deze 
varianten met een speciaal eiwit, dat werkt als een schaar. Vervolgens heb ik gekeken hoe 
de eel deze breuk repareert via homologe recombinatie. Zowel de 'nette' als de 'slordige' 
marrier van herstel werd gebruikt in deze cellen, met een voorkeur voor de 'slordige' 
methode. Als de breuk netjes werd gerepareerd, bleek de eel een voorkeur te hebben voor 
het gebruik van de tweede kopie van het DNA, in plaats van het gebruik van de variant op 
hetzelfde DNA. Een van de eiwitten die van belang zijn bij hornologe recombinatie is 
Rad54. Het effect van Rad54 op het herstel van een dubbelstrengs breuk heb ik 
onderzocht door de dubbelstrengs breuk te maken in cellen waarin geen Rad54 eiwit 
aanwezig is. Het bleek dat in deze cellen de breuk vee! vaker hersteld werd op de 
'slordige' manier en minder vaak op de 'nette' marrier. De conclusie van het onderzoek is 
dan ook dat Rad54 herstel op de 'nette' marrier stimuleert ten koste van 'slordig' herstel. 
Een verklaring hiervoor is dat Rad54 helpt bij het opzoeken van de intacte kopie wanneer 
er een breuk is ontstaan. Voor herstel op de 'slordige' marrier hoeft er niet in het hele 
kookboek gezocht te worden, maar word! de tweede variant iets verderop in dezelfde regel 
gebruikt. Dat kan blijkbaar zonder het gebruik van Rad54. 
Hoofdstuk 3 beschrijft mijn werk aan muizen-Rad54B, een eiwit dat erg lijkt op 
Rad54. Rad54B bleek net als Rad54 in de kern te zitten, de plaats waar DNA herstel 
immers moet plaatsvinden. Daarnaast heb ik gevonden dat het een interactie kan aangaan 
met zichzelf en met Rad51, een ander eiwit dat in homo loge recombinatie een belangrijke 
rol speelt. Dit alles suggereert dat ook Rad54B bij homologe recombinatie betrokken is. 
Het tweede dee! van het proefschrift (hoofdstuk 4 en 5) behandelt het herstel van 
kruisverbindingen in het DNA. Hierover is om verschillende redenen nog niet zoveel 
bekend. Stoffen die kruisverbindingen maken, veroorzaken narnelijk ook allerlei andere 
schade in het DNA. Het is bovendien nog niet mogelijk gecontroleerd een specifieke 
kruisverbinding in het DNA aan te brengen en dan het herstel te analyseren, zoals ik dat 
heb gedaan met een dubbelstrengs breuk. Voor het herstellen van kruisverbindingen 
combineert de eel verschillende mechanismen die ook voor het herstel van andere schade 
gebruikt worden. Zo kan de kruisverbinding gedeeltelijk uit het DNA geknipt worden 
door eiwitten die ook worden gebruikt om schade door UV straling in zonlicht te 
herstellen. De vlek word! dan uit het kookboek geknipt. Vervolgens kan het ontstane gat 
door homo loge recomb ina tie worden opgevuld door het gebruik van een intacte kopie. Er 
is ook een altematief herstelmechanisrne dat geen intacte kopie nodig heeft. Bij dit 
mechanisrne vervangt de eel de vlek door te proberen door de vlek heen de tekst te 
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ontcijferen en -waar die onleesbaar is- zelfiets in te vullen. Het resultaat is wel dater veel 
meer leesfouten ontstaan. 
Naast de eiwitten die ook bij andere herstel mechanismen gebruikt worden, zijn er 
ook eiwitten die aileen bij het herstel van kruisverbindingen betrokken zijn. Een van deze 
eiwitten is Snml. Daarvan heb ik onderzocht wat zijn rol is in zoogdiercellen (hoofdstuk 
5). Snml bleek, net als Rad54, een eiwit in de kern te zijn. Het was bekend dat bij 
gistcellen het ontbreken van het Snml eiwit ertoe leidt dat de cellen gevoelig worden voor 
stoffen die kruisverbindingen rnaken, waarschijnlijk orndat het herstel van 
kruisverbindingen niet goed verloopt. In embryonale muizencellen heb ik het gen voor 
Snml uitgeschakeld en daarrnee het recept voor Snml onleesbaar gemaakt, waardoor deze 
cellen het intacte eiwit missen. Net zoals de gistcellen waren deze muizencellen niet 
gevoeliger voor UV of r6ntgenstraling, maar ze waren wel gevoeliger voor mitomycine C, 
een stof die kruisverbindingen maakt. In tegenstelling tot gistcellen waren ze niet 
gevoelig voor een aantal andere stoffen die kruisverbindingen maken. Een reden hiervoor 
kan zijn dat zoogdiercellen nog twee andere eiwitten hebben die erg op Snml lijken en 
misschien ook de functie van Snrnl gedeeltelijk kunnen ovemernen. Daamaast heb ik 
Snml ook uitgeschakeld in muizen. Deze muizen waren levensvatbaar en groeiden 
normaal. Ze waren echter wel gevoeliger voor mitomycine C dan muizen die wel Snml 
bezitten. Bij een paar testen die aangeven of de homologe recombinatie gestoord is 
tijdens het herstel van kruisverbindingen, was geen verschil te zien tussen muizencellen 
die wel en die geen intact Snrnl eiwit hebben. Snml lijkt dus ook bij rnuizen wel een rol 
te spelen in het herstel van kruisverbindingen, maar niet via het mechanisme van 
homologe recombinatie. 
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